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  Deux	  intellectuels	  assis	  vont	  moins	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  taxi	  pour	  Toubrouk	  (1961)	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SUMMARY	  	  Research	  on	  the	  malaria	  parasite	  Plasmodium	  vivax	  (P.	  vivax)	  lags	  behind	  the	  one	  on	  Plasmodium	  
falciparum	  (P.	  falciparum).	  This	  applies	  also	  to	  the	  parasite’s	  biology	  as	  an	  in	  vitro	  culture	  of	  the	  P.	  
falciparum	  blood	  cycle	  is	  already	  available.	  Conversely,	  despite	  several	  attempts,	  a	  reliable	  and	  reproducible	  P.	  vivax	  in	  vitro	  culture	  is	  not	  currently	  available.	  One	  of	  the	  main	  obstacles	  is	  represented	  by	  the	  P.	  vivax	  preference	  for	  invading	  young	  erythrocyte,	  named	  reticulocytes.	  The	  proportion	  of	  reticulocytes,	  among	  circulating	  red	  blood	  cells,	  in	  the	  adult	  blood	  stream	  is	  extremely	  low	  (0.5-­‐1%)	  and	  their	  lifespan	  (in	  the	  blood	  stream)	  is	  only	  1	  day.	  	  Therefore,	  it	  is	  extremely	  difficult	  to	  obtain	  from	  the	  peripheral	  blood	  an	  adequate	  amount	  of	  reticulocytes	  able	  to	  support	  a	  P.	  vivax	  in	  vitro	  culture.	  	  	  To	  tackle	  this	  problem	  and	  been	  able	  to	  provide	  a	  sufficient	  amount	  of	  target	  cells	  to	  maintain	  the	  parasite	  cycle,	  the	  production	  of	  reticulocytes	  starting	  from	  hematopoietic	  stem	  cells	  (HSC),	  erythrocytes	  progenitors,	  has	  been	  investigated.	  	  HSC	  are	  multipotent	  cells,	  with	  properties	  of	  self-­‐renewal	  and	  erythroid	  differentiation.	  	  Following	  a	  14-­‐day	  protocol,	  reticulocytes	  could	  be	  produced	  from	  3	  different	  sources	  of	  HSC,	  namely	  	  cord	  blood	  (CB,	  18%	  reticulocytes),	  bone	  marrow	  (BM,	  21%	  reticulocytes)	  and	  peripheral	  blood	  mononuclear	  cells	  (PBMC,	  31%	  reticulocytes).	  Reticulocytes	  derived	  from	  any	  of	  these	  sources	  could	  be	  invaded	  by	  P.	  vivax	  and	  some	  re-­‐invasion	  could	  be	  observed	  after	  3	  days.	  Nevertheless,	  no	  real	  in	  vitro	  multiplication	  could	  be	  observed.	  	  The	  possibility	  to	  expand	  the	  population	  of	  HSC	  following	  a	  simple	  5	  days	  protocol	  (10	  fold	  expansion	  for	  CB	  and	  3	  fold	  expansion	  for	  BM)	  coupled	  with	  the	  possibility	  to	  cryopreserve	  reticulocytes	  produced	  allow	  the	  creation	  of	  a	  stock	  of	  reticulocytes	  ready	  to	  be	  used	  for	  a	  continuous	  culture.	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We	  also	  investigated	  the	  influence	  of	  hemoglobin	  in	  the	  development	  of	  P.	  falciparum	  and	  P.	  vivax.	  After	  5	  days,	  P.	  falciparum	  continuous	  synchronous	  culture	  was	  observed	  with	  fetal	  hemoglobin	  (HbF)	  while	  asynchronization	  occurred	  with	  adult	  hemoglobin	  (HbA).	  P.	  vivax	  invasion	  rates	  did	  not	  differ	  according	  to	  the	  type	  of	  hemoglobin	  present	  in	  culture.	  	  	  In	  conclusion,	  P.	  vivax	  could	  invade	  reticulocytes	  produced	  in	  vitro	  from	  HSPC,	  regardless	  of	  their	  source.	  The	  possibility	  of	  expanding	  the	  precursor	  cells	  and	  of	  cryopreserving	  the	  reticulocytes	  produced	  allows	  the	  creation	  of	  adequate	  stocks	  of	  target	  cells	  that	  could	  maintain	  a	  continuous	  culture.	  Nevertheless,	  it	  was	  no	  possible	  to	  achieve	  the	  ultimate	  goal	  of	  a	  continuous	  P.	  vivax	  culture,	  though	  such	  failure	  cannot	  be	  explained	  by	  reticulocyte	  quality	  or	  the	  type	  of	  hemoglobin.	  Some	  elements/factors,	  currently	  unknown,	  are	  probably	  essential	  for	  the	  maintenance	  of	  the	  culture.	  Metabolomics	  studies	  comparing	  in	  
vivo	  and	  in	  vitro	  infections	  may	  be	  able	  to	  identify	  the	  missing	  elements	  necessary	  for	  the	  in	  vitro	  growth	  of	  P.	  vivax.	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SAMENVATTING	  	  Onderzoek	  naar	  de	  malariaparasiet	  Plasmodium	  vivax	  (P.	  vivax)	  loopt	  achter	  op	  dat	  naar	  Plasmodium	  
falciparum	  (P.	  falciparum).	  Dit	  geldt	  zeker	  ook	  voor	  de	  biologie	  van	  de	  parasiet	  aangezien	  er,	  ondanks	  verschillende	  pogingen,	  enkel	  een	  in	  vitro	  cultuursysteem	  van	  de	  	  P.	  Falciparum	  bloedcyclus	  beschikbaar	  is,	  en	  geen	  betrouwbare	  en	  reproduceerbare	  in	  vitro	  kweek	  van	  P	  vivax	  mogelijk	  is.	  Een	  van	  de	  belangrijkste	  obstakels	  voor	  de	  in	  vitro	  expansie	  van	  P	  vivax	  is	  de	  voorkeur	  van	  de	  parasiet	  voor	  het	  binnenvallen	  van	  jonge	  erytrocyten	  ,	  genaamd	  reticulocyten	  .	  Het	  percentage	  reticulocyten	  onder	  circulerende	  rode	  bloedcellen	  in	  de	  volwassen	  bloedstroom	  is	  extreem	  laag	  (	  0,5-­‐1	  %	  )	  en	  hun	  levensduur	  (	  in	  het	  bloed	  )	  is	  slechts	  1	  dag	  .	  Daarom	  is	  het	  uiterst	  moeilijk	  om	  de	  hoeveelheden	  reticulocyten	  die	  nodig	  zijn	  om	  P.	  vivax	  in	  vitro	  te	  ondersteunen	  te	  verkrijgen	  uit	  bloed.	  	  Om	  de	  parasietcyclus	  te	  voorzien	  van	  een	  voldoende	  hoeveelheid	  targetcellen	  werd	  de	  generatie	  van	  reticulocyten	  canuit	  hemapoietische	  stamcellen	  (HSC),	  voorlopers	  van	  de	  errythrocyten,	  onderzocht.	  HSC	  zijn	  multipotente	  cellen	  met	  zowel	  de	  capaciteit	  to	  zelf	  vernieuwing	  als	  die	  tot	  erytrocyt	  differentiatie.	  	  Met	  behulp	  van	  een	  protocol	  van	  14	  dagen	  konden	  we	  reticulocyten	  genereren	  vanuit	  3	  verschillende	  bronnen	  van	  HSC,	  namelijk	  navelstrengbloed	  (CD,	  18%	  reticulocyten),	  beenmerg	  (BM,	  21%	  reticulocyten)	  en	  perifere	  mononucleaire	  bloedcellen	  (PBMC,	  31%	  reticulocyten).	  Er	  kon	  invasie	  worden	  aangetoond	  in	  reticulocyten	  gegenereerd	  van	  elk	  van	  de	  drie	  bronnen	  maar,	  ondanks	  de	  observatie	  van	  enkele	  herinvasies	  na	  drie	  dagen,	  werd	  er	  geen	  echte	  in	  vitro	  multiplicatie	  waargenomen.	  	  De	  mogelijkheid	  om	  de	  HSC	  populatie	  te	  expanderen	  gebruik	  makend	  van	  een	  simpel	  5	  dagen	  durend	  protocol	  (10-­‐voudige	  expansie	  voor	  CB	  en	  3-­‐voudige	  expansie	  voor	  BM),	  gekoppeld	  met	  de	  mogelijkheid	  om	  reticulocyten	  in	  te	  vriezen,	  liet	  wel	  toe	  een	  reticulocytenstock	  aan	  te	  maken	  voor	  gebruik	  in	  een	  continue	  cultuur.	  Verder	  hebben	  we	  ook	  de	  invloed	  van	  hemoglobine	  onderzocht	  op	  de	  ontwikkeling	  van	  P.	  Falciparum,	  	  P.	  
Vivax	  	  en	  een	  continue,	  synchrone	  cultuur	  van	  P.	  Falciparum	  met	  foetale	  hemoglobine	  (HbF).	  Dit	  terwijl	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desynchronisatie	  reeds	  optrad	  na	  5	  dagen	  wanneer	  gebruik	  werd	  gemaakt	  van	  adulte	  hemoglobine(HbA).	  Voor	  P.	  Vivax	  	  bleek	  de	  invasie-­‐efficientie	  niet	  afhankelijk	  van	  het	  gebruikte	  hemoglobinetype.	  Om	  samen	  te	  vatten	  hebben	  we	  aangetoond	  dat	  invasie	  mogelijk	  is	  van	  	  in	  vitro	  van	  HSC	  geproduceerde	  reticulocyten,	  en	  dit	  onafhankelijk	  van	  hun	  bron.	  De	  mogelijkheid	  om	  de	  precursorcellen	  te	  expanderen	  en	  de	  reticulocyten	  te	  cryopreserveren	  liet	  ons	  toe	  voldoende	  grote	  stocks	  aan	  te	  maken	  om	  een	  continue	  cultuur	  te	  onderhouden.	  Ondanks	  dit	  was	  het	  niet	  mogelijk	  om	  het	  uiteindelijke	  doel,	  een	  continue	  in	  vitro	  cultuur	  van	  P	  vivax,	  te	  bekomen.	  	  Dit	  kon	  echter	  niet	  worden	  verklaard	  door	  de	  kwaliteit	  van	  gegenereerde	  reticulocyten	  of	  door	  het	  type	  hemaglobine.	  Waarschijnlijk	  zijn	  sommige	  nog	  ongekende	  elementen	  essentieel	  voor	  het	  onderhouden	  van	  de	  cultuur.	  Een	  studie	  waarin	  het	  metaboloom	  wordt	  bestudeerd	  tijdens	  in	  vitro	  en	  in	  vivo	  infecties	  zou	  de	  onberekende	  elementen	  die	  nodig	  zijn	  voor	  een	  in	  vitro	  groei	  van	  de	  parasiet	  P	  vivax	  kunnen	  identificeren.	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INTRODUCTION:	  	  
Chapter	  I:	  Malaria	  	  
Numbers	  and	  facts	  	  Malaria	  is	  a	  parasitic	  disease	  due	  to	  a	  protozoa	  of	  the	  order	  of	  haemosporida	  genus	  Plasmodium	  [1].	   More	   than	   200	   Plasmodium	   species	   can	   infect	   different	   hosts	   (avian,	   monkey,	   mouse…)	  though	   only	   five	   of	   them,	   P.	   falciparum,	   P.	   vivax,	   P.	   ovale	   (P.	   ovale	   curtisi	  and	   P.	  wallikeri),	   P.	  
malariae	  and	  P.	  kwnolesi,	   can	   infect	  humans.	   In	  2010,	   it	  was	   estimated	   there	  were	   about	  219	  million	   malaria	   cases	   and	   nearly	   660	   000	   malaria-­‐related	   deaths	   (WHO	   report	   2012).	  Artemisinin-­‐based	   combination	   therapies	   (ACTs)	   are	   the	   currently	   recommended	   first	   line	  treatment	  for	  uncomplicated	  P.	  falciparum	  malaria	  (WHO,	  2012).	  For	  severe	  malaria,	  regardless	  of	  the	  parasite	  species,	  intravenous	  artesunate	  or	  quinine,	  when	  the	  former	  is	  not	  available,	  are	  recommended.	   P.	   vivax	   uncomplicated	   malaria	   may	   still	   be	   treated	   with	   chloroquine	   and	  primaquine,	   the	   latter	   to	   clear	   the	   liver	   stages	  of	   the	  parasite.	  Most	   antimalarial	   drugs	   target	  schizonts	   by	   blocking	   the	   detoxification	   of	   the	   heme	   (during	  hemoglobin	  digestion),	  which	   is	  toxic	  for	  the	  parasite	  [3].	  However,	  parasites	  can	  develop	  resistance	  to	  treatment;	  for	  example	  P.	   falciparum	   parasites	   with	   particular	  mutations	   in	   the	   Plasmodium	   falciparum	   Chloroquine	  Resistance	  transporter	  gene	  (pfCRT)	  are	  able	  to	  reduce	  the	  concentration	  of	  chloroquine	  inside	  their	  digestive	  vacuole	  and	  hence	  escape	  to	  the	  drug	  activity	  [4].	  	  
	  
Life	  cycle	  (fig.1)	  	  During	   a	   blood	  meal	   on	   a	   malaria-­‐infected	   person,	   mosquitoes	   may	   ingest	   also	   gametocytes	  present	   in	   the	   blood.	   If	   this	   occurs,	   a	   male	   and	   female	   gametocyte	   fuse	   to	   give	   rise	   to	   an	  ookinete	  that	  migrates	  through	  the	  mosquito’s	  midgut	  where	  it	  further	  develops	  into	  an	  oocyst.	  The	  latter,	  at	  the	  end	  of	  its	  development,	  will	  release	  sporozoites	  that	  migrate	  to	  the	  mosquito’s	  salivary	  glands,	  to	  be	  injected	  in	  the	  human	  host	  at	  the	  next	  blood	  meal.	  	  The	  cycle	  in	  the	  vector	  is	  known	  as	  the	  sexual	  cycle	  of	  the	  parasite.	  	  When	   released	   into	   the	   blood	   stream,	   at	   the	   time	   of	   a	   mosquito	   bite,	   sporozoites	   migrate	  rapidly	   to	   the	   liver	   where	   they	   will	   invade	   hepatocytes.	   Here	   they	   will	   initiate	   a	   phase	   of	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multiplication	   resulting	   in	   the	   formation	   of	   an	   exo-­‐erythrocytic	   schizont	   that	   will	   release	  merozoites	   in	   the	   bloodstream.	  Within	   seconds,	   they	   will	   adhere	   and	   invade	   red	   blood	   cells	  (RBC),	   where	   the	   parasite	   will	   develop	   into	   different	   stages	   (fig.2).	   The	   ring	   stage	   is	  characterized	  by	  the	  presence	  of	  large	  chromatin	  dots	  and	  a	  cytoplasm	  with	  a	  ring-­‐form.	  This	  is	  followed	   by	   the	   trophozoite	   stage,	   with	   an	   amoeboid	   shape	   and	   pigment	   dots,	   known	   as	  hemozoin,	   which	   are	   the	   result	   of	   the	   hemoglobin	   digestion.	   Finally,	   the	   schizont	   stage	   will	  mature	   and	   produce	   a	   new	   generation	   of	  merozoites	   to	   be	   released	   in	   the	   blood	   stream	   and	  invade	   new	   RBC.	   The	   parasite	   reproduces	   asexually	   during	   the	   exo-­‐erythrocytic	   and	  erythrocytic	  cycles	  in	  the	  human	  host.	  Following	   a	   stress	   signal	   (parasite	   density,	   anemia,	   immune	   response),	  malaria	   parasites	  will	  also	   produce	   gametocytes	   (microgametocyte	   male	   and	   macrogametocyte	   female)	   that	   will	  continue	  the	  sexual	  cycle	  in	  the	  vector.	  	  
	  	  
	  	  	  	  
Fig.2:	  Different	  stages	  of	  
Plasmodium	  blood	  cycle	  (Maier	  et	  al.,	  	  Nature	  Rev.	  Microbiol	  2009)	  
Fig	  1:	  Life	  cycle	  of	  malaria	  	  Parasite	  (source:	  CDC)	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Malaria	  epidemiology	  	  Malaria	  is	  a	  tropical	  disease	  that	  is	  located	  mainly	  in	  sub-­‐Saharan	  Africa,	  the	  Amazonian	  region	  and	  South-­‐east	  Asia	  (fig	  3).	  Malaria	  transmission	  can	  be	  perennial	  and	  occur	  the	  whole	  year	  or	  seasonal,	  during	  a	   few	  months,	  mostly	   coinciding	  with	   rainfalls.	   It	   can	  also	  be	   stable,	  when	   it	  does	   not	   vary	   substantially	   between	   years,	   even	   if	   it	   is	   seasonal,	   or	   unstable,	   with	   marked	  variation	  between	  years	  [5].	  	  
P.	   vivax	   transmission	   occurs	  mainly	   in	   South-­‐east	   Asia	   and	   South	   America	  while	   it	   is	   almost	  absent	   in	  Africa	   (fig.4).	   This	   is	   related	   to	   the	  distribution	  of	   the	  Duffy	   receptor	   in	   the	  human	  population,	  a	  receptor	  found	  on	  the	  surface	  of	  the	  RBC	  (fig.5).	  Indeed,	  the	  human	  population	  in	  sub-­‐Saharan	   Africa	   is	   mainly	   Duffy	   negative	   and	   this	   could	   explain	   the	   paucity	   of	   P.	   vivax	  malaria	  as	  the	  Duffy	  receptor	  is	  important	  for	  the	  invasion	  of	  RBC.	  	  	  	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  
Fig	  3:	  Map	  of	  the	  malaria	  global	  	  distribution	  (source:	  CDC)	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Fig	  4.	  :	  Map	  of	  Plasmodium	  	  vivax	  distribution	  in	  2010.	  	  
Fig	  5.	  :	  Map	  of	  the	  duffy	  	  Negative-­‐population	  	  distribution	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Chapter	  II:	  Plasmodium	  vivax	  
	  
Characteristics	  	  
P.	   vivax	   has	   some	   specific	   features.	   One	   of	   the	   most	   important	   is	   its	   capacity	   to	   produce	  dormant	   forms	   (hypnozoites)	   in	   the	   human	   liver	   [6]:	   once	   entered	   in	   the	   liver	   under	   a	  sporozoite	   form,	  P.	  vivax	  can	  either	  develop	  into	  schizont	  and	  release	  merozoites	   in	  the	  blood	  stream	   or	   stop	   its	   development	   and	   remain	   dormant	   until	   an	   unknown	   signal	   activates	   it	   to	  continue	  its	  development	  into	  schizont	  and	  then	  merozoites	  to	  be	  released	  in	  the	  blood	  stream,	  resulting	  	  in	  a	  relapse	  [7].	  Another	   specific	   trait	   of	   P.	   vivax	   is	   its	   preference	   to	   invade	   young	   erythrocytes	   (named	  reticulocytes)	   [8]	   using	   the	   Duffy	   receptor	   (DARC)	   on	   reticulocyte’s	   surface	   and	   the	   PvDBP	  (Plasmodium	   vivax	   Duffy	   Binding	   Protein)	   [9].	   Such	   exclusive	   interaction	  with	   the	   DARC	   has	  been	   recently	   questioned	   as	   there	   have	   been	   reports	   of	   P.	   vivax	   cases	   in	   Duffy	   negative	  individuals	   from	   Sub-­‐Saharan	   Africa	   and	   the	   Amazonian	   region,	   suggesting	   that	   other	  unidentified	  parasite’s	  and	  reticulocyte’s	  receptors	  are	  involved	  in	  the	  invasion	  process	  [10].	  Morphologically,	  P.	  vivax	   can	   be	   discriminated	   from	  other	   plasmodium	   species	   by	   identifying	  the	  presence	  of	   Shuffner’s	   dots	   (brick-­‐red	  dots)	   in	   the	   cytoplasm	  of	   the	   infected	   reticulocyte.	  The	   infected	   reticulocyte	   is	   also	   larger	   than	   a	   P.	   falciparum	   infection	   and	   the	   P.	   vivax	  trophozoite	  has	  an	  “amoeboid”	  shape.	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Plasmodium	  vivax	  in	  vitro	  culture	  
	  	  Keywords:	  Malaria,	  Plasmodium	  vivax,	  in	  vitro	  culture,	  reticulocyte	  	  	  
Abstract	  The	  development	  of	  a	  continuous	  Plasmodium	  vivax	  blood	  cycle	  in	  vitro	  was	  first	  attempted	  one	  hundred	  years	  ago.	  Since	  then,	  and	  despite	  the	  use	  of	  different	  methods,	  only	  short-­‐term	  cultures	  have	  been	  achieved	  so	  far.	  The	  available	  literature	  has	  been	  reviewed	  in	  order	  to	  provide	  a	  critical	  overview	  of	  the	  currently	  available	  knowledge	  on	  P.	  vivax	  blood	  cycle	  culture	  systems	  and	  identify	  some	  unexplored	  ways	  forward.	  Results	  show	  that	  data	  accumulated	  over	  the	  past	  century	  remain	  fragmented	  and	  often	  contradictory,	  making	  it	  difficult	  to	  draw	  conclusions.	  There	  is	  the	  need	  for	  an	  international	  consortium	  on	  P.	  vivax	  culture	  able	  to	  collect,	  update	  and	  share	  new	  evidence,	  including	  negative	  results,	  and	  thusbetter	  coordinate	  current	  efforts	  towards	  the	  establishment	  of	  a	  continuous	  P.	  vivax	  culture.
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The development of a continuous Plasmodium vivax
blood cycle in vitro was first attempted 100 years ago.
Since then, and despite the use of different methods,
only short-term cultures have been achieved so far. The
available literature has been reviewed in order to provide
a critical overview of the currently available knowledge
on P. vivax blood cycle culture systems and identify
some unexplored ways forward. Results show that data
accumulated over the past century remain fragmented
an  often contradictory, making it difficult to draw con-
clusions. There is the need for an international consor-
tium on P. vivax culture able to collect, update, and share
new evidence, including negative results, and thus bet-
ter coordinate current efforts towards the establishment
of a continuous P. vivax culture.
The need for an in vitro model of Plasmodium vivax
The lack of a reliable in vitro model of the P. vivax blood
cycle (see Glossary) is probably a major reason for the
currently existing knowledge gaps on the biology of this
parasite [1]. Research on P. vivax has lagged behind that on
Plasmodium falciparum despite the fact that it is the most
widely distributed human Plasmodium species outside
Sub-Saharan Africa [2]. The focus on P. falciparum was
justified by its burd n and the mergence of resis ance to
commonly used treatments [3]. Moreover, the availability
of a reliable in vitro culture system for P. falciparum [4] has
allowed for an in-depth understanding of its biology and
pathophysiology. Recently, P. vivax has been put at the
forefront of the malaria research agenda following the
recent shift from malaria control to elimination and eradi-
cation [5], which calls for an enhanced knowledge on the
biology of human malaria parasites. In addition, the emer-
gence of P. vivax chloroquine resistance [6] has contributed
to the increased interest in research on this parasite. The
development of an in vitro culture system for P. vivax has
been clearly identified as a research priority by the Malaria
Eradication Research Agenda (malERA) initiative [7].
The first attempt to culture P. vivax was published 100
years ago by Bass and Johns [8]. Since then, other research
groups have attempted to set up a reliable and continuous
culture, but results remain inconclusive and not readily
reproducible. This review summarizes a hundred years of
research on this topic and critically reviews the methods
employed and the results obtained, with the aim of identi-
fying outstanding questions and potential solutions.
A systematic review of the literature (published and
unpublished) was done using PubMed and the Internet
(Google, Google Scholar, and conference reports) with the
f llowing keywords: ‘P. vivax’, ‘in vitro culture’, and ‘blood
cycle’. Moreover, reference lists of all articles were
scr ened anually. No date  language limits were in-
cluded in the search.
P. vivax life cycle stages and in vitro cultures
The life cycle of P. vivax, as for other human parasites,
comprises an exogenous sexual phase (sporogony) in the
Anopheline vector and an endogenous asexual phase (schi-
zogony) with multiplication in the human host. The schi-
zogony includes the parasite’s development in the liver
(exoerythrocytic schizogony) and in red blood cells (RBCs)
(erythrocytic schizogony). There have been several
attempts, with varying degrees of success, to produce in
vitro cultures of the different development stages of the P.
vivax life cycle. Indeed, P. vivax ookinetes, resulting from
Review
Glossary
Blood cycle: asexual cycle of the parasite that occurs in the blood stream.
Duffy receptors: receptors on the reticulocyte that play an important role in
Plasmodium vivax and Plasmodium knowlesi invasion.
Invasion assay: test to observe and quantify invasion of new RBCs by the
parasite.
Liver cycle: cycle of the parasite that occurs in the liver where sporozoites will
mature into merozoites and be released into the blood stream for the blood cycle.
Magnetic activated cell sorting (MACS): selection of population based on
surface marker specific antibody beads retained by a magnet through a column
and flushed to recuperate the population of interest.
Mosquito cycle: sexual stage in the mosquito gut where two gametocytes
(male and female) will fuse to give an oocyte.
Orthochromatic erythroblast: erythrocyte progenitor that is the last stage
before enucleation.
Parasite density: number of infected parasites divided by the total number of
RBCs, expressed in percentage.
Plasmodium vivax Duffy binding protein (PvDBP): ligand of the Duffy receptor
present on the merozoite surface.
Polychromatic erythroblast: erythrocyte progenitor.
Reticulocyte: young RBCs characterized by the presence of RNA that could be
seen using a specific staining (cresyl blue).
Single schizogony cycle (SSC): it corresponds to a full asexual cycle of the
parasite.1471-4922/$ – see front matter
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The	  need	  for	  an	  in	  vitro	  model	  of	  Plasmodium	  vivax.	  The	  lack	  of	  a	  reliable	  in	  vitro	  model	  of	  the	  P.	  vivax	  blood	  cycle	  is	  probably	  a	  major	  reason	  for	  the	   currently	   existing	  knowledge	   gaps	  on	   the	  biology	  of	   this	  parasite	   [11].	   	  Research	  on	  P.	  
vivax	   has	   lagged	  behind	   that	   on	  Plasmodium	  falciparum	   despite	   the	   fact	   that	   it	   is	   the	  most	  widely	  distributed	  human	  Plasmodium	  species	  outside	  Sub-­‐Saharan	  Africa	  [12].	  The	  focus	  on	  
P.	  falciparum	  was	  justified	  by	  its	  burden	  and	  the	  emergence	  of	  resistance	  to	  commonly	  used	  treatments	   [13].	   Moreover,	   the	   availability	   of	   a	   reliable	   in	   vitro	   culture	   system	   for	   P.	  
falciparum	   [14]	   has	   allowed	   for	   an	   in-­‐depth	   understanding	   of	   its	   biology	   and	  pathophysiology.	   Recently,	   P.	   vivax	   has	   been	   put	   at	   the	   forefront	   of	   the	   malaria	   research	  agenda	   following	   the	   recent	   shift	   from	  malaria	   control	   to	   elimination	  and	  eradication	   [15],	  which	   calls	   for	   an	   enhanced	   knowledge	   on	   the	   biology	   of	   human	   malaria	   parasites.	   In	  addition,	   the	   emergence	   of	   P.	   vivax	   chloroquine	   resistance	   [16]	   has	   contributed	   to	   the	  increased	   interest	   in	   the	   research	   on	   this	   parasite.	   The	   development	   of	   an	   in	   vitro	   culture	  system	   for	   P.	   vivax	   has	   been	   clearly	   identified	   as	   a	   research	   priority	   by	   the	   Malaria	  Eradication	  Research	  Agenda	  (malERA)	  initiative	  [17].	  The	  first	  attempt	  to	  culture	  P.	  vivax	  was	  published	  one	  hundred	  years	  ago	  by	  Bass	  et	  al.	  [18].	  Since	  then,	  other	  research	  groups	  have	  attempted	  to	  set	  up	  a	  reliable	  and	  continuous	  culture,	  but	   results	   remain	   inconclusive	   and	   not	   readily	   reproducible.	   This	   review	   summarizes	   a	  hundred	  years	  of	  research	  on	  this	  topic	  and	  critically	  reviews	  the	  methods	  employed	  and	  the	  results	  obtained,	  with	  the	  aim	  of	  identifying	  outstanding	  questions	  and	  potential	  solutions.	  	  A	  systematic	  review	  of	   the	   literature	  (published	  and	  unpublished)	  was	  done	  using	  PubMed	  and	   the	   Internet	   (Google,	   Google	   Scholar,	   and	   conference	   reports)	   with	   the	   following	   key	  words:	   'P.	  vivax'	   'in	  vitro	  culture',	   and	   'blood	   cycle'.	  Moreover,	   reference	   lists	   of	   all	   articles	  were	  screened	  manually.	  No	  date	  or	  language	  limits	  were	  included	  in	  the	  search.	  	  	  
P.	  vivax	  life	  cycle	  stages	  and	  in	  vitro	  cultures	  .	  The	  life	  cycle	  of	  P.	  vivax,	  as	  for	  other	  human	  parasites,	  comprises	  an	  exogenous	  sexual	  phase	  (sporogony)	   in	   the	  Anopheline	  vector	  and	  an	  endogenous	  asexual	  phase	   (schizogony)	  with	  multiplication	  in	  the	  human	  host.	  	  The	  schizogony	  includes	  the	  parasite’s	  development	  in	  the	  liver	  (exo-­‐erythrocytic	  schizogony)	  and	  in	  red	  blood	  cells	  (RBCs)	  (erythrocytic	  schizogony).	  There	   have	   been	   several	   attempts,	   with	   varying	   degrees	   of	   success,	   to	   produce	   in	   vitro	  cultures	  of	  the	  different	  development	  stages	  of	  P.	  vivax	   life	  cycle.	   Indeed,	  P.	  vivax	  ookinetes,	  resulting	   from	   the	  parasite	   sexual	   reproduction	   in	   the	  mosquito’s	  gut,	  have	  been	  produced	  using	   infected	   human	   blood	   incubated	   with	   a	   gametogenesis	   solution,	   with	   the	   resulting	  zygotes	   cultivated	   in	   ookinete	   medium.	   Ookinetes	   were	   produced	   in	   most	   (86%)	   of	   the	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optimized	  in	  vitro	  cultures	  [19].	  Nevertheless,	  an	  in	  vitro	  model	  of	  the	  Anopheles	  midgut	  cells	  for	  the	  culture	  of	  P.	  vivax	  oocysts	  is	  not	  available	  yet.	  	  During	   the	   exo-­‐erythrocytic	   schizogony,	  P.	  vivax	   produces	   dormant	   forms	   (hypnozoites)	   in	  liver	   cells	   that	   are	   responsible	   for	   relapses	   occurring	   several	   months	   or	   years	   after	   the	  primary	  infection	  [20].	   	  Therefore,	  understanding	  the	  biology	  of	  this	  specific	  stage	  is	  crucial	  as	  it	  contributes	  to	  maintain	  the	  human	  parasite	  reservoir	  in	  endemic	  areas	  and	  challenges	  P.	  
vivax	   elimination.	   The	  main	   bottleneck	   for	   the	   liver	   stage	   culture	   is	   the	   establishment	   of	   a	  functional	  hepatocyte	  cell	  line.	  Merozoites	  able	  to	  invade	  RBCs	  were	  produced	  by	  infecting	  a	  human	   hepatocyte	   cell	   line	   (HC-­‐04),	  with	  P.	   vivax	   sporozoites,	   however,	   the	   percentage	   of	  infected	  hepatocytes	  was	  extremely	   low	  (0.066%)	  [21].	  New	  advances	   in	   the	  production	  of	  functional	   hepatocytes	   (glycogen	   storage,	   cytochrome	   activity,	   low-­‐density	   lipoprotein	  uptake,	  etc.)	  derived	  from	  stem	  cells	  [22,	  23]	  may	  overcome	  this	  problem.	  
	  
	  
P.	  vivax	  erythrocytic	  stage	  in	  vitro	  culture:	  
P.	  vivax	  blood	  stage	  in	  vitro	  assays	  and	  culture	  can	  be	  divided	  into	  four	  categories,	  namely:	  (i)	  single	  schizogony	  cycles,	  (ii)	  invasion	  assays,	  (iii)	  short-­‐term,	  and	  (iv)	  long-­‐term	  cultures.	  	  
Single	  schizogony	  cycles	  (SSC)	  	  SSC	  consist	  of	  a	  single	  maturation	  cycle	   from	  ring	  to	  schizont	  stage	  without	  new	  invasions;	  parasites	   collected	   from	   infected	   patients	   are	   maintained	   in	   culture	   for	   up	   to	   48	   hours	  without	  adding	  new	  RBCs.	  This	  type	  of	  culture	  is	  mainly	  used	  to	  determine	  the	  influence	  of	  different	   medium	   components	   on	   the	   intra-­‐erythrocyte	   parasite	   development	   [24]	   or	   the	  parasite’s	   sensitivity	   profile	   to	   different	   anti-­‐malarial	   drugs	   [25-­‐27].	   The	   latter	   have	   been	  established	  using	  either	  (3H)	  hypoxanthine	  [26]	  or	  by	  counting	  the	  number	  of	  rings	  matured	  into	   schizonts	   on	   a	   Giemsa	   stained	   blood	   smear	   [27].	   As	   reported	   earlier	   [25,	   26],	   this	  technique	   is	   limited	   to	   drugs	   acting	   on	   early	   asexual	   blood	   stages,	   and	   results	   are	   highly	  variable,	  though	  Russell	  et	  al.	  [27]	  recently	  reported	  on	  a	  reproducible	   in	  vitro	  test	  for	  drug	  sensitivity	  (Figure	  1).	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Invasion	  assays:	  	  Invasion	   assays	   (Table	   1)	   consist	   of	   a	   first	   maturation	   step,	   as	   for	   the	   SSC,	   followed	   by	   a	  concentration	   step	   of	   the	   infected	   RBCs	   and	   an	   additional	   24h	   culture.	   Parasites	   are	  concentrated	   on	   a	   Percoll	   gradient	   to	   obtain	   over	   90%	   infected	   RBCs.	   The	   latter	   are	   then	  mixed	  with	  new	  reticulocytes	  and	  cultured	  (RPMI	  or	  McCoy	  medium)	  for	  an	  additional	  24h	  to	  allow	   new	   invasions	   (Figure	   2).	   These	   assays	   are	   essential	   to	   study	   the	   role	   of	   specific	  receptors	   involved	   in	   the	   erythrocyte	   invasion,	   e.g.,	   Pv	   Duffy	   Binding	   Protein	   (PvDBP,	  parasite	   surface)	   and	   the	  Duffy	   receptor	   (RBC	   surface)	   [28-­‐30].	  Moreover,	   invasion	   assays	  can	  also	  be	  used	  to	   test	   the	  susceptibility	  of	  reticulocytes	   from	  different	  sources	   to	  P.	  vivax	  invasion	   [31,	   32].	   Nevertheless,	   the	   small	   amount	   of	   infected	   RBCs	   obtained	   after	   Percoll	  centrifugation	   allows	   only	   a	   few	   experiments.	   Among	   the	   six	   published	   invasion	   assays,	  parasite	   densities	   ranged	   from	   0.1%	   and	   22.3%,	   the	   lowest	   value	   being	   observed	   in	   a	  protocol	  without	  concentration	  step	  (Table	  1).	  	  	  	  
the parasite sexual reproduction in the mosquito’s gut, have
been produced using infected human blood incubated with a
gametogenesis solution, with the resulting zygotes cultivat-
ed in ookinete medium. Ookinetes were produced in most
(86%) of the optimized in vitro cultures [9]. Nevertheless, an
in vitro model of the Anopheles midgut cells for the culture of
P. vivax oocysts is not available yet.
During the exoerythrocytic schizogony, P. vivax produces
dormant forms (hypnozoites) in liver cells that are respon-
sible for relapses occurring several months or years after the
primary infection [10]. Therefore, understanding the biology
of this specific stage is crucial as it contributes to maintain
the human parasite reservoir in endemic areas and chal-
lenges P. vivax elimination. The main bottleneck for the
liver stage culture is the establishment of a functional
hepatocyte cell line. Merozoites able to invade RBCs were
produced by infecting a human hepatocyte cell line (HC-04),
with P. vivax sporozoites; however, the percentage of
infected hepatocytes was extremely low (0.066%) [11].
New advances in the production of functional hepatocytes
(glycogen storage, cytochrome activity, low-density lipopro-
tein uptake, etc.) derived from stem cells [12,13] may over-
come this problem.
P. vivax erythrocytic stage in vitro culture
P. vivax blood stage in vitro assays and culture can be
divided into four categories, namely: (i) single schizogony
cycles, (ii) invasion assays, (iii) short-term cultures, and
(iv) long-term cultures.
Single schizogony cycles (SSCs)
SSCs consist of a single maturation cycle from ring to
schizont stage without new invasions; parasites collected
from infected patients are maintained in culture for up to
48 h without adding new RBCs. This type of culture is
mainly used to determine the influence of different medi-
um components on the intra-erythrocyte parasite develop-
ment [14] or the parasite’s sensitivity profile to different
antimalarial drugs [15–17]. The latter have been estab-
lished using either (3H) hypoxanthine [16] or by counting
the number of rings matured into schizonts on a Giemsa-
stained blood smear [17]. As reported earlier [15,16], this
technique is limited to drugs acting on early asexual blood
stages, and results are highly variable, although Russell
et al. [17] recently reported on a reproducible in vitro test
for drug sensitivity (Figure 1).
Invasion assays
Invasion assays (Table 1) consist of a first maturation step,
as for the SSCs, followed by a concentration step of the
infected RBCs and an additional 24-h culture. Parasites are
concentrated on a Percoll gradient to obtain over 90% of
infected RBCs. The latter are then mixed with new reticu-
locytes and cultured (RPMI or McCoy’s medium) for an
additional 24 h to allow new invasions (Figure 2). These
assays are essential to study the role of specific receptors
involved in the erythrocyte invasion, for example, Pv Duffy
binding protein (PvDBP, parasite surface) and the Duffy
receptor (RBC surface) [18–20]. Moreover, invasion assays
can also be used to test the susceptibility of reticulocytes
from different sources to P. vivax invasion [21,22]. Never-
theless, the small amount of infected RBCs obtained after
Percoll centrifugation allows only a few experiments.
Among the six published invasion assays, parasite densities
ranged from 0.1% and 22.3%, the lowest value being ob-
served in a protocol without a concentration step (Table 1).
Count 200 asexual stages and
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TRENDS in Parasitology 
Figure 1. Scheme of the Plasmodium vivax drug test protocol. P. vivax-infected blood (from patient) containing a majority of ring forms is distributed in a 96-well plate
containing 11 serial dilutions of the drug to test. One control well is kept free of drug and will be used for monitoring parasite development. The plate is placed in a candle
jar at 378C for 22–42 h, and the experiment is stopped when at least 40% of schizonts are found in the control well. A thick smear is made from each of the 11 wells and the
number of schizonts per 200 asexual stage parasites is determined for each drug concentration and normalized to the control well. The IC50 corresponds to the drug
concentration required to obtain 50% of inhibition of the schizont maturation.
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Short-­‐term	  cultures	  	  By	   definition,	   these	   in	   vitro	   cultures	   are	  maintained	   for	   less	   than	   a	  month	   and,	   since	   they	  include	   several	   schizogony	   cycles,	   they	   offer	   the	   possibility	   to	   study	   the	   parasite	  development	  in	  RBCs	  (Table	  2).	  In	  1912,	  Bass	  et	  al.	  published	  the	  first	  report	  on	  a	  short-­‐term	  culture	   of	   P.	   vivax	   (collected	   from	   patients)	   that	   could	   be	   maintained	   for	   up	   to	   four	  
Short-term cultures
By definition, these in vitro cultures are maintained for
less than a month, and because they include several schi-
zogony cycles, they offer the possibility to study parasite
development in RBCs (Table 2). In 1912, Bass and Johns
published the first report on a short-term culture of P.
vivax (collected from patients) that could be maintained for
up to four schizogony cycles [8]. Subsequently, in most
published work the parasite density was reported to in-
crease during the first 96 h and then decline [23–26],
although in some experiments the decline was observed
from the very beginning of the culture [27–29]. Golenda
and colleagues were the only ones that reported a doubling
of the parasite population at each cycle by using a P. vivax
Chesson strain adapted in monkeys [30]. This was then
cultured in M5AMM medium regularly supplemented with
blood from hematochromatosis patients, which was
enriched in reticulocytes using centrifugation on homolo-
gous plasma. However, this protocol has never been suc-
cessfully implemented by other research groups.
A preliminary parasite concentration step, before start-
ing the culture, was done in only one of the nine published
studies, but did not result in better parasite growth [29].
All other short-term cultures were initiated with the blood
Table 1. List of publications and methods used in Plasmodium vivax invasion assays













Not provided Not provided [20]







RPM1 1640 with HEPES,
NaHCO3, neomycin + 20% serum
11.9% [22]






RPMI 1640 with HEPES,
hypoxanthine,
D-glucose + 15% serum
15.0% [18]
2007 Infected patients No concentration No concentration McCoy’s 5A medium with HEPES,
NaHCO3, L-glutamine,
gentamicin + 25% serum
0.1% [21]




McCoy’s 5A medium with
L-glutamine, gentamicin,








McCoy’s 5A medium with

















Adjust parasitemia to 0.5–1%
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90% N2, 5%CO 2, 5% O 2
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TRENDS in Parasitology 
Figure 2. Scheme of the Plasmodium vivax invasion assay protocol. P. vivax-infected blood containing a majority of ring forms is kept in vitro for maturation until the
schizont stage. The mature forms are concentrated on 45% Percoll to obtain a population of more than 90% parasites. The latter are then mixed with reticulocyte-enriched
blood for a final 0.5–1% parasitemia in a 96-well plate. The plate is kept at 378C for 24 h in a chamber filled with a gas mixture (90% N2–5% CO2–5% O2). At the end of the
experiment, a blood smear is done and parasites counted after Giemsa staining.
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Figure 2. Scheme of the Plasmodium vivax invasion assay protocol. P. vivax-infected blood containing a majority of ring forms is kept in vitro for maturation until the
schizont stage. The mature forms are concentrated on 45% Percoll to obtain a population of more than 90% parasites. The latter are then mixed with reticulocyte-enriched
blood for a final 0.5–1% parasitemia in a 96-well plate. The plate is kept at 378C for 24 h in a chamber filled with a gas mixture (90% N2–5% CO2–5% O2). At the end of the
experiment, a blood smear is done and parasites counted after Giemsa staining.
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schizogony	   cycles	   [18].	   Subsequently,	   in	   most	   published	   work	   the	   parasite	   density	   was	  reported	   to	   increase	   during	   the	   first	   96	   hours	   and	   then	   decline	   [33-­‐36],	   though	   in	   some	  experiments	   the	   decline	   was	   observed	   from	   the	   very	   beginning	   of	   the	   culture	   [37-­‐39].	  Golenda	   and	   colleagues	   were	   the	   only	   ones	   that	   reported	   a	   doubling	   of	   the	   parasite	  population	  at	  each	  cycle	  by	  using	  a	  P.	  vivax	  Chesson	  strain	  adapted	  in	  monkeys	  [40].	  This	  was	  then	   cultured	   in	   M5AMM	   medium	   regularly	   supplemented	   with	   blood	   from	  hematochromatosis	   patients	   enriched	   in	   reticulocytes	   using	   centrifugation	   on	   homologous	  plasma.	  However,	  this	  protocol	  has	  never	  been	  successfully	   implemented	  by	  other	  research	  groups.	  	  A	  preliminary	  parasite	  concentration	  step,	  before	  starting	  the	  culture,	  was	  done	  in	  only	  one	  of	   the	   nine	   published	   studies,	   but	   did	   not	   result	   in	   better	   parasite	   growth	   [39].	   All	   other	  short-­‐term	  cultures	  were	  initiated	  with	  the	  blood	  of	  infected	  monkeys	  or	  patients,	  to	  which	  reticulocytes	  were	  regularly	  added.	  None	  of	  these	  studies	  investigated	  the	  parasite’s	  biology,	  as	   the	  main	  objective	  was	   the	  optimisation	  of	   the	   culture	   conditions,	   for	   example,	  medium	  [34]	  and	  gas	  composition	  [36].	  	  
	  
of infected monkeys or patients, to which reticulocytes
were regularly added. None of these studies investigated
the parasite’s biology, as the main objective was the opti-
mization of the culture conditions, for example, medium
[24] and gas composition [26].
Long-term cultures
These cultures are maintained for more than 1 month and
aim at obtaining P. vivax laboratory-adapted strains.
Between 1987 and 2007 six long-term cultures were pub-
lished (Table 3), most of them deriving from the Trager and
Jensen protocol for P. falciparum. [4]. Most of them were
maintained for 2 to 3 months, and only one lasted up to 5
months. Although the possibility of restarting a culture
from frozen cultured parasites was published in 1981 [31],
this result was never reproduced. Similarly, the results of
the protocol able to successfully maintain a P. vivax culture
for up to 125 days [32] (without any details on actual
Table 2. List of publications and methods used in Plasmodium vivax short-term in vitro blood cycle
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10 days Low parasitemia [29]
aSupport: recipient where the in vitro culture is done.
bGas: gas environment provided to the parasite culture.
cCandle jar = 79% N2 + 3% CO2 + 18% O2.
dGas mixture 1 = 92% N2 + 3% CO2 + 5% O2.
eGas mixture 2 = 90% N2 + 5% CO2 + 5% O2.
fThe culture was shaken at 100 cpm for 10–12 h during each end of schizogony stage.
gThe pRBCs were concentrated by Percoll centrifugation to obtain a population of over 90% parasites.
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Long-­‐term	  cultures:	  	  These	   cultures	   are	   maintained	   for	   more	   than	   one	   month	   and	   aim	   at	   obtaining	   P.	   vivax	  laboratory	  adapted	  strains.	  Between	  1987	  and	  2007	  six	   long-­‐term	  cultures	  were	  published	  (Table	  3),	  most	  of	  them	  deriving	  from	  the	  Tragger	  and	  Jensen	  protocol	  for	  P.	  falciparum.	  [14].	  Most	  of	  them	  were	  maintained	  for	  2-­‐3	  months,	  and	  only	  one	  lasted	  up	  to	  5	  months.	  Though	  the	  possibility	  of	  re-­‐starting	  a	  culture	  from	  frozen	  cultured	  parasites	  was	  published	  in	  1981	  [41],	   this	   result	   was	   never	   reproduced.	   Similarly,	   the	   results	   of	   the	   protocol	   able	   to	  successfully	  maintain	  a	  P.	  vivax	  culture	  for	  up	  to	  125	  days	  [42]	  (without	  any	  details	  on	  actual	  parasite	   growth)	   could	   not	   be	   reproduced.	   Most	   publications	   did	   not	   report	   any	   in	   vitro	  parasite	  multiplication;	  actually,	  parasite	  densities	   remained	  extremely	   low	   throughout	   the	  experiments.	  	  	  	  
	  	  	  	  	  	  
parasite growth) could not be reproduced. Most publica-
tions did not report any in vitro parasite multiplication;
actually, parasite densities remained extremely low
throughout the experiments.
The key players
Sources of P. vivax
Non-human primates are used as in vivo models for P.
vivax cultures, as this parasite can infect monkeys. The
Chesson strain of P. vivax was first adapted to non-human
primates in 1969 [33] and was soon followed by several
other P. vivax strains (Table 4). Comparing human and
non-human models with the Chesson strain, Collins et al.
[34] concluded there was no difference in terms of maxi-
mum parasite densities obtained, although in non-human
models the time to reach the same density was longer (18.9
versus 8.5 days). Monkey-adapted P. vivax strains have
been used to start in vitro cultures [27,30] and are available
online at the Malaria Research and Reference Reagent
Resource Centre (MR4; www.mr4.org).
The need of fresh blood samples from infected patients
and the usually low parasite densities in P. vivax infections
have been major obstacles for initiating in vitro cultures.
Although freshly infected blood can be immediately used
for culture [35–37], a prior Percoll centrifugation, as done
by Borlon et al. [29], could partially solve the problem of low
parasite density. However, this procedure has not been
implemented in long-term cultures yet. In addition, the
recent development of a cryopreservation protocol for
human P. vivax isolates [38] that enables acquisition of
isolates with similar invasion efficiency as fresh isolates
[29] could represent, if reproducible, an important devel-
opment towards a continuous in vitro culture.
The in vitro adaptability of P. vivax isolates directly
from human patients is extremely variable and depends on
the initial density as well as on other inherent character-
istics of the parasite. Indeed, according to Lu [39], 60%
of isolates with a density !0.1% could be successfully
Table 4. Plasmodium vivax strains adapted in monkey hosts
P. vivax strains Monkey hosts
NICA Aotus trivirgatus
ONG A. trivirgatus griseimembra
Panama A. trivirgatus
Thai III A. azare bolivensis, A. nancymai, A. lemurinus
bolivensis, Saimiri sciureus bolivensis
India VII A. trivirgatus, A. azare bolivensis, A. nancymai, A.
lemurinus bolivensis, S. sciureus bolivensis, Pan
troglodytes
Indonesia XIX A. lemurinus griseimembra, A. vociferans, A.
nancymai S. boliviensis
Brazil I A. vociferans, S. bolivensis
Chesson A. lemurinus griseimembra, A. vociferans, A.
nancymai, A. azare bolivensis
NAM A. vociferans
Apastepeque A. trivirgatus
Salvador I A. lemurinus griseimembra, A. azare bolivensis,
A. nancymai, S. sciureus bolivensis, Pan
troglodytes
Table 3. List of publications and methods used in Plasmodium vivax long-term in vitro blood cycle
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aSupport: recipient where the in vitro culture is done.
bGas: gas environment provided to the parasite culture.
cMedium was prepared with a pH acid for the first 6 days and was changed three times a day.
dCandle jar = 79% N2 + 3% CO2 + 18% O2.
eGas mixture = 90% N2 + 5% CO2 + 5% O2.
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The	  key	  players	  
Sources	  of	  P.	  vivax	  	  Non-­‐human	   primates	   are	   used	   as	   in	   vivo	   models	   for	   P.	   vivax	   cultures,	   as	   this	   parasite	   can	  infect	  monkeys.	  The	  Chesson	  strain	  of	  P.	  vivax	  was	   first	  adapted	   to	  non-­‐human	  primates	   in	  1969	  [43]	  and	  was	  soon	  followed	  by	  the	  several	  other	  P.	  vivax	  strains	  (Table	  4).	  Comparing	  human	  and	  non-­‐human	  models	  with	   the	  Chesson	   strain,	   Collins	  et	  al.	   [44]	   concluded	   there	  was	  no	  difference	   in	   terms	  of	  maximum	  parasite	  densities	   obtained,	   though	   in	  non-­‐human	  models	   the	   time	   to	   reach	   the	   same	   density	   was	   longer	   (18.9	   versus	   8.5	   days).	   Monkey-­‐adapted	  P.	  vivax	   strains	  have	  been	  used	   to	   start	   in	  vitro	   cultures	   [37,	  40]	  and	  are	  available	  online	   at	   the	   Malaria	   Research	   and	   Reference	   Reagent	   Resource	   Centre	   (MR4;	  www.mr4.org).	  	  	  
	  The	  need	  of	  fresh	  blood	  samples	  from	  infected	  patients	  and	  the	  usually	  low	  parasite	  densities	  in	  P.	  vivax	  infections	  have	  been	  major	  obstacles	  for	  initiating	  in	  vitro	  cultures.	  Though	  freshly	  infected	  blood	  can	  be	  immediately	  used	  for	  culture	  [45-­‐47],	  a	  prior	  Percoll	  centrifugation,	  as	  done	  by	  Borlon	  et	  al.	  [39],	  could	  partly	  solve	  the	  problem	  of	  low	  parasite	  density.	  However,	  this	  procedure	  has	  not	  been	   implemented	   in	   long-­‐term	  cultures	  yet.	   In	  addition,	   the	  recent	  development	   of	   a	   cryopreservation	   protocol	   for	   human	   P.	   vivax	   isolates	   [48]	   that	   enables	  acquisition	  of	  isolates	  with	  similar	  invasion	  efficiency	  as	  fresh	  isolates	  [39]	  could	  represent,	  if	  reproducible,	  an	  important	  development	  towards	  a	  continuous	  in	  vitro	  culture.	  	  	  
parasite growth) could not be reproduced. Most publica-
tions did not report any in vitro parasite multiplication;
actually, parasite densities remained extremely low
throughout the experiments.
The key players
Sources of P. vivax
Non-human primates are used as in vivo models for P.
vivax cultures, as this parasite can infect monkeys. The
Chesson strain of P. vivax was first adapted to non-human
primates in 1969 [33] and was soon followed by several
other P. vivax strains (Table 4). Comparing human and
non-human models with the Chesson strain, Collins et al.
[34] concluded there was no difference in terms of maxi-
mum parasite densities obtained, although in non-human
models the time to reach the same density was longer (18.9
versus 8.5 days). Monkey-adapted P. vivax strains have
been used to start in vitro cultures [27,30] and are available
online at the Malaria Research and Reference Reagent
Resource Centre (MR4; www.mr4.org).
The need of fresh blood samples from infected patients
and the usually low parasite densities in P. vivax infections
have been major obstacles for initiating in vitro cultures.
Although freshly infected blood can be immediately used
for culture [35–37], a prior Percoll centrifugation, as done
by Borlon et al. [29], could partially solve the problem of low
parasite density. However, this procedure has not been
implemented in long-term cultures yet. In addition, the
recent development of a cryopreservation protocol for
hu a  P. vivax isolates [38] that enables acquisition of
isolates with similar invasion efficiency as fresh isolates
[29] could represent, if reproducible, an important devel-
opment towards a continuous in vitro culture.
The in vitro adaptability of P. vivax isolates directly
from human patients is extremely variable and depends on
the initial density as well as on other inherent character-
istics of the parasite. Indeed, according to Lu [39], 60%
of isolates with a density !0.1% could be successfully
Table 4. Plasmodium vivax strains adapted in monkey hosts
P. vivax strains Monkey hosts
NICA Aotus trivirgatus
ONG A. trivirgatus griseimembra
Panama A. trivirgatus
Thai III A. azare bolivensis, A. nancymai, A. lemurinus
bolivensis, Saimiri sciureus bolivensis
India VII A. trivirgatus, A. azare bolivensis, A. nancymai, A.
lemurinus bolivensis, S. sciureus bolivensis, Pan
troglodytes
Indonesia XIX A. lemurinus griseimembra, A. vociferans, A.
nancymai S. boliviensis
Brazil I A. vociferans, S. bolivensis
Chesson A. lemurinus griseimembra, A. vociferans, A.
nancymai, A. azare bolivensis
NAM A. vociferans
Apastepeque A. trivirgatus
Salvador I A. lemurinus griseimembra, A. azare bolivensis,
A. nancymai, S. sciureus bolivensis, Pan
troglodytes
Table 3. List of publications and methods used in Plasmodium vivax long-term in vitro blood cycle
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aSupport: recipient where the in vitro culture is done.
bGas: gas environment provided to the parasite culture.
cMedium was prepared with a pH acid for the first 6 days and was changed three times a day.
dCandle jar = 79% N2 + 3% CO2 + 18% O2.
eGas mixture = 90% N2 + 5% CO2 + 5% O2.
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The	   in	   vitro	   adaptability	   of	   P.	   vivax	   isolates	   directly	   from	   human	   patients	   is	   extremely	  variable	  and	  depends	  on	  the	  initial	  density	  as	  well	  as	  on	  other	  inherent	  characteristics	  of	  the	  parasite.	   Indeed,	   according	   to	   Lu	   [49],	   60%	   of	   isolates	   with	   a	   density	   ≥0.1%	   could	   be	  successfully	  maintained	  in	  vitro	  for	  42	  hours	  while	  only	  25%	  of	  those	  with	  a	  density	  <0.02%	  could	  achieve	  the	  same	  result.	  	  
Sources	  of	  reticulocytes:	  	  Reticulocytes	  are	  the	  target	  cells	  for	  P.	  vivax	  during	  the	  erythrocytic	  schizogony	  [50].	  Though	  whole	   human	   blood	   has	   been	   previously	   used	   as	   source	   of	   reticulocytes	   [41,	   45],	   their	  relatively	   low	   concentration	   (1%	   of	   total	   RBCs)	   and	   short	   lifespan	   (24h)	   in	   the	   blood	  circulation	  makes	  it	  unsuitable	  for	  P.	  vivax	  culture.	  Therefore,	  several	  methods	  for	  a	  reliable	  and	  continuous	   source	  of	   reticulocytes	  have	  been	  developed.	  One	  of	   them	  uses	  blood	   from	  hemochromatosis	   patients	   who	   have	   relatively	   higher	   reticulocyte	   concentrations	   due	   to	  regular	   therapeutic	  phlebotomies	   [40].	  Reticulocyte	  concentration	  can	  be	   further	   increased	  to	   15-­‐20%	   by	   two	   ultracentrifugation	   cycles	   in	   autologous	   plasma.	   Although	   technically	  simple,	   this	   method	   requires	   continuous	   access	   to	   hemochromatosis	   patients,	   which	   also	  implies	  inter-­‐individual	  variability	  of	  reticulocytes.	  	  Cord	  blood	  contains	  a	  higher	  percentage	  of	  reticulocytes	  (4-­‐5%)	  than	  peripheral	  blood	  and	  has	   been	   used,	   even	   without	   concentration	   step,	   for	   short-­‐term	   P.	   vivax	   cultures	   [46,	   47].	  Reticulocyte	  concentration	  can	  be	  increased	  up	  to	  58%	  by	  centrifugation	  on	  a	  70%	  isotonic	  Percoll	  [29,	  51],	  or	  up	  to	  70%	  by	  lysing	  red	  blood	  cells	  with	  a	  hypotonic	  lysing	  solution	  [52];	  though	  the	  latter	  technique	  is	  appropriate	  only	  for	  cord	  blood	  and	  not	  for	  adult	  blood.	  	  A	   third	   source	   of	   reticulocytes	   is	   the	   production	   of	   erythroid	   cells	   from	   stem	   cells,	   either	  hematopoietic	   (HSC)	   or	   embryonic	   (ESC).	   Reticulocytes	   produced	   from	   HSCs	   have	   been	  shown	  to	  be	  suitable	  target	  cells	  for	  P.	  vivax	  invasion	  [53,	  54]	  and	  may	  represent	  a	  major	  step	  towards	  the	  continuous	  culture.	  A	  differentiation	  protocol,	  on	  mouse	  stromal	  cells	  (MS5),	  of	  HSCs	  (isolated	  from	  umbilical	  cord	  blood)	  into	  fully	  mature	  human	  RBCs	  was	  first	  published	  in	  2005	  [55].	  Using	  a	  modified	  protocol	  without	  stromal	  cells,	  Panichakul	  et	  al.	  [54]	  obtained	  0.5%	  of	  reticulocytes	  after	  14	  days	  of	  maturation,	  while	  Noulin	  et	  al.	  [53]	  reported	  yields	  up	  to	   20%	   of	   reticulocytes.	   	   In	   addition,	   the	   latter	   could	   be	   cryopreserved	   and	   successfully	  invaded	  by	  P.	  vivax	  after	  thawing.	  	  	  	  
Culture	  conditions	  	  Culture	   conditions	   can	   be	   divided	   in	   two	  major	   groups,	   that	   is,	   the	   physical	   environment	  (temperature,	  oxygen,	  movements,	  etc.)	  and	  the	  medium	  composition.	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Early	   attempts	   of	   culture	   have	   used	   high	   temperatures	   (39-­‐40°C)	   with	   the	   rationale	   of	  mimicking	   the	   febrile	   conditions	   of	   clinical	   malaria	   [18,	   34].	   However,	   parasite	   growth	   at	  high	  temperatures	  was	  poor,	  a	  fact	  later	  confirmed	  when	  the	  optimal	  temperature	  for	  P.	  vivax	  development	  was	  established	  at	  37°C	  [46].	  	  Three	  different	  approaches	  have	  been	  used	   for	   the	  gas	  compositions:	   (i)	  candle	   jar,	   (ii)	  5%	  CO2,	   and	   (iii)	   the	   gas	   mixture	   of	   90%	   N2-­‐5%	   CO2-­‐5%	   02.	   	   Despite	   lack	   of	   evidence	   on	   its	  superiority,	   the	  90%	  N2-­‐5%	  CO2-­‐5%	  02	  gas	  mixture	   is	   the	  most	   commonly	  used	   for	  both	  P.	  
falciparum	  [56]	  and	  P.	  vivax	  cultures	  	  [29,	  39,	  47].	  Oxygen	  concentrations	  below	  5%	  or	  above	  20%	   are	   fatal	   for	   the	   parasite	   [56],	   and	   a	   concentration	   of	   5-­‐10%	   has	   been	   shown	   to	   be	  optimal.	  Moreover,	  with	  5%	  CO2	  at	  37°C,	  cultures	  could	  be	  maintained	  for	  prolonged	  periods,	  though	  without	  effective	  parasite	  growth	  [38,	  54].	  	  Contradicting	  reports	  on	  the	  need	  of	  movement	  for	  culture	  (static	  versus	  non-­‐static	  culture)	  have	  been	  published.	  For	  some	  authors	  movement	  is	  very	  important,	  particularly	  during	  the	  schizont	  stage	  to	  enhance	  merozoite	  release	  [40,	  47],	  while	  other	  authors	   found	  movement	  deleterious,	   and	   parasites	   matured	   better	   in	   a	   static	   culture	   [36,	   37].	   Since	   good	   parasite	  growth	  has	  been	  observed	  in	  static	  cultures	  [40],	  movement	  is	  	  probably	  not	  	  a	  critical	  factor	  for	  P.	  vivax	  growth.	  	  	  The	  medium	  composition	  is	  crucial	  for	  the	  culture	  as	  it	  should	  contain	  all	  necessary	  nutrients	  for	  the	  parasites	  to	  survive	  and	  multiply.	  Two	  basic	  media	  have	  been	  used	  for	  P.	  vivax:	  RPMI	  1640,	  the	  most	  commonly	  used	  (reported	  in	  11	  out	  of	  the	  15	  publications	  on	  short	  and	  long-­‐term	  cultures),	  and	  McCoy’s	  medium	  (in	  3	  out	  of	  15	  publications).	  The	  composition	  of	  these	  two	  media	  is	  similar	  since	  McCoy’s	  medium	  was	  derived	  from	  RPMI	  1640.	  Indeed,	  it	  includes	  all	   additives	   as	   in	  RPMI	  1640	   (with	   slightly	   different	   concentrations)	   plus	   some	   additional	  vitamins	  and	  amino	  acids:	  (i)	  nicotinic	  acid	  (vitamin	  B3,	  involved	  in	  tissular	  respiration),	  (ii)	  ascorbic	   acid	   (vitamin	   C,	   anti-­‐oxidant),	   (iii)	   pyridoxal	   (vitamin	   B6,	   involved	   in	   aerobic	  metabolism),	  and	  (iv)	  peptone	  (source	  of	  amino	  acids).	  Other	  media	  such	  as	  Locke’s	  fluid	  [1],	  Waymouth	  752/1,	  or	  SCMI	  612	  [19]	  have	  been	  tested	  and	  abandoned	  though	  Brockelman	  et	  
al.	   [34]	   reported	   a	   better	   P.	   vivax	   multiplication	   with	   SCMI	   compared	   to	   RPMI	   medium.	  Similarly,	   the	   human	   serum	   concentration	   varied	   considerably	   between	   the	   15	   protocols	  (ranging	  from	  10%	  to	  50%)	  as	  did	  the	  haematocrit	  level	  (ranging	  from	  3%	  to	  25%),	  without	  any	  significant	  difference	  observed	  in	  terms	  of	  parasite	  growth	  and	  density.	  	  	  Other	  Plasmodium	  species	  blood	  cycle	  in	  vitro	  	  Among	   human	   Plasmodium	   species,	   the	   long-­‐term	   in	   vitro	   culture	   of	   P.	   falciparum	   was	  published	   in	  1975	  by	  Trager	  and	   Jensen	   [14],	  and	  several	   laboratory	  adapted	  strains	  (3D7,	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DD2,	   W2,	   among	   others)	   are	   currently	   available	   	   (www.mr4.org).	   Recently,	   a	   successful	  adaptation	  of	  Plasmodium	  knowlesi,	  a	  simian	  species	  infecting	  humans	  in	  Asia,	  to	  continuous	  culture	  in	  human	  erythrocytes	  has	  been	  reported	  by	  Moon	  et	  al.	  [57].	  The	  culture	  was	  started	  with	   a	   frozen	   P.	   knowlesi	   A1	   strain	   (previously	   maintained	   in	   rhesus	   macaques)	  supplemented	   with	   fresh	   RBCs	   from	   the	   natural	   host	   (Maccacus	   fascicularis)	   at	   2%	  hematocrit	   in	   a	  modified	  RPMI	  medium	   containing	   10%	  human	   serum,	   in	   static	   culture	   at	  37°C.	   The	   strain	   was	   adapted	   over	   a	   10-­‐month	   period	   with	   a	   progressive	   change	   from	  monkey	   to	   human	   RBCs.	   Given	   the	   similarities	   between	   both	   P.	   knowlesi	  and	   P.	   vivax	   (for	  example,	  genetic,	  hosts,	  and	  target	  cells),	  this	  protocol	  could	  open	  new	  perspectives	  for	  the	  in	  
vitro	  adaptation	  of	  P.	  vivax.	  	  	  Other	  non-­‐human	  Plasmodium	   species,	   (simian,	   rodent,	  avian)	  have	  been	  cultivated	   in	  vitro	  [58-­‐63],	   and	   a	   long	   term	   culture	   system	   is	   available	   for	   four	   of	   them,	   that	   is	   P.	   knowlesi,	  
Plasmodium	  cynomolgi,	  Plasmodium	  gonderi	  and	  Plasmodium	  berghei	  (Table	  5).	  Useful	  clues	  for	   P.	   vivax	   culture	   may	   be	   obtained	   by	   sharing	   expertise	   gained	   from	   these	   non-­‐human	  
Plasmodium	   cultures,	   despite	   the	   fact	   that	   all	   of	   them	   use	   similar	   protocols	   as	   for	   the	   P.	  





that all of them use similar protocols as for the
P. falciparum culture.
Concluding remarks
Since the first attempt in 1912, the achievement of reliable
and continuous culture of P. vivax remains elusive, despite
different culture conditions tested. The most puzzling
aspect in this 100-year-old history is the lack of reproduc-
ibility of the published protocols. Golenda and colleagues
[30] were able to achieve a thriving culture, with parasite
counts doubling at each schizogonic cycle that was main-
tained for 15 days. Nevertheless, the reasons for disconti-
nuing this apparently successful protocol after 15 days as
well as the inability of other research groups to reproduce it
are unclear. This also applies to the protocol (125-day
culture with a final parasite density of 8.6%) published
by Renapurkar et al. [35] in 1983. Potentially, the addi-
tional publication of negative results could be useful in
understanding published positive results and in identify-
ing unsuccessful protocol conditions. A large consortium
including all research groups working on P. vivax culture
in which all results, including the negative ones, would be
shared and discussed could be extremely useful as it would
avoid replicating nonviable protocols indefinitely.
In several reports, cultured parasites developed well
only during the first schizogonic cycle, after which parasite
density decreased dramatically. The reasons for such a
drastic drop are unknown but may be related to ‘environ-
mental shock’ due to the sudden change from the host to in
vitro conditions. The protocol by Golenda and colleagues
[30] supports this hypothesis as the P. vivax Chesson strain
was first maintained for several cycles in Aotus monkeys
before adapting it to in vitro conditions by slowly and
regularly supplying reticulocytes from hemochromatosis
patients. Thus, a gentle adaptation, starting with P. vivax
monkey-adapted strains and continuing with the gradual
replacement of monkey blood with human reticulocytes
could be, as recently shown for P. knowlesi [47], a possible
solution.
A crucial step for the establishment of long-term culture
is the availability of a continuous and reliable source of
target cells (reticulocytes). The in vitro invasion of reticu-
locytes by P. vivax may be affected by the concentration
method. Indeed, centrifugation on Percoll renografin has
been reported to interfere with invasion [27], whereas this
is not the case for Percoll alone [19], and ultracentrifuga-
tion in homologous plasma is likely to be even less disrup-
tive for the invasion process [30]. Similarly, parasite
invasion was less efficient with reticulocytes concentrated
on Percoll than with those by MACS (magnetic activated
cell sorting) [54]. It has been shown that in vitro parasit-
ized reticulocytes were very fragile, and an early disrup-
tion of the membrane occurred before the end of intra-
erythrocytic maturation. Moreover, such P. vivax mero-
zoites seemed to adhere to mature RBC membranes in-
stead of infecting them, resulting in the rapid loss of
parasites and reduced infection capacity [27].
To overcome these difficulties, the production of reti-
culocytes derived from HSCs or ESCs represents an inter-
esting alternative as they would not be weakened by a
Percoll concentration step. In addition, because the differ-
entiation process produces a heterogeneous population of
erythroid cells at different stages of differentiation, the
maturation of orthochromatic erythroblasts into reticulo-
cytes would occur at different time points, meaning a
regular influx of new target cells for P. vivax merozoites.






Blood source Days in
culture
Refs





Human blood Lab strains [4]
P. knowlesi Monkey,
human
Reticulocytes RPMI 1640 + HEPES +
sodium bicarbonate,
dextrose + hypoxanthine +
















Monkey blood 34 days [49]





Monkey blood 6 months [52]
P. berghei Rodent RBCs RPMI 1640 + HEPES +









aSupport: recipient in which the in vitro culture is done.
bGas: gas environment provided to the parasite culture.
cCandle jar = 79% N2 + 3% CO2 + 18% O2.
dGas mixture 1 = 90% N2 + 5% CO2 + 5% O2.
eThe temperature was kept at 308C for the first 20 h.
fGas mixture 2 = 85% N2 + 5% CO2 + 10% O2.
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Concluding	  remarks:	  	  Since	  the	  first	  attempt	  in	  1912,	  the	  achievement	  of	  the	  reliable	  and	  continuous	  culture	  of	  P.	  
vivax	  remains	  elusive,	  despite	  different	  culture	  conditions	  tested.	  The	  most	  puzzling	  aspect	  in	  this	   100-­‐year	   old	   history	   is	   the	   lack	   of	   reproducibility	   of	   the	   published	   protocols.	   Golenda	  and	  colleagues	  [40]	  were	  able	  to	  achieve	  a	  thriving	  culture,	  with	  parasite	  counts	  doubling	  at	  each	   schizogonic	   cycle,	   that	   was	   maintained	   for	   15	   days.	   Nevertheless,	   the	   reasons	   for	  discontinuing	   this	   apparently	   successful	   protocol	   after	   15	   days,	   as	   well	   as	   the	   inability	   of	  other	  research	  groups	  to	  reproduce	  it	  are	  unclear.	  This	  applies	  also	  to	  the	  protocol	  (125-­‐day	  culture	  with	  a	   final	  parasite	  density	  of	  8.6	  %)	  published	  by	  Renapurkar	  et	  al.	  [45]	   in	  1983.	  	  Potentially,	   the	   additional	   publication	   of	   negative	   results	   could	   be	   useful	   in	   understanding	  published	   positive	   results	   and	   in	   identifying	   unsuccessful	   protocol	   conditions.	   A	   large	  consortium	   including	   all	   research	   groups	   working	   on	   P.	   vivax	   culture	   in	   which	   all	   results,	  including	  the	  negative	  ones,	  would	  be	  shared	  and	  discussed	  could	  be	  extremely	  useful	  as	   it	  would	  avoid	  replicating	  non-­‐viable	  protocols	  indefinitely.	  	  	  In	  several	  reports,	  cultured	  parasites	  developed	  well	  only	  during	  the	  first	  schizogonic	  cycle,	  after	  which	  parasite	  density	  decreased	  dramatically.	  The	  reasons	  for	  such	  a	  drastic	  drop	  are	  unknown	  but	  may	  be	  related	  to	  the	  ′environmental	  shock′	  due	  to	  the	  sudden	  change	  from	  the	  host	   to	   in	   vitro	   conditions.	   The	   protocol	   by	   Golenda	   and	   colleagues	   [40]	   supports	   this	  hypothesis	   as	   the	   P.	   vivax	   Chesson	   strain	   was	   first	   maintained	   for	   several	   cycles	   in	   Aotus	  monkeys	   before	   adapting	   it	   to	   in	   vitro	   conditions	   by	   slowly	   and	   regularly	   supplying	  reticulocytes	   from	   hemochromatosis	   patients.	   Thus,	   a	   gentle	   adaptation,	   starting	   with	   P.	  
vivax	  monkey-­‐adapted	  strains	  and	  continuing	  with	  the	  gradual	  replacement	  of	  monkey	  blood	  with	   human	   reticulocytes	   could	   be,	   as	   recently	   shown	   for	   P.	   knowlesi	   [57],	   	   a	   possible	  solution.	  	  	  A	  crucial	  step	  for	  the	  establishment	  of	  the	  long-­‐term	  culture	  is	  the	  availability	  of	  a	  continuous	  and	  reliable	  source	  of	  target	  cells	  (reticulocytes).	  The	   in	  vitro	   invasion	  of	  reticulocytes	  by	  P.	  
vivax	   may	   be	   affected	   by	   the	   concentration	   method.	   Indeed,	   centrifugation	   on	   Percoll	  renographin	  has	  been	  reported	  to	  interfere	  with	  the	  invasion	  [37]	  while	  this	  is	  not	  the	  case	  for	  Percoll	  alone	  [29],	  and	  ultracentrifugation	  in	  homologous	  plasma	  is	  likely	  to	  be	  even	  less	  disruptive	   for	   the	   invasion	  process	   [40].	   Similarly,	  parasite	   invasion	  was	   less	  efficient	  with	  reticulocytes	   concentrated	   on	   Percoll	   than	   with	   those	   by	   MACS	   (Magnetic	   Activated	   Cell	  Sorting)	  [64].	  It	  has	  been	  shown	  that	  in	  vitro	  parasitized	  reticulocytes	  were	  very	  fragile,	  and	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an	   early	   disruption	   of	   the	   membrane	   occurred	   before	   the	   end	   of	   the	   intra-­‐erythrocytic	  maturation.	  Moreover,	  such	  P.	  vivax	  merozoites	  seemed	  to	  adhere	  to	  mature	  RBC	  membranes	  instead	   of	   infecting	   them,	   resulting	   in	   the	   rapid	   loss	   of	   parasites	   and	   reduced	   infection	  capacity	  [37].	  	  	  To	   overcome	   these	   difficulties,	   the	   production	   of	   reticulocytes	   derived	   from	   HSC	   or	   ESC	  represents	   an	   interesting	   alternative	   since	   they	   would	   not	   be	   weakened	   by	   a	   Percoll	  concentration	  step.	   In	  addition,	   since	   the	  differentiation	  process	  produces	  a	  heterogeneous	  population	   of	   erythroid	   cells	   at	   different	   stages	   of	   differentiation,	   the	   maturation	   of	  orthochromatic	   erythroblasts	   into	   reticulocytes	   would	   occur	   at	   different	   time	   points,	  meaning	   a	   regular	   influx	   of	   new	   targets	   cells	   for	  P.	  vivax	  merozoites.	   	   This	   is	   a	   potentially	  interesting	   feature	   for	   maintaining	   a	   P.	   vivax	   culture	   even	   though	   orthochromatic	  erythroblasts	  themselves	  are	  known	  to	  be	  only	  poorly	  invaded	  by	  parasites	  [65].	  	  ESCs	  have	  been	  previously	  differentiated	  into	  erythroid	  lineage	  using	  different	  protocols	  and	  are	  commercially	  available	  [66].	  This	  is	  a	  major	  advantage	  as	  it	  would	  allow	  the	  development	  of	   a	   standardized,	   continuous	   and	   independent	   source	   of	   reticulocytes.	   However,	   the	   cost,	  and	   for	   some	   countries	   the	   need	   for	   special	   authorizations,	   could	   make	   this	   method	   less	  accessible.	   Mice	   stem	   cells	   and	   induced	   pluripotent	   stem	   cells	   (iPSC)	   could	   also	   be	   used,	  though	  their	  enucleation	  rate	  was	  reportedly	  lower	  than	  for	  ESC	  [67].	  One	   potential	   problem	   of	   using	   HSC	   from	   cord	   blood	   or	   ESC/iPSC	   is	   that	   the	   produced	  reticulocytes	   contain	   foetal	   haemoglobin.	   Indeed,	   the	   presence	   of	   foetal	   haemoglobin	   has	  been	  reported	  to	  decrease	  the	  susceptibility	  of	  RBCs	  to	  P.	  falciparum	  in	  vitro	  [68].	  However,	  this	  was	  contradicted	  by	  another	  report	  showing	  no	  difference	  in	  P.	  vivax	  maturation	  when	  using	   reticulocytes	   originating	   from	   cord	   blood	   or	   from	   hematochromatosis	   patients,	   the	  latter	  containing	  mainly	  adult	  haemoglobin	  [47].	  The	  use	  of	  HSC	  from	  bone	  marrow	  (BM)	  or	  from	   peripheral	   blood	   may	   represent	   a	   good	   alternative	   as	   showed	   previously	   in	   a	   P.	  
falciparum	  culture	  using	  BM	  HSC	  derived	  RBCs	  [69].	  However,	  the	  question	  on	  the	  potential	  deleterious	  effect	  of	   foetal	  haemoglobin	  on	   the	  parasite	  growth	  still	  needs	   to	  be	  answered.	  This	   requires	   further	   studies	   comparing	   the	   intra-­‐erythrocyte	   parasite	   development	   with	  foetal	  or	  adult	  haemoglobin.	  	  Besides	  the	  availability	  and	  suitability	  of	   target	  cells,	   the	  use	  of	  an	  optimal	  culture	  medium	  with	  adequate	   supplementation	   is	  of	  major	   concern.	  Currently,	   the	  available	  knowledge	  on	  the	   biology	   of	   P.	   vivax	   blood	   stage	   parasites	   is	   inadequate	   to	   identify	   any	   missing	   or	  insufficient	  concentrations	  of	  nutrients.	  P.	  vivax	  culture	  conditions	  have	  often	  been	  based	  on	  the	   experience	   gained	   with	   P.	   falciparum	   cultures,	   though	   the	   two	   species	   differ	   in	   many	  aspects	  [70].	  The	  difficulty	  in	  setting	  up	  an	  optimal	  culture	  medium	  for	  P.	  vivax	  is	  illustrated	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by	  the	  often	  contradictory	  results	  obtained	  by	  different	  research	  groups	  and	  the	  obvious	  lack	  of	   continuity	   and	   reproducibility	   of	   published	   work.	   For	   instance,	   despite	   Brockelman’s	  report	  on	  RPMI1640	  being	  inferior	  to	  other	  culture	  media,	  this	  medium	  continued	  to	  be	  used	  [34].	  The	  only	  conclusion	  on	  the	  most	  suitable	  culture	  medium	  is	  that	  the	  McCoy’s	  medium	  supplemented	   with	  glucose	  is	  the	  minimum	  requirement	  for	  parasite	  growth.	  According	  to	  our	  own	  experience,	  other	  supplements	  (ascorbic	  acid,	  hypoxanthin,	  iron,	  and	  magnesium)	  do	  not	  seem	  essential	  for	  P.	  vivax	  growth,	  at	  least	  in	  the	  first	  in	  vitro	  maturation	  cycle	  (Celine	  Borlon,	  unpublished	  data).	  However,	  future	  studies	  are	  necessary	  to	  determine	  the	  optimal	  medium	  conditions	  for	  
P.	  vivax	  growth,	  and	  in	  this	  respect,	   future	  metabolomic	  studies	  may	  help	  in	  identifying	  key	  elements	  in	  the	  parasite	  maturation.	  	  In	   conclusion,	   after	   one	   century	   of	   efforts,	   research	   on	   a	   continuous	   P.	   vivax	   culture	   is	   as	  fragmentary	   and	   uncoordinated	   as	   ever.	   Rapid	   advances	   can	   be	  made	   only	   by	   sharing	   the	  accumulated	   knowledge,	   published	   and	   unpublished,	   for	   example	   negative	   results	   and	  comparing	  different	  protocols.	  A	  concerted	  effort	  is	  definitely	  needed	  for	  the	  ultimate	  goal	  of	  the	  long-­‐term	  culture	  for	  P.	  vivax.	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Chapter	  III:	  Stem	  cells	  	  Stem	  cells	  are	  undifferentiated	  cells	  that	  can	  differentiate	  in	  different	  cell	  types	  as	  well	  as	  self-­‐renew.	  We	  can	  distinguish	  2	  types	  of	  stem	  cells:	  embryonic	  stem	  cells	  (ESC)	  derived	  from	  the	  blastocyst	  and	  adult	  stem	  cells	  found	  in	  diverse	  adult	  tissues.	  Noteworthy,	  umbilical	  cord	  blood	  stem	  cells	  are	  also	  considered	  “adult”	  even	  if	  they	  are	  obviously	  obtained	  from	  newborns.	  The	   characteristics	   of	   stem	   cells	   are	   that	   they	   can	   self-­‐renew;	   the	   cells	   can	  multiply	  without	  losing	  their	  undifferentiated	  state.	  They	  are	  also	  characterized	  by	  different	  degrees	  of	  potency,	  i.e.	  which	  cell	  types	  they	  can	  develop	  into.	  Totipotent	  stem	  cells	  	  (the	  equivalent	  of	  the	  fertilized	  egg	   and	   the	   morula)	   can	   develop	   into	   all	   the	   embryonic	   and	   extra-­‐embryonic	   cell	   types.	  Pluripotent	   stem	   cells	   (the	   equivalent	   of	   the	   inner	   cell	   mass	   of	   the	   embryo,	   and	   cell	   lines	  derived	  from	  this,	  such	  as	  ESCs)	  can	  develop	  into	  all	  the	  embryonic	  cell	  types	  (the	  three	  germ	  layers	   and	   gametes).	  Multipotent	   stem	   cells	   can	   be	   found	   in	   the	   different	   germ	   layers	   and	   in	  nearly	  all	   tissues.	  They	  are	  multipotent	  as	   they	  can	  generate	  all	   cells	  of	  a	  given	   tissue,	  but	  no	  longer	   cells	   from	   other	   tissues,	   such	   as	   the	   hematopoietic	   system,	   mesenchymal	   stem	   cells,	  neural	   stem	  cells,	   gastrointestinal	   stem	  cells,	   to	  name	  a	   few.	   Subsequently	  potency	  decreases	  further	   to	  oligopotent	   and	  unipotent	   stem/progenitor	   cells	   (such	  as	   the	   spermatogonial	   stem	  cell)	  	  	  
Human	  embryonic	  stem	  cells	  (hESC)	  	  hESC	   are	   pluripotent	   cells	   that	   can,	   during	   embryogenesis,	   develop	   into	   3	   germ	   layers:	  endoderm,	  mesoderm	  and	  ectoderm.	  These	  3	  different	  germ	  layers	  will	  then	  be	  at	  the	  origin	  of	  different	  organs	  formation	  (fig.6).	  hESC	  are	  pluripotent	  cells	  derived	  from	  the	  inner	  cell	  mass	  of	  blastocyst-­‐stage	  embryos	  fertilized	  in	  vitro.	  The	  pluripotency	  can	  be	  monitored	  by	  assessing	  the	  expression	  of	  specific	  transcription	  factors	  i.e.	  Oct-­‐4,	  Sox-­‐2,	  Nanog,	  by	  a	  compliment	  of	  specific	  cell	  surface	  antigens	  (in	  human	  TRA-­‐160	  and	  SSEA4).	  For	  murine	  ESC,	  proof	  that	  pluripotency	  requires	  that	  the	  cell	  can	  for	  chimeric	  animals,	  even	  when	  injected	  in	  tetraploid	  blastocysts.	  In	  human,	  this	  is	  obviously	  impossible	  to	  do,	  and	  the	  best	  test	  to	  demonstrate	  pluripotency	  is	  by	  teratoma	   assay	  where	   hESC	   are	   injected	   sub-­‐cutaneous	   into	   immunodeficient	  mice.	   After	   3O	  days,	   teratomas	   form	  and	   can	   then	  be	   analyzed	  using	   immunohistochemistry	   to	  demonstrate	  presence	  of	  the	  3	  germ	  layers.	  Mouse	  ESC	  were	  first	  isolated	  in	  1981	  [71]	  and	  can	  be	  maintained	  in	  culture	  undifferentiated	  on	  a	  inactivated	  murine	  embryonic	  fibroblasts	  (iMEF)	  feeder	  layer	  with	  fetal	  bovine	  serum	  (FBS)	  and	  leukemia	  inhibitor	  factor	  (LIF)[72].	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The	   first	  description	  of	  hESC	  was	   reported	   in	  1998	   [73]	  where	  Thomson	  et	   al,	   demonstrated	  that	   cells	   could	   be	   harvested	   from	   the	   ICM	   of	   human	   fibroblasts,	   expanded	   in	   vitro,	   while	  maintaining	   pluripotency	   characteristics,	   when	   cultured	   on	   iMEF	   with	   addition	   of	   specific	  growth	   factors	   [74].	   The	   self-­‐renewal	   of	   hESC	   is	   under	   the	   dependence	   of	   the	   transformer	  growth	   factor	  beta	   (TGFbeta)/activin/Nodal	   signaling	   [75]	   and	  basic	   fibroblast	   growth	   factor	  (bFGF)	  [76].	  Notably,	  differentiated	  cells	  can	  be	  “undifferentiated”	  by	  forcing	  the	  expression	  of	  4	  pluripotent	  markers	  called	  Yamanaka	  factors:	  Oct-­‐4,	  Sox-­‐2,	  Klf-­‐4	  and	  c-­‐Myc	  [77].	  Those	  cells	  named	  induced	  pluripotent	  stem	  cells	  (iPSC)	  can	  be	  maintain	  and	  multiplied	  in	  vitro	  before	  been	  differentiated	  de	  novo.	  	  	  	  One	  way	   of	   allowing	   differentiation	   of	   hESC	   is	   to	   allow	   them	   to	   form	  organoids,	   also	   termed	  embryoid	   bodies	   (EBs),	  where	   the	   ESC	   spontaneously	   differentiate	   in	   cells	   of	   the	   three	   germ	  layers.	   Much	   more	   difficult,	   however,	   is	   to	   create	   homogenous	   differentiated	   progeny	   in	   a	  coordinated	  manner.	  Even	  if	  we	  know	  many	  things	  about	  development	  and	  about	  the	  end	  cell	  one	   wishes	   to	   create	   from	   ESCs,	   most	   differentiation	   protocols	   to	   date,	   whether	   for	   neural,	  cardiac,	  hepatic	  or	  hematopoietic	  cells,	  fall	  short	  in	  creating	  transplantable	  cell	  populations,	  or	  even	  fully	  mature	  cells	  that	  would	  be	  suitable	  for	  disease	  in	  a	  dish	  studies,	  as	  in	  this	  thesis.	  	  hESC	  could	  be	  used	  in	  many	  applications,	  especially	  for	  cell-­‐based	  therapies.	  The	  production	  of	  hESC-­‐derived	  organs	  or	   tissues	  could	  be	  of	  great	   interest	   in	   the	   frame	  of	   the	   transplantations	  that	  are	   still	  dependent	  of	  organ	  donors.	   Indeed,	   the	  generation	  of	  pancreatic	   cells	  producing	  insulin	  would	  be	  of	  great	  interest	  for	  peoples	  suffering	  of	  diabetes.	  	  The	  development	   of	   iPSCs	  would	   be	   also	   of	   great	   interest	   in	   order	   to	   resolve	   the	  problem	  of	  histocompatibility	  by	  dedifferentiating	  cells	  from	  the	  patient	  in	  order	  to	  generate	  the	  necessary	  tissue	  or	  organ	  for	  an	  autologous	  transplantation.	  	  	  
	  
Fig.	  6:	  Commitment	  of	  ESC	  into	  different	  germ	  layers	  and	  tissues.	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Adult	  stem	  cells	  (somatic	  cells)	  	  Adult	  stem	  cells	  are	  multipotent	  cells	  that	  can	  give	  rise	  to	  several	  types	  of	  cells	  but	  with	  a	  less	  broad	   range	   than	  ESCs.	   	   Their	  main	   function	   is	   the	  maintenance	   and	   reparation	  of	   the	   tissue	  where	  they	  are	  found,	  inside	  their	  stem	  cell	  niche	  [78].	  The	  adult	  stem	  cells	  can	  stay	  quiescent	  (inactivated	  stage)	  until	  they	  will	  be	  activated	  due	  to	  a	  specific	  need	  of	  cell	  by	  the	  tissue	  for	  its	  reparation	  of	  for	  replacing	  cells	  after	  apoptosis	  [79].	  Hematopoietic	  stem	  cells	  (HSC)	  are	  the	  most	  studied	  “adult”	  stem	  cells	  [80]	  and	  also	  commonly	  used	  for	  cell	  therapy	  against	  several	  blood	  diseases	  [81,	  82].	  Also	  many	  other	  somatic	  cells	  exist	  and	   are	   the	   origin	   of	   several	   cell	   types	   i.e.	   mesenchymal	   stem	   cells	   (osteoblasts,	   adipocytes,	  chondrocytes),	  neural	  stem	  cells	  (neurons,	  oligodendrocytes,	  astrocytes),	  dental	  pulp	  stem	  cells	  (teeth).	  	  Somatic	  cells	  can	  also	  be	  used	  for	  therapeutic	  treatment	  i.e;	  mesenchymal	  stem	  cells	  for	  bone	  or	  cartilage	  repair	  or	  umbilical	  cord	  blood	  stem	  cells	  to	  treat	  blood	  disorders	  [83,	  84].	  	  
Hematopoiesis	  	  Hematopoiesis	   is	   the	  process	  wherein	  different	  mature	  blood	  cells	  are	  being	  produced	  from	  a	  multipotent	   stem	   cell	   named,	   hematopoietic	   stem	   cell	   (HSC).	   During	   the	   embryonic	  development,	  hemangioblasts	  that	  are	  precursors	  of	  HSC	  and	  endothelial	  cells	  will	  migrate	  from	  yolk	  sac	  to	  aorta-­‐gonad-­‐mesonephros	  (AGM)	  where	  the	  first	  HSC	  can	  be	  observed.	  HSC	  will	  then	  seed	   into	   fetal	   liver	  where	   they	  will	  mature	  and	  expand.	  During	  adult	   life,	  hematopoiesis	  will	  occur	  in	  the	  bone	  marrow	  (fig.7).	   	  
	  	  
Fig	  7:	  localization	  of	  the	  hematopoiesis	  process	  during	  life	  (figure	  from	  Michal	  Komorniczak)	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Different	  stages	  of	  the	  erythroid	  development	  (fig.8)	  	  If	   we	   focus	   on	   the	   erythroid	   development	   that	   concerns	   our	   work,	   the	   production	   of	  erythrocytes	   follows	  the	   following	  pattern	  starting	   from	  HSC	  that	  are	  present	   in	  the	  adult	  BM	  and	  very	  few	  in	  the	  PB.	  However	  at	  birth,	  when	  HSC	  migrate	  from	  the	  liver	  to	  BM,	  they	  can	  be	  found	   in	   large	   numbers	   in	   the	   umbilical	   cord	   blood	   (UCB).	   Their	  morphology	   is	   close	   to	   the	  lymphocyte	  one	  with	  an	  important	  nucleus	  and	  a	  very	  round	  shape.	  We	   can	   distinguish	   2	   kinds	   of	   HSC:	   those	   that	   are	   able	   of	   self-­‐renewal	   and	   restore	  hematopoietic	   system	  over	  some	  months	  called	   long	   term	  HSC	  and	   those	   that	   restore	  rapidly	  the	  hematopoietic	  system	  but	  are	  not	  able	  of	  self-­‐renewal	  called	  short-­‐term	  HSC.	  The	  specific	  surface	  markers	  to	  identify	  the	  HSC	  population	  are:	  CD34+,	  CD59+,	  CD90/Thy1+,	  CD38low/-­‐,	  c-­‐Kit-­‐/low,	  and	  Lin-­‐	  Notably,	  the	  long	  term	  HSC	  have	  the	  capacity	  of	  self-­‐renewal,	  which	  mean	  that	  they	  can	  multiply	  and	  keep	   their	  stemness.	  This	  process	   involves	  several	  genes	   that	  when	  expressed,	  direct	   the	  HSC	  to	  self-­‐renew,	  i.e.	  Notch	  1,	  Ikaros,	  HoxB4	  or	  GATA-­‐2	  [85].	  The	  expansion	  of	  HSC	  will	  also	  be	  under	   the	   influence	   of	   growth	   factors	   i.e.	   thrombopoietin	   (TPO),	   stem	   cell	   factor	   (SCF),	  interleukin	  6	  (IL-­‐6)	  or	  FMS-­‐like	  tyrosine	  kinase	  3	  ligand	  (FLT-­‐3L)	  [86].	  Following	   the	   HSC	   stage,	   we	   find	   the	   Colony	   Formation	   Units-­‐Granulocyte,	   Erythrocyte,	  Monocyte,	  Megakaryocyte	   (CFU-­‐GEMM)	   stage	   corresponding	   to	   the	  multipotential	   progenitor	  cells	  at	  the	  origin	  of	  the	  myeloid	  lineage.	  They	  can	  be	  characterized	  by	  the	  expression	  of	  CD33+	  and	  CD34+	  The	   CFU-­‐GEMM	   will	   then	   evolve	   in	   burst	   forming	   unit-­‐erythroid	   (BFU-­‐E)	   cells	   that	   are	   the	  earliest	  erythroid	  precursor	  cells.	  They	  express	  on	  their	  surface	  the	  CD33+,	  CD34+	  and	  HLA-­‐DR.	  The	  colony-­‐forming	  units	  erythroid	   (CFU-­‐E)	   stage	   follows	  as	   they	  are	  more	  mature	  cells	   than	  BFU-­‐E	   and	   their	   development	   is	   under	   the	   dependence	   of	   erythropoietin	   (EPO),	   and	   they	  express	  the	  CD36+,	  CA1+	  and	  CD71+	  markers.	  The	  earliest	  stage	  of	  the	  erythroid	  development	  is	  the	  pro-­‐normoblast	  stage.	  These	  cells	  (12-­‐20	  μm)	  are	  characterized	  by	  an	   important	  nucleus,	  with	  multiple	  nucleoli,	  occupying	  80%	  of	   the	  cell	   and	  a	  blue	  cytoplasm.	  They	  express	  on	   their	   surface	   the	  CD36+,	  CD71+,	  CD117+,	  CD235a+,	  and	  HLA-­‐DR.	  The	   following	   stage	   is	   the	   basophilic	   normoblast	   stage	   These	   cells	   (12-­‐17	   μm)	   are	  morphologically	  close	  to	  the	  pro-­‐normoblasts	  with	  the	  exception	  that	  they	  do	  not	  have	  multiple	  nucleoli	  and	  they	  express	  the	  same	  surface	  markers	  excepted	  the	  CD117+	  The	   polychromatophilic	   normoblasts	   are	   the	   following	   stage;	   the	   nucleus	   becomes	   smaller	  compared	   with	   previous	   erythroid	   stage	   due	   to	   the	   chromatin	   condensation.	   The	   cytoplasm	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starts	   to	  acquire	  hemoglobin,	   resulting	   in	  a	  more	  blue	  color.	  Their	   size	   is	  between	  12	  and	  15	  μm:	  and	  they	  do	  not	  express	  the	  HLA-­‐DR	  unlike	  the	  basophilic	  normoblast	  The	   orthochromatophilic	   normoblasts	   are	   the	   last	   stage	   of	   nucleated	   erythroid	   cells.	   The	  nucleus	  is	  condensed	  and	  the	  cytoplasm	  gets	  coloration	  close	  to	  the	  one	  of	  mature	  normoblast	  for	  a	  size	  of	  8-­‐12 μm	  and	  on	  expression	  on	  their	  surface	  of	  CD36+,	  CD71+	  and	  CD235a+	  At	  this	  stage,	   cells	   will	   enucleate	   in	   vivo	   as	   a	   result	   of	   contact	   between	   the	   orthochromatophilic	  normoblast	   and	   a	  macrophage.	   Orthochromatophilic	   normoblasts	   interact	   with	  macrophages	  through	  an	  interaction	  between	  surface	  receptor	  (Vascular	  cell	  adhesion	  molecule	  1:	  V-­‐CAM	  1,	  intercellular	   adhesion	   molecule:	   I-­‐CAM	   4	   and	   erythroblast	   macrophage	   protein:	   EMP	   for	  macrophages	   and	   α4β1,	   α5	   and	   EMP	   for	   orthochromatophilic	   normoblast)	   to	   form	   an	  erythroblastic	  island	  [87].	  The	   first	   stage	   of	   erythroid	   cells	   without	   nucleus	   is	   named	   reticulocyte.	   The	   lifespan	   of	  reticulocytes	   is	  nearly	  2	  days	  (one	  day	   in	   the	  bone	  marrow	  and	  one	  day	   in	   the	  blood	  stream)	  and	  their	  express	  the	  CD235a+	  and	  CD71+	  markers,	  for	  a	  size	  of	  7-­‐9	  μm.	  Erythrocytes	  are	  the	  final	  erythroid	  stage.	  Erythrocytes	  are	  no	  longer	  round,	  but	  are	  bi-­‐concave	  cells	  without	  nucleus	  or	  mitochondria	  for	  a	  size	  of	  6-­‐8	  μm.	  Their	  lifespan	  is	  about	  120	  days	  and	  while	   it	   reaches	   this	   period,	   modification	   its	   membrane	   with	   the	   expression	   of	  phosphatidylserine	  on	  their	  surface,	  recognizable	  by	  macrophages	  that	  will	  phagocytize	  them	  in	  spleen,	   liver	   or	   lymphoid	   nodes.	   This	   phenomenon	   is	   called	   eryptosis.	   They	   express	   on	   their	  surface	  the	  CD235a+	  marker.	  	  	  
	  	  
Fig.8:	  hematopoiesis	  and	  erythropoiesis	  lineage	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Hemoglobin	  (Hb)	  	  Hemoglobin	  is	  a	  quaternary	  structure	  with	  two	  kinds	  of	  polypeptide	  chains:	  alpha	  (α)	  and	  beta	  (β).	  It	  represents	  97%	  of	  the	  dry	  erythrocyte	  content	  (35%	  of	  the	  total	  content)	  and	  contains	  a	  pocket	  that	  binds	  the	  heme	  group	  (fig.9).	  Hemoglobin	  serves	  as	  an	  oxygen	  carrier	  from	  the	  respiratory	  organs	  to	  the	  rest	  of	  the	  body.	  Its	  capacity	  is	  1.34	  mL	  of	  O2	  per	  gram.	  Beside	  O2,	  hemoglobin	  can	  carry	  in	  smaller	  quantity	  other	  gases:	  CO2	  and	  NO.	  Fetal	  hemoglobin	  (HbF):	  mainly	  present	  during	  the	   last	  7	  months	  of	   fetus	  development	  and	  6	  months	   after	   birth.	   Whereas	   adult	   Hb	   (HbA)	   is	   composed	   of	   2	   α	   and	   2	   β	   chains,	   HbF	   is	  composed	  of	  2	  α	  and	  2	  γ	  chains.	  HbF	   has	   a	   greater	   affinity	   for	   O2	   than	   HbA	   (fig.10)	   due	   to	   its	   lower	   interaction	   with	   2,3-­‐bisphosphoglycerate	  (2,3	  DPB),	  molecule	  decreasing	  the	  affinity	  of	  Hb	  for	  O2	  [88].	  During	  hematopoiesis,	  Hb	  is	  being	  expressed	  during	  the	  polychromatophilic	  normoblast	  stage	  and	   the	   switch	   between	   HbF	   and	   HbA	   occurred	   during	   the	   orthochromatophilic	   normoblast	  stage.	  The	  switching	  mechanism	  from	  HbF	  to	  HbA	  is	  a	  unique	  phenomenon	  in	  animal	  reign	  as	  it	  can	  be	  found	  only	   in	  humans	  and	  old	  world	  monkey	  even	  if	   the	  mechanism	  underlying	  this	  switch	   is	  still	   poorly	   understood.	   A	   recent	   study	   has	   demonstrated	   that	   BCL11A	   is	   responsible	   for	  silencing	  γ	  globin	  expression	  [89],	  but	  how	  this	  is	  triggered	  is	  still	  unknown	  [90].	  	  
	  	  
Fig.9:	  adult	  hemoglobin	  	  structure	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Fig.10:	  O2	  affinity	  curves	  for	  adult	  (red)	  and	  fetal	  (blue)	  hemoglobin.	  On	  the	  Y	  axis,	  the	  percentage	  of	  saturation	  and	  on	  the	  X	  axis,	  the	  O2	  pressure	  in	  mmHg	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AIMS	  AND	  OBJECTIVES	   	  	  The	  main	  goal	  of	  this	  work	  is	  to	  produce	  reticulocytes	  that	  are	  suitable	  for	  the	  invasion	  and	  maintenance	  of	  an	  in	  vitro	  culture	  of	  P.	  vivax.	  	  
• Objective	  1:	  Produce	  reticulocytes	  derived	  from	  hematopoietic	  stem	  cells	  isolated	  from	  umbilical	  cord	  blood	  and	  test	  their	  permissiveness	  to	  P.	  vivax.	  
P.	  vivax	  needs	  reticulocytes	  as	  target	  cells,	  nevertheless	  we	  need	  to	  increase	  the	  quantity	  of	   reticulocytes	   to	   facilitate	   the	   meeting	   between	   the	   parasite	   and	   its	   host	   cell.	  Hematopoietic	   stem	   cells	   provide	   a	   good	   starting	  point	   to	  differentiate	   erythroid	   cells	  and	   produce	   reticulocytes	   in	   a	   sufficient	   amount	   to	   provide	   target	   cells	   the	   in	   vitro	  culture	  of	  P.	  vivax.	   	  	  
• Objective	  2:	  Produce	  reticulocyte	  from	  different	  sources	  of	  hematopoietic	  stem	  cells	  and	  identify	  the	  best	  source	  for	  P.	  vivax	  culture.	  Even	   if	   P.	   vivax	   can	   successfully	   invade	   UCB/CD34+-­‐derived	   reticulocytes,	   we	   cannot	  observe	   an	   in	   vitro	   multiplication	   of	   the	   parasite.	   We	   propose	   here	   to	   investigate	  different	  sources	  of	  HSC	  in	  order	  to	  identify	  which	  one	  could	  produce	  the	  most	  suitable	  cells	   to	   the	   parasite.	  Moreover	  we	  will	   try	   to	   increase	   the	   starting	   population	   of	   HSC	  from	   each	   source	   using	   a	   protocol	   of	   expansion	   to	   optimize	   the	   production	   of	  reticulocyte.	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We	  will	  also	  investigate	  the	  influence	  of	  the	  hemoglobin	  stage	  as	  it	  has	  been	  previously	  described	  in	  the	  literature	  that	  fetal	  hemoglobin	  could	  slow	  down	  the	  intra-­‐erythrocyte	  development	  of	  the	  parasite.	   	  	  
• Objective	  3:	  	  To	  set	  up	  a	  reliable	  protocol	  of	  cryopreservation	  for	  the	  different	  reticulocytes	  produced.	  	  
P.	   vivax	   completes	   its	   blood	   life	   cycle	   in	   48	   hours	   and	   the	   reticulocyte	  maturate	   into	  mature	  erythrocyte	   in	  the	  same	  laps	  of	  time	  implying	  a	  frequent	  add	  of	  reticulocyte	  to	  support	   the	   multiplication	   of	   the	   parasite.	   Knowing	   that	   the	   full	   protocol	   of	  differentiation	  is	  14	  days,	   the	  possibility	  to	  create	  a	  stock	  of	   frozen	  reticulocytes	  could	  be	   a	   very	   interesting	   asset	   to	   handle	   the	   differentiation	   and	   the	   parasite	   culture	   in	  parallel.	  	  	  
• Objective	  4:	  Produce	  reticulocytes	  from	  embryonic	  stem	  cells	  (ESC).	  	  The	  possibility	  to	  use	  ESC	  as	  starting	  material	  for	  differentiation	  into	  reticulocytes	  could	  allow	  standardizing	  the	  protocol.	  Indeed,	  we	  would	  get	  an	  unlimited	  source	  of	  stem	  cells	  independent	   of	   inter-­‐individual	   variations.	   Moreover,	   the	   possibility	   to	   genetically	  modify	  those	  cells	  could	  be	  of	  great	  interest	  to	  create	  reticulocytes	  more	  suitable	  for	  P.	  
vivax	  in	  vitro.	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  The	  development	  of	  a	  system	  for	  the	  continuous	  culture	  of	  Plasmodium	  vivax	  in	  vitro	  would	  benefit	  from	  the	  use	  of	  reticulocytes	  derived	  from	  differentiated	  hematopoietic	  stem	  cells	  (HCS).	  At	  present,	  the	  need	  to	  use	  both	  fresh	  reticulocytes	  and	  fresh	  P.	  vivax	  isolates	  represents	  a	  major	  obstacle	  towards	  this	  goal,	  particularly	  for	  laboratories	  located	  in	  non-­‐endemic	  countries.	  Here,	  we	  describe	  a	  new	  method	  for	  the	  cryopreservation	  of	  HSC-­‐derived	  reticulocytes	  to	  be	  used	  for	  both	  P.	  falciparum	  and	  P.	  vivax	  invasion	  tests.	  Cryopreserved	  P.	  falciparum	  and	  P.	  vivax	  isolates	  could	  invade	  both	  fresh	  and	  cryopreserved	  HSC-­‐derived	  reticulocytes	  with	  similar	  efficiency.	  This	  new	  technique	  allows	  the	  storage	  of	  HSC-­‐derived	  reticulocytes	  which	  can	  be	  used	  for	  later	  invasion	  tests	  and	  represents	  an	  important	  step	  towards	  the	  establishment	  of	  a	  continuous	  P.	  
vivax	  culture.	  	  	  	  Keywords:	  Hematopoietic	  stem	  cells,	  reticulocytes,	  Plasmodium	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Abstract
The development of a system for the continuous culture of Plasmodium vivax in vitro would benefit from the use of
reticulocytes derived from differentiated hematopoietic stem cells (HCS). At present, the need to use both fresh
reticulocytes and fresh P. vivax isolates represents a major obstacle towards this goal, particularly for laboratories located in
non-endemic countries. Here, we describe a new method for the cryopreservation of HSC-derived reticulocytes to be used
for both P. falciparum and P. vivax invasion tests. Cryopreserved P. falciparum and P. vivax isolates could invade both fresh
and cryopreserved HSC-derived reticulocytes with similar efficiency. This new technique allows the storage of HSC-derived
reticulocytes which can be used for later invasion tests and represents an important step towards the establishment of
a continuous P. vivax culture.
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Introduction
Outside sub-Saharan Africa, Plasmodium vivax is the most
common human plasmodium specie [1]. Though it has long
been considered as less dangerous than P. falciparum, severe and
fatal P. vivax cases as well as drug resistant parasites are now
increasingly reported [2,3,4,5]. Understanding of the biology and
the transmission dynamics of P. vivax lags behind that of
P. falciparum, partly because the maintenance of a continuous line
of this parasite in vitro has not been established. The availability of
an in vitro culture system would improved our understanding of the
biology of P. vivax, e.g. invasion and relapse mechanisms,
resistance markers, and would contribute to the development of
new treatments and vaccines.
P. vivax preferentially invades reticulocytes [6] and thus in order
to achieve a continuous in vitro culture system the availability of
large amounts of these young red blood cells, which circulate in
the peripheral blood at low concentration (1% of total red blood
cells) and for a very short time (24 h), is required. Russell et al. [7]
recently published a reliable invasion assay protocol using fresh
P. vivax schizonts from fresh clinical isolates and enriched cord
blood reticulocytes. It has been previously shown that reticulocytes
can also be successfully produced through the differentiation of
hematopoietic stem cells (HSC) [8] and that such HSC-derived
reticulocytes may be used for P. vivax culture, though both the
reticulocyte production and the parasite densities obtained were
extremely low [9]. The contribution of this paper is to report an
improved method to produce and cryopreserve HSC-derived
reticulocytes to be later invaded by P. vivax, allowing research on
P. vivax culture to be carried out outside endemic areas, increasing
the number of teams potentially working on this subject and hence
the chances for major discoveries.
Materials and Me hods
Ethics Statement
P. vivax sample collection: MUTM 2008-15 from the
ethics Committee of the faculty of Tropical Medicine, Mahidol
University, Bangkok, Thailand.
Cord blood sample collection: blood was collected
anonymously and patients were informed orally with a possibility
of opting-out. Each Patient was notified on the hospital admission
form of this opting-out possibility.
Procedure was accepted by ethic committee of UZA and ITM.
Study was approved by the ITM review board, number:
SBB.219.2007/1410.
Hematopoietic Stem Cell (HSC) Isolation
Umbilical cord blood samples (40 ml each) were collected from
pregnant women delivering at the University hospital, Antwerp
(UZA), after obtaining an individual informed consent. Mono-
nuclear cells (MNC) were separated by Ficoll-Isopaque (GE
Healthcare) centrifugation (250 g, 10 min) and enriched for
CD34+ cells by supermagnetic microbead selection using Mini-
MACS columns (Miltenyi Biotech) according to a previously
published procedure [10].
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Introduction	  	  Outside	  sub-­‐Saharan	  Africa,	  Plasmodium	  vivax	   is	  the	  most	  common	  human	  plasmodium	  species	  [1].	  Though	  it	  has	  long	  been	  considered	  as	  less	  dangerous	  than	  P.	  falciparum,	  severe	  and	  fatal	  P.	  
vivax	   cases	   as	   well	   as	   drug	   resistant	   parasites	   are	   now	   increasingly	   reported	   [2,3,4,5].	  Understanding	   of	   the	  biology	   and	   the	   transmission	  dynamics	   of	  P.	  vivax	   lags	   behind	   that	   of	  P.	  
falciparum,	  partly	  because	  the	  maintenance	  of	  a	  continuous	  line	  of	  this	  parasite	  in	  vitro	  has	  not	  been	   established.	   The	   availability	   of	   an	   in	   vitro	   culture	   system	   would	   improved	   our	  understanding	   of	   the	   biology	   of	   P.	   vivax,	   e.g.	   invasion	   and	   relapse	   mechanisms,	   resistance	  markers,	  and	  would	  contribute	  to	  the	  development	  of	  new	  treatments	  and	  vaccines.	  	  
P.	  vivax	  preferentially	  invades	  reticulocytes	  [6]	  and	  thus	  in	  order	  to	  achieve	  a	  continuous	  in	  vitro	  culture	  system	  the	  availability	  of	  large	  amounts	  of	  these	  young	  red	  blood	  cells,	  which	  circulate	  in	  the	  peripheral	  blood	  at	  low	  concentration	  (1%	  of	  total	  red	  blood	  cells)	  and	  for	  a	  very	  short	  time	  (24h),	   is	  required.	   	  Russell	  et	  al.	   [7]	  recently	  published	  a	  reliable	  invasion	  assay	  protocol	  using	  fresh	  P.	  vivax	  schizonts	  from	  fresh	  clinical	  isolates	  and	  enriched	  cord	  blood	  reticulocytes.	  	  It	  has	  been	   previously	   shown	   that	   reticulocytes	   can	   also	   be	   successfully	   produced	   through	   the	  differentiation	   of	   hematopoietic	   stem	   cells	   (HSC)	   [8]	   and	   that	   such	   HSC-­‐derived	   reticulocytes	  may	   be	   used	   for	   P.	   vivax	   culture,	   though	   both	   the	   reticulocyte	   production	   and	   the	   parasite	  densities	   obtained	   were	   extremely	   low	   [9].	   The	   contribution	   of	   this	   paper	   is	   to	   report	   an	  improved	  method	  to	  produce	  and	  cryopreserve	  HSC-­‐derived	  reticulocytes	  to	  be	  later	  invaded	  by	  
P.	  vivax,	  allowing	  research	  on	  P.	  vivax	  culture	  to	  be	  carried	  out	  outside	  endemic	  areas,	  increasing	  the	   number	   of	   teams	   potentially	   working	   on	   this	   subject	   and	   hence	   the	   chances	   for	   major	  discoveries.	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Materials	  &	  Methods:	  
Ethics	  statement:	  	  
P.	  vivax	   sample	  collection:	  MUTM	  2008-­‐15	   from	  the	  ethics	  Committee	  of	   the	   faculty	  of	  Tropical	  Medicine,	  Mahidol	  University,	  Bangkok,	  Thailand	  Cord	   blood	   sample	   collection:	   blood	   was	   collected	   anonymously	   and	   patients	   were	  informed	   orally	   with	   a	   possibility	   of	   opting-­‐out.	   Each	   Patient	   was	   notified	   on	   the	  hospital	  admission	  form	  of	  this	  opting-­‐out	  possibility.	  Procedure	  was	  accepted	  by	  ethic	  committee	  of	  UZA	  and	  ITM.	  Study	  was	  approved	  by	  the	  ITM	  review	  board,	  number:	  SBB.219.2007/1410	  	  	  	  
Hematopoietic	   stem	   cell	   (HSC)	   isolation.	  Umbilical	  cord	  blood	  samples	  (40ml	  each)	  were	   collected	   from	   pregnant	   women	   delivering	   at	   the	   University	   hospital,	   Antwerp	  (UZA),	   after	   obtaining	   an	   individual	   informed	   consent.	  Mononuclear	   cells	   (MNC)	  were	  separated	   by	   Ficoll-­‐Isopaque	   (GE	   Healthcare)	   centrifugation	   	   (250	   g,	   10	   min)	   and	  enriched	   for	   CD34+	   cells	   by	   supermagnetic	   microbead	   selection	   using	   Mini-­‐MACS	  columns	  (Miltenyi	  Biotech)	  according	  to	  a	  previously	  published	  procedure	  [10].	  
HSC	  culture.	  The	  amplification	  procedure	  was	  adapted	  from	  a	  three-­‐step	  expansion	  of	  CD34+	   cells	  by	   sequential	   supply	  of	   the	   culture	  with	   specific	   combination	  of	   cytokines	  and	  growth	  factors	  [11].	  HSCs	  isolated	  from	  cord	  blood	  were	  cultured	  at	  37°C,	  5%	  CO2	  in	  a	   modified	   serum-­‐free	   media	   (IMDM,	   Biochrom)	   supplemented	   with	   L-­‐	   Glutamine	   (4	  mM,	   Sigma),	   Penicilline/	   Streptomycine	   (1	  %,	   Invitrogen),	   Inositol	   (40	   µg/ml,	   Sigma),	  Folic	   acid	   (10µg/ml,	   Sigma),	   Monothioglycerol	   (1.6	   10-­‐4	   M,	   Sigma),	   Transferrin	   (120	  µg/ml,	   Sigma),	   insulin	   (10	   µg/ml,	   Sigma),	   Bovine	   Serum	  Albumin	   detoxified	   by	   beads	  resin	  AG501-­‐X8	  (Biorad)	  (BSA,	  100	  mg/ml,	  PAA)	  [12].	  	  
Step	  1	  (day	  0	   to	  8):	   CD34+	   cells	  were	   cultured	  with	   Stem	  Cell	   Factor	   (SCF,	   100	  ng/ml,	  Bioke),	   IL-­‐3	   (5	   ng/ml,	   R&D	   System),	   Hydrocortisone	   (HDS,	   10-­‐6	   M,	   Sigma),	   and	  
CHAPTER	  I:	  CB/HSC	   	   Plasmodium	  vivax	  
	  	  	  	  	  	  	  	  	  	  	  	  
42	  
Erythropoietin	   (EPO,	   3	   IU/ml,	  R&D	  System).	  At	   day	  4,	   cells	  were	  diluted	  1:2	   in	   IMDM	  medium	  completed	  with	  all	   the	   four	  above	  mentioned	  growth	  factors	  and	  incubated	  at	  37°C	   for	   4	   additional	   days.	   At	   day	   7,	   cells	   were	   re-­‐suspended	   (106	   cells	   per	   vial)	   in	  culture	   medium	   (IMDM)	   and	   an	   equal	   volume	   of	   80%	   Foetal	   Calf	   Serum	   (FCS)/20%	  DMSO	   solution	   was	   added	   drop	   by	   drop	   to	   obtain	   an	   IMDM/40%	   FCS	   /10%	   DMSO	  solution	  before	  progressively	  freezing	  them	  at	  -­‐80°C	  using	  a	  Mr	  Frosty	  [13].	  
Step	  2	  (day	  8-­‐11):	   	  at	  day	  8,	  250	  000	  cells	  were	  added	  to	  each	  25cm2	  flask	  and	  incubated	  in	  5	  ml	  of	  IMDM	  medium	  supplemented	  with	  only	  EPO	  (3	  IU/mL).	  
Step	   3	   (day	   11-­‐20):	   the	   culture	   was	   maintained	   in	   IMDM	   without	   growth	   factors	   or	  cytokines	  and	  the	  medium	  was	  changed	  every	  3	  days.	  The	  culture	  was	  stopped	  at	  day	  14	  corresponding	   to	   the	   peak	   of	   reticulocytes	   counts	   determined	   by	   microscopic	  examination	   of	   thin	   films	   done	   by	   cytospin	   (Thermo	   scientific):	   200	   000	   cells	   were	  washed	   with	   PBS	   once	   and	   re-­‐suspended	   in	   50	   µL	   of	   PBS.	   50	   µL	   of	   	   Cresyl	  Blue(Merck)(previously	   diluted	   1/100)	   were	   added	   to	   the	   tube	   and	   incubated	   30	  minutes.	  FCS	  (30	  µL)	  was	  added	  to	  protect	  cells	  during	  cytospin	  centrifugation	  and	  the	  cells	  were	  placed	  in	  a	  cytospin	  funnel.	  After	  a	  centrifugation	  (700	  rpm,	  3	  minutes),	  slides	  were	  removed	  from	  the	  funnel	  and	  stained	  with	  Giemsa.	  A	  reticulocyte	  scoring	  positive	  would	  contain	  two	  or	  more	  blue-­‐stained	  RNA	  granules.	  	  
HSC	   cryopreservation.	   HSC	   derived	   reticulocytes	   at	   day	   14	   in	   the	   culture	   were	  subjected	  to	  three	  different	  cryopreservation	  protocols:	  	   	  
Glycerolyte	  solution	  [14]:	  100	  µL	  of	  Glycerolyte	  (Baxter)	  were	  drawn	  up	  to	  the	  cell	  pellet	  using	   an	   insulin	   syringe.	   Firstly,	   20%	   of	   the	   volume	   of	   Glycerolyte	   was	   added	   to	   the	  blood	   cell	   suspension	   drop	   by	   drop	   while	   continuously	   agitating	   the	   tube	   to	   mix	   the	  content.	  This	  suspension	  was	   incubated	  5	  minutes	  at	  room	  temperature	  before	  adding	  the	  rest	  of	  Glycerolyte.	  RBC-­‐Glycerolyte	  mixture	  was	   then	  aliquoted	   into	  cryovials	  and	  frozen	  at	  -­‐80	  °C	  overnight	  before	  being	  stored	  in	  liquid	  nitrogen.	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Glycerol	   &	   Sorbitol	   solution	   [15]:	   Cells	   were	   frozen	   in	   a	   medium	   composed	   of	   28%	  glycerol,	  3%	  sorbitol,	  and	  0,9%	  NaCl	  diluted	  in	  distillate	  water.	  This	  solution	  was	  added	  drop	  by	  drop	  to	  packed	  cells,	  at	  room	  temperature.	  Cells	  were	  immediately	  transferred	  at	  -­‐80°C.	  	  
IMDM/10%	   DMSO/40%	   FCS	   solution[16]:	   Cells	   were	   frozen	   according	   to	   a	   standard	  method	  with	  medium	  containing	  10%	  DMSO/40%	  FCS	  as	  described	  above	  for	  the	  HSC	  culture	  at	  day	  7.	  Reticulocytes	  were	  kept	  in	  liquid	  nitrogen	  up	  to	  1	  year.	  Cells	  were	  thawed	  following	  the	  same	  protocol	  as	  for	  Plasmodium	  falciparum:	  the	  volume	  (V)	  of	  the	  thawed	  content	  was	  measured	  and	  transferred	  to	  a	  50ml	  centrifuge	  tube.	  Then	  0.1	  V	  of	  pre-­‐warmed	  (37°C)	  12	  %	  NaCl	  solution	  was	  added	  drop	  by	  drop	  to	  the	  parasitized	  red	  blood	  cells	  (pRBC),	  which	  were	  allowed	  to	  stay	  for	  5	  min	  at	  room	  temperature.	  Subsequently	  10	  V	  of	  1.6	  %	  NaCl	  solution	  (pre-­‐warmed	  at	  37	  °C)	  were	  carefully	  added	  to	  the	  cells,	  which	  were	  then	  centrifuged	   for	   10	   min	   at	   650	   g	   without	   applying	   a	   break.	   The	   supernatant	   was	  discarded	  and	  10	  ml	  of	  0.9%	  NaCl	  solution	  pre-­‐warmed	  at	  37	  °C	  was	  carefully	  added	  to	  the	   pellet,	   followed	   by	   a	   5	   min	   centrifugation	   at	   650	   g	   [17].	   The	   cryopreservation	  protocols	  were	  evaluated	  according	  to	  the	  following	  criteria:	   	  viability	  of	  the	  cells	  after	  thawing,	  preservation	  of	   the	  reticulocyte	  population,	  presence	  or	  absence	  of	  clots,	  and	  presence	  of	  invaded	  reticulocytes	  by	  Plasmodium.	  
FACS	  analysis.	  HSCs	  cultures	  were	  analysed	  by	  flow	  cytometer	  at	  day	  8,	  11,	  14	  and	  17	  of	   their	   in-­‐vitro	  maturation.	   After	   thawing	   the	   cryopreserved	   reticulocytes	   they	  were	  analysed	  by	  FACS,	  to	  assess	  the	  expression	  of	  stage	  specific	  markers:	  CD36,	  CD45,	  CD71	  and	  CD235a.	  Briefly,	  200	  000	  cells	  were	  centrifuged	  for	  5	  min	  at	  650	  g.	  The	  pellet	  was	  re-­‐suspended	  in	  100µL	  of	  PBS	  buffer.	  5	  µl	  of	  CD45-­‐PE	  (BD	  bioscience),	  10	  µL	  of	  CD71-­‐APC	  (BD	  bioscience),	  5	  µL	  of	  CD36-­‐FITC	  (BD	  bioscience),	  and	  5	  µL	  of	  CD235-­‐PerCP	  (BD	  bioscience),	  were	  added	  to	   the	  cells	  and	   incubated	   for	  15	  min	  at	  room	  temperature	   in	  the	   dark.	   One	   tube	   containing	   only	   antibody	   isotypes	   coupled	   to	   fluorochromes	   was	  used	   as	   a	   negative	   control:	   10	   µL	   of	   IgG1γ-­‐PE	   (BD	   bioscience),	   5	   µL	   of	   IgM-­‐FITC	   (BD	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bioscience),	  5	  µL	  of	   IgG1	  K	   isotype-­‐PerCP	  (BD	  bioscience),	  and	  5	  µL	  of	   IgG1	  K	   isotype-­‐APC	   (BD	   bioscience).	   	   After	   incubation	   cells	   were	  washed	  with	   FACS	   buffer	   (Miltenyi	  Biotech)	   and	   re-­‐suspended	   in	   500	   µL	   of	   buffer	   before	   analysis.	   FACS	   analysis	   were	  carried	  out	  on	  a	  FACScalibur	  4	  color	  cytometer	  (BD	  bioscience).	  	  
Hemoglobin	   content.	  The	  haemoglobin	  (Hb)	  content	  (foetal	  or	  adult	  haemoglobin)	  of	  the	  HSC	  derived	  reticulocytes	  was	  analyzed	  using	  the	  Kleihauer	  method	  [18].	  Umbilical	  cord	  blood	   (≥95%	  of	   foetal	  Hb)	  and	  adult	  peripheral	  blood	   (≥95%	  of	   adult	  Hb	   )	  were	  used	  as	  controls.	  Cells	  containing	  foetal	  haemoglobin	  will	  be	  stained	  in	  red	  whereas	  cells	  containing	   adult	   haemoglobin	   will	   look	   empty	   and	   only	   their	   membranes	   will	   be	  observed.	  
Plasmodium	  falciparum.	  P.	  falciparum	  D10	  strains,	  cultured	  and	  cryopreserved	  in	  the	  Institute	  of	  Tropical	  Medicine,	  Antwerp,	  Belgium,	   (ITMA)	   cryobank	  were	  used	   for	   this	  study.	  Parasite	  isolates	  were	  thawed	  in	  a	  37°C	  incubator	  until	  no	  ice	  was	  left	  in	  the	  tube.	  The	  thawing	  protocol	  was	  the	  same	  as	  the	  one	  used	  for	  reticulocytes.	  To	  check	  for	  the	  invasion	  of	  new	  RBCs	  (RBC	  derived	  from	  HSC	  maturation)	  by	  P.	  falciparum,	  pRBC	  were	  concentrated	  on	  a	  Percoll	  gradient	  (	  90	  %,	  70	  %,	  and	  40	  %;	  Sigma)	  [19]	  and	  centrifuged	  for	  30	  min	  at	  2600g	  without	  applying	  a	  break.	  After	   centrifugation,	   the	   layer	  between	  the	  70	  %	  and	  40	  %	  Percoll	  was	  kept,	  transferred	  into	  a	  new	  tube	  and	  washed	  with	  RPMI	  (Lonza).	  1	  µl	  of	  purified	  pRBC	  (≥	  90%	  mature	  forms)	  was	  mixed	  with	  4	  µL	  of	  the	  HSCs	  derived	   reticulocytes	   and	   94	  µL	   of	   RPMI	  medium	   supplemented	  with	  HEPES	   (25	  mM,	  Lonza),	   L-­‐glutamine	   (1	   mM),	   gentamycin	   (40	   µg/ml,	   Sigma),	   D-­‐glucose	   (2	  %,	   Sigma),	  hypoxanthine	  (50	  mg/L,	  Sigma)	  diluted	  in	  NaOH	  1M	  and	  10	  %	  heat	  inactivated	  Human	  Serum	  (final	  volume:	  100	  µL,	  haematocrit	  5	  %).	  The	  culture	  was	  incubated	  in	  a	  hermetic	  chamber	  flushed	  gas	  (90%	  N2,	  5%	  CO2,	  5%	  O2)	  at	  37°C	  for	  24	  h.	  Parasite	  invasion	  was	  determined	   by	  microscopic	   examination	   of	   Giemsa	   stained	   thin	   films.	   The	   number	   of	  newly	  invaded	  cells	  by	  P.	  falciparum	  ring	  stages	  were	  counted	  and	  divided	  by	  the	  total	  number	  of	  cells	  to	  obtain	  the	  parasite	  density	  (%	  of	  invaded	  RBC).	  For	  each	  experiment,	  two	  technicians	  independently	  examined	  the	  slides	  and	  the	  mean	  parasite	  density	  was	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taken	  as	  the	  final	  value	  .	  If	  reading	  results	  were	  discordant	  (parasite	  counting	  difference	  ≥30%),	  both	  technicians	  re-­‐read	  the	  slide	  until	  an	  agreement	  was	  found.	  	  	  
Plasmodium	   vivax.	   P.	  vivax	   isolates	  were	   collected	   from	  patients	  with	   acute	   P.	   vivax	  malaria	   (mono-­‐infection	  with	   a	   density	   of	   >1parasite/1000	   red	   blood	   cells)	   attending	  the	  clinics	  of	  the	  Shoklo	  Malaria	  Research	  Unit	  (SMRU,	  Mae	  Sot,	  North-­‐West	  Thailand),	  after	   obtaining	   their	   individual	   written	   informed	   consent.	   P.	   vivax	   isolates	   contained	  more	   than	   80%	   early	   ring	   forms.	  White	   blood	   cells	   were	   removed	   after	   filtration	   on	  CF11	   column	   (Whatmann)	   [20];	   Parasites	  were	   frozen	   in	  Glycerolyte	   solution	   [21],	   as	  described	   above,	   and	   then	   transferred	   and	   kept	   in	   liquid	   nitrogen	   at	   the	   ITMA.	  Subsequently,	  P.	  vivax	   isolates	  were	   thawed	   following	   the	   same	  protocol	   as	   described	  above	   for	   P.	   falciparum,	   and	   were	   re-­‐suspended	   in	   pre-­‐warmed	   37°C	   McCoy’s	   5A	  (Gibco)	  medium	   supplemented	  with	  20%	  heat	   inactivated	  human	   serum	   from	  normal	  AB	   group	   donors	   and	   0.5%	   D-­‐glucose.	   The	   medium	   containing	   P.	   vivax	   	   was	   then	  transferred	  to	  a	  25	  cm2	  culture	   flask,	   flushed	  with	  gas	  (90%	  N2,	  5%	  CO2,	  5%	  O2),	  and	  placed	   in	   a	   37°C	   incubator	   for	   36	   to	   44	   hours	   to	   allow	   the	  maturation	   into	   schizonts.	  Parasite	  stage	  was	  determined	  by	  microscopic	  examination	  of	  Giemsa	  stained	  thick	  and	  thin	  films.	  Mature	  schizonts	  were	  concentrated	  in	  45%	  Percoll	  by	  centrifugation	  for	  15	  minutes	   at	   1580	   g	   without	   applying	   a	   break	   (Sigma)[22].	   Purified	   schizonts	   (≥	   90%	  mature	   forms)	   were	   mixed	   with	   HSCs	   derived	   reticulocytes	   resulting	   in	   a	   starting	  parasite	  density	  between	  0.5	  and	  1	  %.	  Complete	  Mc	  Coy’s	  medium	  was	  added	  in	  order	  to	  obtain	   a	   5%	   haematocrit	   level	   and	   the	   culture	   was	   incubated	   at	   37°C	   in	   a	   hermetic	  chamber	   flushed	   for	   24h	   with	   gas	   (90%	   N2,	   5%	   CO2,	   5%	   O2)	   [7].	   The	   efficiency	   of	  invasion	  was	  checked	  as	  described	  above	  for	  P.	  falciparum.	  	  
	  
Data	  analysis:	  During	  HSC	  maturation,	  reticulocytes	  and	  RBC	  were	  counted	  for	  each	  selected	  day	  during	  the	  maturation	  process.	  Median	  value	  and	  interquartile	  range	  (IQR)	  were	  calculated	  for	  the	  reticulocytes	  counts	  (6	  independent	  experiments)	  as	  well	  as	  for	  the	  expression	  of	  the	  surface	  markers	  measured	  by	  FACS	  (3	  independent	  experiments).	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Parasite	  densities	  for	  P.	  vivax	  invasion	  assays	  were	  calculated	  per	  500	  counted	  cells.	  The	  number	  of	  infected	  cells	  was	  divided	  by	  the	  total	  number	  of	  counted	  cells	  and	  multiplied	  by	  100	  to	  obtain	  a	  percentage.
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Results:	  
Amplification	  of	  erythroid	  cells.	  Microscopic	  examination	  of	  thin	  films	  of	  the	  erythroid	  cells	  (Figure	  1)	  confirmed	  a	  normal	  differentiation	  pattern	  and	  the	  commitment	  of	   the	  HSC	   culture	   to	   the	   erythroid	   lineage	   as	   defined	   elsewhere	   [23].	   A	   total	   of	   30	  independent	   experiments	   were	   successfully	   carried	   out,	   and	  median	   reticulocyte	   and	  RBC	  population	  counts	  were	  computed	  at	  regular	  intervals	  (every	  3	  days	  between	  day	  8	  and	  day	  20)	  for	  6	  experiments	  (Figure	  2).	  The	  first	  reticulocytes	  were	  observed	  at	  day	  12	  of	  differentiation,	  and	  their	  number	  dramatically	  increased	  between	  days	  13	  and	  14	  (from	   5%	   to	   18%),	   corresponding	   to	   a	   peak	   of	   enucleation.	   Subsequently,	   the	  percentage	  of	  reticulocytes	  decreased	  steadily	  (10%	  at	  day	  16)	  and	  almost	  disappeared	  at	  day	  19	  of	  differentiation.	  The	  haemoglobin	  content	  measured	  at	  day	  14	  of	  maturation	  was	  mainly	  foetal	  (about	  90	  %,	  data	  not	  shown).	  Mature	  red	  blood	  cells	  (RBC)	  showed	  an	  opposite	  trend	  as	  compared	  to	  reticulocytes	  as	  they	  started	  to	  increase	  following	  the	  reticulocyte	   peak	   (0.4%	   at	   day	   15),	   outnumbered	   the	   reticulocytes	   at	   day	   17	   and	  reached	  a	  plateau	  of	  above	  20%	  at	  day	  20.	  After	  cryopreservation,	  the	  cells	  viability	  was	  up	   to	   70	  %	   and	   the	   proportion	   of	   reticulocytes	   remained	   stable	   compared	   to	   the	   one	  before	  freezing	  (except	  for	  glycerolyte	  which	  was	  not	  tested	  due	  to	  the	  presence	  of	  clots	  during	  the	  thawing	  process).	  	  
FACS	  analysis	  of	  HSC	  maturation.	  The	  proportion	  of	  positive	  cells	  expressing	  different	  surface	  markers	  was	  calculated	  at	  different	  time	  points	  (Figure	  3a).	  The	  CD45,	  a	  specific	  marker	  for	  young	  cells	  (pre-­‐proerythroblast	  stage),	  decreased	  dramatically	  from	  90%	  at	  day	   8	   to	   3%	   at	   day	   11,	   while	   CD235a	   (Glycophorin	   A	  marker)	   followed	   the	   opposite	  trend.	   Both	   CD71	   and	   CD36	   (both	  markers	   of	   stages	   between	   the	   proerytroblast	   and	  mature	   RBC)	   were	   highly	   expressed	   at	   day	   8,	   100%	   and	   80%	   respectively,	   and	  decreased	   following	   a	   different	   pattern	   until	   day	   17:	   	   the	   CD71	   decreased	   slightly	   to	  65%	  at	   day	  17,	  while	   the	  CD36	  dramatically	   decreased	   to	   less	   than	  10%	  at	   day	  17.	  A	  freezing	  cycle	  (up	  to	  1	  year	  in	  the	  frame	  of	  this	  work)	  of	  the	  HSC	  derived	  reticulocytes	  which	  were	  matured	   till	   day	   14	   did	   not	   affect	   the	   expression	   of	   specific	   reticulocytes	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markers	   for	  any	  of	   the	   three	  protocols	   tested.	   Indeed	   the	  comparison	  with	   the	   freshly	  produced	  HSC	  derived	  reticulocytes	  gave	  similar	  results:	  	  (Figure	  3b)	  a	  high	  expression	  of	   CD71	   (between	   95	  %	   and	   98	  %	   according	   to	   the	   freezing	   protocol	   versus	  90%	   for	  fresh	  reticulocytes	  at	  day	  14),	  and	  CD235a	  (between	  90	  and	  98	  %	  versus	  90	  %	  in	  fresh	  reticulocytes),	  a	  quasi-­‐absence	  of	  CD45	  (around	  0.5	  %	  versus	  1%),	  and	  the	  expression	  of	  CD36	  reaching	  30	  %	  for	  the	  3	  protocols	  tested	  (versus	  40%).	  	  
Invasion	  assays.	  Both	  P.	  falciparum	  and	  P.	  vivax	   could	  successfully	   invade	   freshly	  HSC	  derived	   reticulocytes	   (Figure	   4a	   and	   4b).	   Parasite	   density	   after	   invasion	   of	   fresh	  reticulocytes	  was	  around	  0.5	  %	  for	  P.	  vivax	  and	  4%	  for	  P.	  falciparum.	  Parasite	  invasion	  was	   then	   tested	   on	   the	   cryopreserved	   reticulocytes	   derived	   from	  HSC	  maturation.	   	  P.	  
falciparum	   could	   invade	   cryopreserved	   reticulocytes	   subjected	   to	   any	   of	   the	   3	  cryopreservation	   methods	   (parasite	   density:	   4.2	   %	   for	   glycerol	   solution,	   	   4.1%	   for	  Glycerolyte	   and	   8%	   for	   the	   IMDM/10%	   DMSO/40%	   FCS;	   3	   independent	   assays).	  However,	   the	   method	   using	   the	   Glycerolyte	   solution	   was	   discarded	   as	   clots	   were	  observed	  during	  the	  thawing	  process.	  Therefore,	  for	  P.	  vivax	  invasion,	  only	  reticulocytes	  cryopreserved	   with	   the	   Glycerol	   solution	   and	   the	   Medium/10%	   DMSO/40%	   FCS	  solutions	   were	   used.	   These	   were	   successfully	   invaded	   with	   the	   identification	   of	   ring	  stages	   24h	   post	   invasion	   and	   the	   parasite	   density	  was	   counted	   for	   all	   8	   independent	  experiments	  (Figure	  5).	  P.	  falciparum	  and	  P.	  vivax	  could	  invade	  the	  erythroblasts	  stages,	  with	  both	  fresh	  and	  cryopreserved	  HSC	  derived	  cells	  (Figure	  4c).	  
Parasite	   density	   obtained	   after	   invasion	   of	   cryopreserved	   HSC	   derived	   reticulocytes	  varied	   substantially	   (from	   0.19%	   to	   2.43%)	   according	   to	   the	   P.	   vivax	   isolate	   used.	  However,	   parasite	   density	   for	   each	   single	   parasite	   isolate	   did	   not	   vary	   when	   using	  different	   batches	   of	   cryopreserved	   reticulocytes.	   The	   range	   of	   parasite	   densities	   after	  invasion	   was	   between	   0.19	   %	   and	   2.43	   %	   for	   reticulocyte	   cryopreserved	   in	   the	  IMDM/10%	   DMSO/	   40%	   FCS	   solution.	   In	   comparison,	   invasion	   rate	   of	   reticulocytes	  cryopreserved	  in	  glycerol	  solution	  was	  30	  to	  50	  %	  less	  efficient	  in	  4	  replicates)	  (Figure	  5).	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This	   is	   the	   first	   report	   showing	   a	   reliable	   cryopreservation	   protocol	   for	   HSC-­‐derived	  reticulocytes	   derived	   that	   can	   be	   successfully	   invaded	   by	   both	   cryopreserved	   P.	  
falciparum	   and	   P.	   vivax	   isolates.	   This	   will	   contribute	   to	   the	   establishment	   of	   a	  continuous	  P.	  vivax	  culture,	  since	  the	  latter	  requires	  a	  continuous	  supply	  of	  reticulocytes	  in	  a	   large	  amount.	  Until	  now,	  availability	  of	  adequate	  quantities	  of	   reticulocytes	  was	  a	  bottleneck,	   as	   they	   represent	  only	  1%	  of	   all	   circulating	   cells	   in	   the	  blood	   stream	   [24].	  Several	   approaches	   have	   been	   tested	   to	   tackle	   this	   problem.	   One	   used	   blood	   from	  hematochromatosis	   patients	   [25]	   as	   they	  need	   to	   be	   regularly	   bled	   and	  have	   a	   higher	  percentage	  of	  reticulocytes.	  This	  method	  allowed	  for	  short-­‐term	  P.	  vivax	  in	  vitro	  cultures	  for	   up	   to	   15	   days.	   However,	   the	   limited	   access	   to	   hemochromatosis	   patients	   is	   a	  drawback.	   A	   second	   source	   of	   reticulocytes	   is	   cord	   blood,	   in	   which	   the	   reticulocyte	  concentration	   is	   slightly	   higher	   (3-­‐8	   %)	   than	   in	   adult	   blood;	   this	   source	   has	   been	  previously	   used	   permitted	  maintaining	  P.	  vivax	   fresh	   isolates	   in	   culture	   for	   about	   one	  month	   [26].	   However,	   the	   low	   amount	   of	   reticulocytes	   obtained	   did	   not	   allow	   for	   an	  optimal	   parasite	   multiplication	   (parasite	   density	   <0.7	   %).	   Moreover,	   substantial	  variation	  of	  parasite	  densities	  obtained	  makes	   this	  protocol	  unsuitable	   for	   studying	  P.	  
vivax	  biology.	  	  	  	  Cord	   blood	   HSCs	   represent	   a	   valuable	   source,	   as	   reticulocytes	   can	   be	   produced	   in	  substantial	   quantities	   [9,27].	  The	  differentiation	  protocol	   presented	  here	  was	   adapted	  from	  the	  one	  published	  by	  Giarratana	  et	  al.	   [8,28],	  which	  originally	  matured	  HSCs	   into	  erythroid	  lineage	  by	  using	  a	  co-­‐culture	  with	  stromal	  cells.	  The	  latter	  are	  mainly	  used	  to	  retain	   nucleated	   cells,	   free	   nuclei	   and	   debris	   so	   that	   the	   culture	   appears	   cleaner.	  We	  have	   modified	   this	   technique	   by	   omitting	   the	   co-­‐culture	   with	   stromal	   cells,	   which	  resulted	   in	   a	   less	   pure	   population	   of	   enucleated	   cells	   in	   our	   model	   (20%	  enucleated/80%	  nucleated	  cells	  versus	  100	  %	  enucleated	  cells	  when	  using	  stromal	  cells)	  since	   the	   nucleated	   cells	   were	   not	   retained	   by	   the	   MS5	   layer.	   Nevertheless,	   while	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Giarratana	  aimed	  at	  obtaining	  RBCs	  with	  a	  lifespan	  of	  about	  120	  days,	  achieved	  during	  the	   later	   stages	   of	   RBC	   maturation,	   our	   purpose	   was	   to	   obtain	   reticulocytes	   whose	  lifespan	   is	   2	   days.	   This	   explains	   why	   maturation	   was	   stopped	   at	   the	   peak	   of	   the	  reticulocyte	  concentration	  (D14).	  Moreover,	  reticulocytes	  obtained	  after	  maturation	  on	  a	  MS5	  layer	  gave	  similar	  result	  in	  term	  of	  invasion	  than	  those	  produced	  without	  stromal	  cells	   (data	   not	   shown).	   A	   previous	   attempt	   of	   producing	   HSC-­‐derived	   reticulocytes	  without	  using	  stromal	  cells	  in	  co-­‐culture	  attained	  a	  maximum	  reticulocyte	  concentration	  of	  0.5%	  [9].	  This	  is	  in	  contrast	  with	  the	  results	  of	  our	  methods	  which	  produced	  a	  40-­‐fold	  (20%)	  higher	  concentration	  of	  reticulocytes.	  The	  low	  efficiency	  of	  the	  previous	  method	  could	  be	  explained	  by	  several	  factors	  such	  as	  the	  use	  of	  non-­‐detoxified	  BSA	  (a	  key	  factor	  for	  the	  last	  steps	  of	  maturation	  and	  enucleation)	  [27],	  a	  very	  high	  (lethal?)	  concentration	  of	   monothioglycerol,	   or	   the	   absence	   of	   inositol	   or	   folic	   acid.	   It	   is	   also	   important	   to	  mention	   that	   the	   parasite	   density	   in	   culture	   supported	   by	   HSC-­‐derived	   reticulocytes	  obtained	   with	   our	   method	   was	   substantially	   higher	   (2.5%	   vs	   0.0015	   %)	   than	   that	  reported	   for	   the	   previous	   one	   [9],	   providing	   sufficient	   biological	   material	   to	   possibly	  keep	  the	  culture	  for	  a	  longer	  period.	  During	  the	  invasion	  assays	  we	  performed,	  the	  cell	  population	  was	  not	  purely	  composed	  by	  reticulocytes	  but	  contained	  also	  erythroblasts.	   	  Both	  P.	  falciparum	  and	  P.	  vivax	  were	  able	  to	  invade	  these	  cells,	  as	  previously	  reported	  [29].	  No	  information	  on	  the	  quality	  of	  the	  parasite	  development	  in	  this	  type	  of	  cells	  is	  currently	  available.	  	  FACS	  analyses	  of	  both	  fresh	  and	  cryopreserved	  reticulocytes	  showed	  the	  expression	  of	  CD235a	  marker	  (Glycophorin	  A),	  an	  important	  receptor	  for	  P.	  falciparum	  invasion	  [30].	  Its	  role	  in	  P.	  vivax	   invasion	  has	  not	  been	  described	  yet	  but	  its	  homology	  with	  the	  Duffy	  Binding	  Protein	  (DBP)	  [31,32]	  suggests	  a	  potential	  role	  in	  the	  P.	  vivax	   invasion	  process	  of	  the	  reticulocytes.	  Thus	  the	  cryopreservation	  protocol	  kept	  the	  important	  receptors	  on	  the	  reticulocyte	  membrane.	  The	  added	  value	  of	  the	  work	  presented	  is	  the	  set	  up	  of	  a	  cryopreservation	  technique	  for	  the	   long-­‐term	  storage	  of	  cord	  blood	  HSC-­‐derived	  reticulocytes,	  providing	  a	  continuous	  source	  for	  the	  performance	  of	  invasion	  assays	  and	  possibly	  the	  maintenance	  of	  a	  P.	  vivax	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in	  vitro	  culture.	  	  The	  technique	  is	  robust	  as	  it	  has	  been	  tested	  on	  several	  HSCs	  batches	  of	  that	  gave	  comparable	  results	  with	  a	  single	  P.	  vivax	   isolates	  (Fig.5,	  PV3/	  CB	  81	  and	  23).	  The	  reticulocyte	  cryopreservation	  using	  Glycerolyte	  was	  abandoned	  due	  to	  the	  presence	  of	  clots	  during	  thawing.	  It	  is	  unclear	  why	  this	  occurred	  but	  a	  possible	  hypothesis	  would	  be	  the	  harmful	  effect	  of	  glycerolyte	  on	  nucleated	  cells.	  	  The	   source	   of	   reticulocytes	   for	   a	  P.	  vivax	   invasion	   assay	   is	   not	   limited	   to	  HSC-­‐derived	  cells.	   	   Borlon	   et	   al	   [32]	   were	   able	   to	   maintain	   a	   short-­‐term	   (up	   to	   10	   days)	   P.	   vivax	  culture	  using	   reticulocytes	  directly	   concentrated	   from	  cord	  blood.	  This	  was	  done	  with	  similar	  efficacy	  with	  both	  fresh	  and	  frozen	  parasites	  and	  reticulocytes	  (using	  Glycerolyte	  57	  as	  cryopreservant).	  The	  advantage	  of	  concentrating	  reticulocytes	  from	  cord	  blood	  is	  that	   these	  are	  almost	   immediately	   available	   (pending	  availability	  of	   cord	  blood)	  while	  HSC-­‐derived	  ones	  need	  14	  days	  to	  mature.	  Nevertheless,	  with	  the	  former	  technique	  the	  concentration	   process	   (percoll	   centrifugation,	   application	   of	   several	  washing/concentration	  steps)	  could	  damage	  the	  cells	  and	  affect	  the	  invasion	  efficiency	  while	   using	   HSC-­‐derived	   reticulocytes	   may	   guarantee	   a	   more	   homogeneous	   and	  standardised	   cell	   population.	   Eventually,	   using	   both	  methods:	   concentrated	   from	   cord	  blood	   and	   HSC-­‐derived	   reticulocytes	   could	   substantially	   increase	   the	   amount	   of	  available	  reticulocytes	  from	  a	  single	  cord	  blood	  sample.	  	  In	   conclusion,	   the	   cryopreservation	   method	   described	   in	   this	   paper	   provides	   a	  continuous	   and	   substantial	   source	  of	   reticulocytes,	   possibly	   a	   first	   step	   to	   achieve	   the	  continuous	  in	  vitro	  culture	  of	  P.	  vivax.	  In	  addition,	  the	  possibility	  of	  cryopreserving	  both	  reticulocytes	   and	   parasites	   offers	   the	   opportunity	   of	   investigating	   P.	   vivax	   invasion	  assays/	   culture	   in	   non-­‐endemic	   countries,	   opening	   this	   field	   of	   research	   to	   more	  research	  groups	  thus	  increasing	  the	  probability	  of	  fast	  advances	  in	  knowledge.	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Figure	   1:	   Production	   of	   reticulocytes	   from	   HSCs,	   morphologic	   analysis	   after	  Giemsa	  staining.	   (A)	  Human	  CD34+	  cells	   isolated	   from	  cord	  blood	  (B)	  Day	  4	  of	  culture,	   (C)	   Day	   8-­‐	   	   (D)	   Day	   11-­‐	   (E)	   Day	   14	   of	   culture,	   reticulocytes	   are	  highlighted	  by	  cresyl	  blue	  staining	  (arrows).	  	  
Figure	  2:	  Evolution	  of	  reticulocytes	  (continuous	  line)	  and	  red	  blood	  cells	  (dotted	  line)	  counts	  from	  day	  12	  to	  day	  20	  of	  HSCs	  maturation.	  Each	  value	  represents	  the	  median	   a	   total	   of	   6	   independent	   experiments,	   and	   vertical	   bars	   represent	   the	  interquartile	  range	  (IQR).	  Reticulocytes	  were	  identified	  by	  cresyl	  blue	  staining.	  	  	  
Figure	   3:	   	   Expression	   of	   reticulocyte	   surface	   markers	   by	   flow	   cytometry.3a:	  Expression	  of	  HSCs	  surface	  markers	  at	  different	  maturation	  stages	  characterized	  by	  flow	  cytometry.	  Cells	  were	  collected,	  respectively	  at	  8	  days,	  11	  days,	  14	  days	  and	   17	   days	   of	  maturation	   and	   stained	  with	   specific	   antibodies	   against	   CD36,	  CD45,	   CD71	   and	   CD325a	   receptors,	   respectively.	   Each	   value	   represents	   the	  median	  percentage	   for	  3	   independent	  experiments	   (vertical	  bars	   represent	   the	  extreme	  values	  in	  this	  case).	  3b:	  Comparison	  of	  the	  surface	  markers	  expression	  (%)	  at	  day	  14	  after	  thawing	  for	  3	  different	  cryopreservation	  protocols	  compared	  to	   fresh	   HSC	   derived	   reticulocytes	   (median	   %	   values	   of	   3	   independent	  experiments;	  vertical	  bars	  represent	  the	  extreme	  values	  in	  this	  case).	  	  
	  
Figure	   4:	   Pictures	   of	   HSC-­‐derived	   reticulocyte	   invaded	   by	   Plasmodium.4a:	  Infected	   enucleated	   cells	   by	   P.	   falciparum	   24h	   after	   invasion.	   (A)	   Fresh	  reticulocytes	   derived	   from	   HSCs	   maturation,	   (B)	   Cryopreserved	   reticulocytes	  with	   glycerolyte,	   (C)	   Cryopreserved	   reticulocytes	   with	   glycerol	   solution,	   (D)	  Cryopreserved	  reticulocytes	  with	  Medium	  /40%	  FCS/10%	  DMSO	  (3	  replicates).	  
4b:	  Infected	  reticulocytes	  by	  P.	  vivax	  24h	  after	  invasion.	  (A)	  Fresh	  reticulocytes	  derived	   from	   HSCs	   maturation,	   (B)	   Cryopreserved	   reticulocytes	   with	   glycerol	  solution,	  (C)	  Cryopreserved	  reticulocytes	  with	  Medium	  /40%	  FCS	  /	  10%	  DMSO	  (8	  replicates).	   4c:	   Infected	  erythroblast	   (A)	  By	  P.	  falciparum.	   (B)	  By	  P.	  vivax	   (8	  replicates).	  	  
Figure	   5:	   Parasitemia	   of	   infected	   HSC	   derived	   cells	   for	   the	   2	   protocols	   of	  cryopreservation	  (Medium/10%DMSO/40%FCS	  and	  Glycerol	  solution)	  24h	  after	  invasion	  assay	  with	  P.	  vivax	  cryopreserved	  isolates.	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Fig	  1.	  Production	  of	  reticulocytes	  from	  HSCs,	  morphologic	  analysis	  after	  Giemsa	  staining.	  (A)	  Human	  CD34+	  cells	  isolated	  from	  cord	  blood	  (B)	  Day	  4	  of	  culture,	  (C)	  Day	  8-­‐	  	  (D)	  Day	  11-­‐	  (E)	  Day	  14	  of	  culture,	  reticulocytes	  are	  highlighted	  by	  Cresyl	  blue	  staining	  (arrows).	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Fig	  3a.	  Expression	  of	  HSCs	  surface	  markers	  at	  different	  maturation	  stages	  characterized	  by	  flow	  cytometry.	  Cells	  were	  collected,	  respectively	  at	  8	  days,	  11	  days,	  14	  days	  and	  17	  days	  of	  maturation	  and	  stained	  with	  specific	  antibodies	  against	  CD36,	  CD45,	  CD71	  and	  CD325a	  receptors,	  respectively.	  Each	  value	  represents	  the	  median	  percentage	  for	  3	  independent	  experiments.	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Fig	  4a.	  Infected	  enucleated	  cells	  by	  P.	  falciparum	  24h	  after	  invasion.	  	  (A)	  Fresh	  reticulocytes	  derived	  from	  HSCs	  maturation,	  (B)	  Cryopreserved	  reticulocytes	  with	  glycerolyte,	  (C)	  Cryopreserved	  reticulocytes	  with	  glycerol	  solution,	  (D)	  Cryopreserved	  reticulocytes	  with	  Medium	  /40%	  FCS	  /	  10%	  DMSO	  (3	  replicates)	  	  	  	  	  	  
	  	   	  	   	  
Fig	  4b.	  Infected	  reticulocytes	  by	  P.	  vivax	  24h	  after	  invasion.	  (A)	  Fresh	  reticulocytes	  derived	  from	  HSCs	  maturation,	  (B)	  Cryopreserved	  reticulocytes	  with	  glycerol	  solution,	  (C)	  Cryopreserved	  reticulocytes	  with	  Medium	  /40%	  FCS	  /	  10%	  DMSO	  (8	  replicates)	  	  
	  	   	  
Fig	  4c.	  Infected	  erythroblast	  (A)	  By	  P.	  falciparum.	  (B)	  By	  P.	  vivax	  (8	  replicates)	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  SUMMARY	  
The	  affinity	  of	  Plasmodium	  vivax	  (P.	  vivax)	   for	   reticulocytes	   constitutes	  a	  major	  hurdle	  for	   its	   in	  vitro	  culture.	  Hematopoietic	   stem	  progenitor	   cells	   (HSPC)	  have	  been	  used	   to	  produce	   reticulocytes;	   however,	   this	   has	   not	   yet	   enabled	   the	   establishment	   of	   a	   long	  term	  P.	  vivax	   culture.	  The	  main	  objective	  of	  our	  study	  was	   to	  assess	   if	   the	  presence	  of	  fetal	  hemoglobin	  (HbF)	  impedes	  the	  in	  vitro	  development	  of	  Plasmodium	  falciparum	  (P.	  
falciparum),	  as	  well	  as	  the	  reticulocytes	  invasion	  by	  P.	  vivax.	  The	  second	  objective	  was	  to	  determine	  which	  source	  of	  HSPC	  would	  generate	  the	   largest	  yield	  of	  reticulocytes.	  Our	  results	   showed	   that	   HbF	   did	   not	   affect	   the	   erythrocyte	   invasion	   by	   P.	   vivax	   or	   P.	  
falciparum,	  neither	  did	  it	  influence	  the	  in	  vitro	  development	  of	  P.	  falciparum.	  .	  Moreover,	  the	   ex-­‐vivo	   expansion	   of	   umbilical	   cord	   blood	   HSPCs	   yielded	   in	   significantly	   higher	  amounts	  of	  reticulocytes	  compared	  to	  either	  peripheral	  blood	  or	  bone	  marrow	  HSPCs.	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INTRODUCTION	  
Plasmodium	  vivax	  (P.	  vivax)	  is	  the	  most	  widespread	  malaria	  parasite	  outside	  Africa,	  and	  accounts	   for	   80	   to	   300	  million	   of	  malaria	   cases	   per	   year	   (Price	   et	   al.,	   2007).	   In	   2010,	  50%	   of	   all	   malaria	   cases	   outside	   Africa	  were	   due	   to	   P.	   vivax	   and	   occurred	   mainly	   in	  South-­‐East	   Asia	   and	   South	   America	   (WHO	   report	   2012).	   Control	   measures	   in	   areas	  where	  both	  P.	  falciparum	  and	  P.	  vivax	  occur	  have	  had	  a	  major	  impact	  on	  the	  burden	  of	  P.	  
falciparum	   infections,	   but	   less	   so	   on	   P.	   vivax,	   indicating	   its	   “resistance”	   to	   currently	  available	   control	   methods	   developed	   mainly	   against	   P.	   falciparum	   (Feachem	   et	   al.,	  2010).	  This	  is	  due	  to	  a	  number	  of	  factors	  among	  which	  the	  existence	  of	  P.	  vivax	  dormant	  liver	   stages	   (hypnozoites)	   causing	   relapsing	   infections	   months	   or	   years	   after	   the	  primary	  infection,	  and	  the	  early	  production	  of	  P.	  vivax	  gametocytes	  before	  the	  infection	  becomes	   symptomatic.	  Moreover,	   the	   specificity	   of	  P.	  vivax	   for	   preferentially	   invading	  reticulocytes	   constitutes	   one	   of	   the	   bottlenecks	   for	   its	   establishment	   in	   long-­‐term	  cultures	  (Moreno-­‐Perez	  et	  al.,	  2013;	  Noulin	  et	  al.,	  2013).	  Indeed,	  reticulocytes	  represent	  1%	  of	   the	  circulating	  red	  blood	  cells	  (RBCs)	  and	  have	  a	  half-­‐life	  of	  2	  days	  (including	  1	  day	  in	  the	  peripheral	  blood),	  therefore	  they	  are	  difficult	  to	  obtain	  in	  sufficient	  amount	  to	  sustain	  the	  in	  vitro	  development	  of	  P.	  vivax	  .	  	   
Two	   approaches	   have	   been	   used	   to	   increase	   the	   number	   of	   reticulocytes	   both	   with	  limited	   success.	   One	   is	   the	   concentration	   of	   reticulocytes	   from	   adult	   or	   cord	   blood	  samples	  using	  either	  a	  70%	  percoll	  solution	  (Russell	  et	  al.,	  2011)or	  a	  plasma	  autologous	  ultra-­‐centrifugation	   (Golenda	   et	   al.,	   1997).	   The	   second	   approach	   is	   based	   on	   in	   vitro	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culture	  of	  CD34+	  cells	  to	  induce	  erythroid	  differentiation	  (supplementary	  figure	  1),	  and	  hence	  produce	  reticulocytes.	  One	  study	  has	  reported	  a	  P.	  vivax	  culture	  for	  up	  to	  85	  days	  in	   reticulocytes	   differentiated	   from	   umbilical	   cord	   blood	   (UCB)-­‐hematopoietic	  stem/progenitor	   cells	   (HSPC),	   but	   parasite	   densities	  were	   very	   low	   (Panichakul	   et	   al.,	  2007).	  We	  recently	  showed	  that	  P.	  vivax	  parasites	  appeared	  not	  to	  develop	  beyond	  one	  schizogony	   cycle	   when	   cultured	   in	   UCB/CD34+	   derived	   reticulocytes	   (Noulin	   et	   al.,	  2012).	   	   Recently,	   reticulocytes	   derived	   from	   CD34+	   cells	   isolated	   from	   bone	   marrow	  (BM)	  and	  peripheral	  blood	  mononuclear	  cells	  (PBMC)	  were	  shown	  to	  be	  permissive	  to	  P.	  
vivax	  but	  no	  details	  were	   given	   about	   the	   efficiency	   of	   invasion	   and	   the	  quality	   of	   the	  parasites’	  in	  vitro	  development	  (Fernandez-­‐Becerra	  et	  al.,	  2013a).	  
Many	  authors	  have	  argued	  that	  P.	  vivax	  failure	  to	  growth	  in	  vitro	  when	  using	  cord	  blood	  as	   source	   of	   reticulocytes	   (either	   by	   concentration	   or	   derived	   from	   HSPC),	   could	   be	  attributed,	  at	  least	  partially,	  to	  the	  presence	  of	  fetal	  hemoglobin	  (HbF)	  in	  the	  cord	  blood	  reticulocytes	   (Borlon	   et	   al.,	   2012;	   Noulin	   et	   al.,	   2012;	   Panichakul	   et	   al.,	   2007).	   This	  hypothesis	   is	   based	   on	   earlier	  work	   published,	   by	   Pasvol	   et	   al	   in	   1977	   (Pasvol	   et	   al.,	  1977)	  in	  which	  the	  authors	  compared	  P.	  falciparum	  invasion	  and	  parasite	  development	  in	  adult	  blood	  and	  blood	  from	  patients	  with	  hereditary	  persistence	  of	  fetal	  hemoglobin	  (HPFH).	   They	   observed	   that	   the	   invasion	   rate	   was	   the	   same	   for	   both	   RBC	   sources;	  however	   P.	   falciparum	   growth	   was	   delayed	   in	   the	   presence	   of	   HbF.	   Therefore,	   the	  authors	   concluded	   that	   the	   presence	   HbF	   negatively	   affected	   the	   development	   of	   P.	  
falciparum,	  possibly	  due	  to	  the	  fact	  that	  P.	  falciparum	  parasites	  use	  hemoglobin	  also	  as	  a	  source	  of	  amino	  acids	  during	  their	  development	  (Sherman,	  1977),	  besides	  	  the	  fixation	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of	   02	   molecules.	   The	   question	   on	   the	   influence	   of	   HbF	   on	   P.	   falciparum	   in	   vitro	  development	   has	   not	   been	   revisited	   since	   then,	   and	   the	   same	   relationship	   has	   been	  assumed	  for	  P.	  vivax,	  possibly	  explaining	  its	  poor	  in	  vitro	  multiplication	  obtained	  so	  far.	  	  	  
Apart	   from	   UCB,	   other	   sources	   of	   multipotent	   CD34+	  cells,	   such	   as	   BM	   or	   peripheral	  blood	  (PB)	  can	  be	  used	  to	  generate	  reticulocytes.	  These	  “adult”	  sources	  of	  HSPC,	  unlike	  the	   UCB	   HSPC,	   differentiate	   into	   reticulocytes	   and	   RBCs	   that	   do	   not	   contain	   HbF	  (Fernandez-­‐Becerra	  et	  al.,	  2013b).	  	  
The	   objectives	   of	   the	   current	   study	   were	   to	   assess	   whether	   the	   presence	   of	   HbF	  influenced	   the	   reticulocyte	   invasion	   by	   P.	   vivax	   or	   by	   P.	   falciparum	   and,	   for	   the	   later	  species,	  the	  in	  vitro	  development.	  The	  second	  objective	  was	  to	  determine	  which	  source	  of	  HPSC,	  ie	  UCB,	  BM,	  or	  PB,	  would	  be	  best	  to	  produce	  highest	  yields	  of	  reticulocytes.	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RESULTS	  
Reticulocyte	  production	  and	  characterization	  
We	   obtained	   reticulocytes	   differentiated	   from	   magnetically	   sorted	   CD34-­‐enriched	  populations	   originating	   from	   three	   different	   sources,	   i.e.	   UCB,	   PBMC	   and	   BM.	   We	  observed	  a	  peak	  of	  enucleation	  after	  14	  days	  of	  differentiation	   for	  all	   three	  sources	  of	  cells.	   Enucleation	   of	   erythroid	   cells	   from	   PBMC	   (mean=31%,	   SD±6)	   was	   significantly	  higher	  (p=0.002)	  than	  that	  of	  UCB	  (18%,	  SD±1.4)	  and	  BM	  (21%,	  SD±1.5)	  (Table	  1).	  	  
BM	  and	  PBMC	  CD34+	  enriched	  cells	  produced	  reticulocytes	  contained	  HbA	  while	  those	  derived	  from	  UCB	  CD34+	  cell-­‐derived	  reticulocytes	  contained	  HbF,	  as	  assessed	  using	  the	  Kleihauer	   method.	   The	   concentration	   of	   hemoglobin	   per	   cell	   (or	   Mean	   Corpuscular	  Hemoglobin;	  MCH)	  was	  higher	  in	  all	  three	  groups	  of	  in	  vitro	  generated	  reticulocytes,	  i.e.	  50,	  60	  and	  39	  pg/cell	   respectively	   for	  UCB,	  BM	  and	  PBMC,	  compared	   to	   the	  normal	   in	  
vivo	  range	  i.e.	  29.5-­‐33.5	  pg/cell.	  
HSPC	  expansion	  	  
The	  enrichment	  for	  CD34+	  cells	  in	  the	  sorted	  populations	  was	  55%	  (SD±6),	  35%	  (SD±8)	  and	  16%	  (SD±6)	  for	  UCB,	  BM	  and	  PBMC	  respectively	  (n=3).	  After	  5	  days	  of	  expansion,	  the	   total	   cell	  populations	   increased	  by	  more	   than	  10-­‐fold	   in	  cultures	  seeded	  with	  UCB	  CD34+	   cells,	   3-­‐fold	   for	   BM	   cells	   and	   no	   expansion	  was	   observed	   for	   PBMC	   (Table	   2).	  FACS	  analyses	  showed	  an	  increase	  in	  the	  CD34+/CD45+	  population	  for	  all	  three	  sources:	  from	  55	  %	  at	  D0	  to	  70%	  (SD±2)	  at	  D5	  for	  UCB,	  35%	  to	  55%	  (SD±5)	  for	  BM,	  and	  16%	  to	  29%	  (SD±16)	  for	  PBMC	  (n=3	  for	  CB	  and	  BM,	  n=2	  for	  PBMC)(Figure	  1)	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Following	   expansion,	   a	   similar	   number	   of	   cells	   (irrespective	   of	   the	   CD34+	   content	   or	  expansion)	   were	   dispensed	   in	   a	   6-­‐wells	   plate	   to	   induce	   reticulocyte	   differentiation.	  Following	  erythrocyte	  differentiation	  step,	  the	  total	  cell	  number	  was	  3	  times	  higher	  for	  CD34+	   cells	   from	   either	   source,	   compared	   with	   CD34+	   cells	   that	   were	   immediately	  induced	   into	  differentiation.	  After	  12	  days	  of	  differentiation,	   expanded	  cells	  expressed	  more	  than	  80%	  of	  glycophorin	  A	  in	  all	  three	  groups	  of	  HPSC	  sources	  (data	  not	  shown).	  We	   observed	   a	   5	   to	   10-­‐fold	   higher	   proportion	   of	   reticulocytes	   at	   day	   14	   for	   the	   cells	  derived	   from	   in	   vitro	   expanded	   CD34+	   cells	   vs.	   cells	   differentiated	   directly	   from	  unexpanded	  cells	  for	  the	  different	  sources	  of	  HSPC.	  
P.	  falciparum	  invasion	  and	  intra-­‐erythrocyte	  development	  	  
In	  order	  to	  determine	  which	  factors	  affect	  invasion	  and	  development	  of	  P.	  falciparum	  in	  erythrocytes,	  we	  used	  different	  sources	  of	  erythrocytes:	  i)	  derived	  from	  CD34+	  cells	  from	  CB,	   BM	   and	   PBMC,	   ii)	   directly	   from	   normal	   adult	   donors	   (HbA)	   peripheral	   blood,iii)	  directlyfrom	   one	   adult	   donor	   with	   β	   thalassemia	   minor	   (HbA,	   but	   lower	   Hb	  concentration	   per	   cell),	   iv)	   and	   from	   UCB	   (HbF).	   We	   followed	   the	   intra-­‐erythrocyte	  development	  of	  P.	  falciparum	  every	  day	  for	  7	  days.	  P.	  falciparum	  invaded	  and	  developed	  in	   erythrocytes	   obtained	   from	   the	   three	   HSPC	   sources	   as	   well	   as	   in	   peripheral	   blood	  from	  normal	   adult	   donor,	   β	   thalassemia	  minor	   and	   from	  UCB	   for	   7	   days	   (figure	   2).	  P.	  
falciparum	   cultures	   became	   asynchronous,	   after	   5	   days	   when	   cultured	   with	   PB	   from	  normal	   adult	   donors	   (62%	   of	   rings	   and	   28%	   of	   schizonts),	   and	   after	   7	   days	   when	  cultured	  with	   the	  β	   thalassemia	  minor	  patient’s	   blood	   (63%	  rings	   and	  27%	  schizont),	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while	  the	  48-­‐hour	  cycle	  was	  still	  maintained	  up	  to	  day	  7	  when	  cultured	  with	  UCB	  (84%	  of	  rings	  stages	  and	  14%	  schizont	  stages).	  Moreover,	  the	  multiplication	  ratio	  (number	  of	  new	   rings	   stage	   from	  each	   schizont	   stage	   burst)	  was	   comparable	   for	   the	   3	   sources	   of	  blood	   i.e.	  UCB,	  PB,	  and	  β	   thalassemia	  minor	  patient	   (around	  3-­‐fold	  at	  each	  schizogony	  cycle).	   The	   same	   experiments	   were	   repeated	   with	   20%	   O2,	   which	   resulted	   in	   a	  substantial	  reduction	  of	  parasite	  growth	  in	  PB	  from	  normal	  adult	  after	  3	  days	  compared	  to	  cultures	  in	  5%	  02	  (3.9%	  versus	  1.1%)	  and	  a	  growth	  deficiency	  of	  in	  presence	  of	  HbF.	  
P.	  falciparum	  could	  also	  invade	  and	  develop	  in	  HSPC-­‐derived	  erythrocytes	  (expanded	  or	  not)	   for	   7	   days	   (synchronous	   culture	   up	   to	   day	   7;	   data	   not	   shown).	   However,	   the	  invasion	  rate	  was	   lower	  than	  with	  UCB	  or	  adult	  blood	  as	  the	  proportion	  of	  target	  cells	  (enucleated	  cells+	  orthoerythroblasts)	  was	  30-­‐40	  %	  while	  in	  whole	  blood	  (UCB,	  PB	  or	  β	  thalassemia	  minor)	  all	  cells	  (reticulocytes+	  erythrocytes)	  can	  potentially	  be	  invaded.	  
P.	  vivax	  invasion	  and	  intra-­‐erythrocyte	  development	  	  
We	   also	   tested	   if	   reticulocytes	   derived	   from	   CD34+	   cells	   from	   the	   UCB,	   BM	   or	   PBMC	  could	  be	  invaded	  by	  P.	  vivax.	  As	  shown	  in	  figure	  3,	  reticulocytes	  generated	  in	  vitro	  from	  CD34+	  cells	  or	  directly	  enriched	  blood	  (PB	  or	  UCB)	  could	  both	  be	  invaded.	  When	  using	  the	  same	  P.	  vivax	  isolate,	  the	  invasion	  rate	  did	  not	  differ	  between	  different	  HSPC	  sources	  (figure	   4a).	   Nevertheless,	   when	   using	   the	   same	   HSPC-­‐derived	   reticulocytes	   with	   two	  different	  P.	  vivax	   isolates,	   the	   invasion	   rate	   varied	  by	   isolate	   (figure	  4b;	   PV1	   and	  PV2,	  p<0.001).	  After	  3	  days,	  only	  few	  rings	  (parasite	  density	  <	  0.05%)	  could	  be	  observed	  and	  none	  survived	  longer	  than	  72	  hours,	  regardless	  of	  the	  HSPC	  source.	  Interestingly,	  HSC-­‐
CHAPTER	  II:	  Hb	  influence	  and	  HSC	  sources	   	   	  
	  	  	  	  	  	  	  	  	  	  	  	  
70	  
derived	   reticulocytes	   seemed	   more	   vulnerable	   to	   P.	   vivax	   invasion	   than	   reticulocytes	  from	   enriched	   blood.	   Indeed,	   when	   using	   the	   same	   P.	   vivax	   isolate	   and	   comparing	   to	  HSPC-­‐derived	  reticulocytes,	  the	  parasite	  density	  24	  hours	  post-­‐invasion	  was	  up	  to	  9-­‐fold	  lower	  for	  UCB-­‐concentrated	  reticulocytes	  (PV2:	  1.8%	  versus	  0.2%,	  respectively),	  and	  18-­‐fold	  lower	  for	  adult	  peripheral	  blood-­‐concentrated	  reticulocytes	  (PV2:	  2.1%	  versus	  0.1%	  respectively)	   	   (supplementary	   data	   2).	   The	   parasite	   densities	   were	   not	   significantly	  different	  between	  HSPC-­‐derived	  reticulocytes	  (5%)	  and	  UCB	  concentrated	  reticulocytes	  (4.6%	   p=0.056)	   and	   PB	   concentrated	   reticulocytes	   (3.5%	   p=0.06)	   for	   a	   reticulocyte	  proportion	  of	  20%	  for	  HSPC-­‐derived	  reticulocyte	  versus	  70%	  and	  60%	  for	  UCB	  and	  PB	  concentrated	  reticulocytes	  respectively..	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DISCUSSION	  
The	   present	   study	   investigated	   the	   influence	   of	   HbF	   on	   the	   in	   vitro	   development	   of	  
plasmodium	  and	  tried	  to	   identify	  the	  best	  source	  of	  HSPC	  to	  produce	  reticulocytes.	  We	  showed	   that	  when	  magnetically	   sorted	  CD34+	   cells	   from	  either	   PBMC,	  BM	  or	  UCB	   are	  used	  to	  produce	  reticulocytes	  for	   in	  vitro	  culture	  of	  P.	  vivax,	  no	  significant	  difference	  is	  observed	   in	   the	   efficiency	   whereby	   the	   parasite	   invades	   the	   reticulocytes.	   However,	  none	  of	   the	  currently	  available	  systems	  supported	  the	   full	  development	  and	   long-­‐term	  culture	  of	  P.	  vivax.	  	  Moreover,	  we	  showed	  that	  the	  invasion	  efficiency	  depended	  on	  the	  P.	  
vivax	  isolate.	  Our	  results	  also	  suggest	  that	  the	  number	  of	  reticulocytes	  derived	  from	  UCB	  CD34+	  enriched	  cell	  populations	  can	  be	  substantially	  increased	  when	  the	  CD34+	  cells	  are	  first	   expanded	   for	   5	   days	   yielding	   a	   30-­‐fold	   higher	   reticulocyte	   number	   following	  differentiation.	  
The	   ability	   to	   substantially	   increase	   the	   number	   of	   reticulocytes	   generated	   per	   CD34+	  cell	  from	  UCB,	  BM	  and	  PBMC	  (30-­‐fold	  UCB,	  9-­‐fold	  BM),	  using	  a	  simple	  5-­‐day	  protocol,	  is	  of	   great	   interest	   for	   the	   development	   of	   P.	   vivax	   in	   vitro	   culture.	   We	   previously	  demonstrated	   that	   reticulocytes	   can	   be	   cryopreserved	   (Noulin	   et	   al.,	   2012)	   and	   then	  used	   for	   P.	   vivax	   invasion.	   Noteworthy,	   when	  magnetically	   sorted	   PBMC/	   CD34+	   cells	  that	  were	  cultured	  in	  similar	  expansion	  culture	  conditions	  showed	  a	  limited	  increase	  of	  HSPC	   compared	   to	   CB/HSPC	   and	   BM/HSPC.	   This	   is	   likely	   due	   to	   the	   fact	   that	   the	  frequency	   of	   CD34+	   cell	   in	   non-­‐mobilized	   PBMC	   is	   low	   (Bender	   et	   al.,	   1994)	   and	   that	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PBMC	   may	   be	   less	   immature	   than	   cells	   from	   UCB	   and	   BM	   respectively	   (Steidl	   et	   al.,	  2002).	  	  
	  The	   experiments	   clearly	   showed	   that	   the	   type	   of	  Hb	   in	   reticulocytes/erythrocytes	   did	  not	   affect	   the	   invasion	   of	  P.	  vivax	   or	  P.	   falciparum,	  neither	   did	   it	   influence	   the	   in	  vitro	  development	   of	  P.	   falciparum.	   .	   Unlike	  Pasvol	  et	  al	   (Pasvol	   et	   al.,	   1977),	  who	   reported	  that	  HbF	  negatively	  affects	  the	  development	  of	  P.	  falciparum	  in	  culture.	  Our	  experiments	  showed	   that	   the	   presence	   of	   HbF	   or	   lower	   levels	   of	   HbA	   do	   not	   affect	   P.	   falciparum	  invasion	   and	   development.	   Moreover,	   we	   did	   observe	   that	   the	   time	   to	   asynchronous	  culture	   of	   the	  P.	   falciparum	   culture	  was	   5	   days	  when	   reticulocytes/erythrocytes	   from	  PBMC	  were	  used,	  while	   this	  occurred	  only	  after	  7	  days	   for	   the	  beta	   thalassemia	  blood	  (lower	   HbA	   concentration)	   and	   after	   7	   days,	   the	   culture	  was	   still	   synchronous	   in	   the	  presence	  of	  UCB	  (HbF).	  These	   results	  may	  be	  explained	  by	   the	  different	  gas	   composition	  used	  during	  parasite	  culture:	  while	  Pasvol	  et	  al	  using	  a	  gas	  composition	  of	  75%	  N2,	  5%	  CO2	  and	  20%	  O2,	  the	  gas	  composition	  in	  our	  cultures	  (and	  commonly	  used	  for	  P.	  falciparum	  culture	  (Butcher,	  1979))	  was	  90%	  N2,	  5%	  C02	  and	  5%	  O2.	  This	  relatively	  lower	  O2	  concentration	  may	  have	  decreased	  the	  influence	  of	  the	  type	  of	  hemoglobin	  in	  the	  target	  cells	  as	  confirmed	  by	  the	  poor	  multiplication	  of	  P.	  falciparum	  in	  presence	  of	  20%	  O2.	  	  
The	   presence	   of	   HbF	   did	   also	   not	   affect	   the	   ability	   of	   the	   P.	   vivax	   to	   invade	   freshly	  isolated	   reticulocytes	   or	   reticulocytes	   derived	   from	   UCB	   CD34+	   cells.	   However,	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irrespective	  of	  the	  origin	  of	  the	  cell	  source	  (PBMC,	  BM	  or	  UCB)	  and	  hence	  the	  type	  of	  Hb	  present,	  few	  P.	  vivax	  parasites	  could	  mature	  in	  vitro	  and	  invade	  new	  reticulocytes.	  This	  is	  not	  surprising,	  since	  long	  term	  in	  vitro	  culture	  of	  P.	  vivax	  has	  never	  been	  fully	  achieved	  so	  far	  despite	  numerous	  reports	  of	  successful	  invasions	  never	  followed	  by	  maturation	  to	  subsequent	  schizogony	  cycles	  with	  parasite	  expansion	  (Noulin	  et	  al.,	  2013).	  
Our	   preliminary	   observations	   could	   indicate	   a	   marked	   preference	   of	   P.	   vivax	   for	  immature	   reticulocytes	   as	  we	   could	   observe	   a	  more	   important	   permissiveness	   of	   our	  reticulocytes	   derived	   from	   any	   HSPC	   source	   compared	   to	   those	   concentrated	   from	  either	  UCB	  or	  PB.	  The	  more	  important	  invasion	  rate	  in	  reticulocytes	  concentrated	  from	  CB	  compared	  to	  those	  from	  PB	  could	  be	  explained	  by	  the	  distribution	  of	  the	  reticulocyte	  populations	   they	   contain.	   Indeed,	   Paterakis	   et	   al	   (Paterakis	   et	   al.,	   1993)	   classified	  reticulocytes	  according	  to	  their	  RNA	  content	  by	  FACS	  analysis	  and	  divided	  them	  into	  3	  categories:	  immature	  reticulocytes	  (high	  amount	  of	  RNA),	  median	  and	  old	  reticulocytes	  (medum	   and	   low	   amount	   of	   RNA	   respectively).	   They	   found	   that	   in	   the	   global	  reticulocyte	  population,	  UCB	  contains	  more	  immature	  reticulocytes	  (13,6%)	  than	  adult	  peripheral	  blood	  (1%).	  Furthermore,	  the	  HSPC-­‐derived	  reticulocyte,	  they	  were	  collected	  at	   the	   peak	   of	   enucleation	  meaning	   that	   they	  were	   very	   immature	   reticulocytes.	   This	  could	   reinforce	   the	   idea	   of	   a	   preference	   of	   P.	   vivax	   for	   immature	   reticulocytes.	  Interestingly,	  when	   reticulocyte-­‐enriched	   blood	   from	  UCB	   and	  PB	  were	   used	   at	   3-­‐fold	  higher	   reticulocyte	   concentrations	   (70	   %	   and	   60%,	   respectively),	   the	   invasion	   rates	  became	  similar	  to	  those	  obtained	  with	  HSPC-­‐derived	  reticulocytes	  (20	  %	  for	  HSPC).	  This	  is	   in	   line	  with	   a	   recently	   published	   report	   by	  Martín-­‐Jaular	   et	  al	   (Martin-­‐Jaular	   et	   al.,	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2013)	   in	   which	   the	   authors	   could	   observed	   a	   predominant	   invasion	   of	   CD71high-­‐expression	  cells	  (CD71	  being	  a	  marker	  of	  reticulocyte	  maturation)	  by	  P.	  yoelii	  (a	  mouse	  parasite	   that	   also	   invade	   preferentially	   reticulocytes).	   All	   these	   observations	   need	  further	   in-­‐depth	   investigations	   that	   could	   provide	   new	   insights	   into	   the	   invasion	  mechanisms	  of	  P.	  vivax	   and	  more	  specifically	  on	   the	  critical	   stage-­‐specific	   receptors.	   If	  confirmed,	   this	   hypothesis	   would	   justify	   the	   use	   of	   reticulocytes	   derived	   from	   HSPC	  instead	  of	  reticulocyte-­‐enriched	  blood	  as	  target	  cells	  for	  the	  establishment	  of	  continuous	  
P.	  vivax	  culture.	  
In	  conclusion,	  the	  presented	  results	  are	  of	  particular	  interest	  as	  they	  shed	  a	  new	  light	  on	  the	   possibility	   of	   producing	   large	   amounts	   of	   reticulocytes,	   which	   can	   be	   efficiently	  invaded	  by	  P.	  vivax.	  The	  ability	  to	  derive	  reticulocytes	  from	  HSPCs	  offers	  the	  advantage	  of	   developing	   a	   standardized	   and	   continuous	   source	   of	   reticulocytes	   required	   for	   the	  long	  term	  P.	  vivax	  culture.	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Experimental	  procedures	  
CD34+	   cell	   isolation:	   The	   differentiation	   of	   HSPC	   to	   reticulocytes	   has	   been	   previously	  described	  (Giarratana	  et	  al.,	  2005).	  Umbilical	  cord	  blood	  (UCB)	  samples	  were	  obtained	  from	   the	  Belgian	  Cord	  Blood	  Bank	  at	   the	  Gasthuisberg	  Hospital	  Leuven.	  Bone	  marrow	  (BM)	  samples	  were	  obtained	  from	  volunteer	  donors	  and	  human	  peripheral	  blood	  (PB)	  was	  obtained	  from	  the	  Antwerp	  Red	  Cross.	  Mononuclear	  cells	  from	  PB	  (PBMC),	  UCB	  and	  BM	  were	  isolated	  on	  a	  Ficoll	  gradient	  (GE	  Healthcare)	  by	  centrifugation	  for	  30	  minutes	  at	   400	   g.	   The	   mononuclear	   cells	   were	   collected	   and	   washed	   twice	   with	   PBS.	  Hematopoietic	  stem/progenitor	  cells	  (HSPC)	  were	  isolated	  by	  CD34+	  Magnetic	  Assorting	  Cell	  Sorting	  (MACS,	  Biotenyl	  biotech)	  as	  per	  manufacturer	  recommendations.	  Cell	  purity	  was	  assessed	  by	  FACS,	  using	  CD34	  and	  CD45	  antibodies	  (ebioscence).	  
Differentiation	   towards	  reticulocytes:	   CD34	   enriched	   cells	  were	   dispended	   in	   a	   6	  wells	  plates	   with	   IMDM	   medium	   (Gibco)	   supplemented	   with	   L-­‐glutamine	   (4M,	   Sigma),	  penicillin-­‐streptomycin	   (1%,	   Invitrogen),	   folic	   acid	   (10	   μg/mL,	   Sigma),	   inositol	   (40	  μg/mL,	  Sigma),	   transferrin	   (120	  μg/mL,	  Sigma),	  monothioglycerol	   (1.6	  10-­‐4	  M,	  Sigma),	  insulin	  (10	  mg/mL,	  Sigma)	  and	  10%	  human	  plasma.	  During	  the	  first	  8	  days,	  the	  medium	  was	   supplemented	  with	   specific	   growth	   factors:	   hydrocortisone	   (HDS,	   10-­‐6	  M,	   Sigma),	  interleukin-­‐3	  (IL-­‐3,	  5	  ng/mL,	  R&D	  system),	  stem	  cell	  factor	  (SCF,	  100	  ng/mL,	  Bioke)	  and	  erythropoietin	  (EPO,	  3	  IU/mL,	  R&D	  system)	  and	  placed	  at	  37°C	  in	  a	  5%	  CO2	  incubator.	  The	  initial	  volume	  of	  medium	  was	  4	  mL	  and	  after	  4	  days,	  an	  extra	  3	  mL	  was	  added.	  After	  8	   days,	   the	   cells	   were	   centrifuged	   for	   5	   minutes	   at	   300	   g,	   fresh	   IMDM	   medium	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supplemented	  with	  EPO	  (3	  IU/mL)	  was	  added	  and	  the	  cells	  were	  transferred	  in	  a	  flask	  25	   cm2.	   At	   day	   11,	   the	   medium	   was	   changed	   and	   only	   complete	   IMDM	  medium	  was	  added.	  Afterwards,	  medium	  was	  changed	  every	  3	  days	  and	  10%	  heat	  inactivated	  human	  serum	  was	  added	  to	  protect	  cells	  against	  destruction.	  
CD34+	  cell	  expansion	  (supplementary	  data	  3):	  CD34+	  enriched	  cells	  were	  dispensed	  in	  a	  6	  well	   plate	  with	  4	  mL	  SFEM	  medium	   (Sigma)	  with	   SCF	   (50	  ng/mL),	  TPO	   (50	  ng/mL,	  R&D	  system),	  FLT3	  (50	  ng/mL,	  R&D	  system)	  and	   IL-­‐6	  (50	  ng/	  mL,	  R&D	  system)	   for	  5	  days	  at	  37°C,	  5%	  CO2.	  At	  day	  5,	  the	  cells	  were	  counted	  and	  transferred	  into	  a	  new	  6	  well	  plate	  to	  induce	  reticulocyte	  differentiation.	  
Reticulocyte	  counting:	   	  Cells	  were	  centrifuged	  at	  300	  g	  for	  5	  minutes	  and	  re-­‐suspended	  in	  50	  μL	  of	  PBS,	  50	  μL	  of	  Cresyl	  blue	  (Roche)	  diluted	  1:1000	  was	  added	  and	  cells	  were	  incubated	  at	  room	  temperature	  for	  30	  minutes.	  After	  cytospin	  centrifugation	  (3	  minutes	  at	   700	   rpm),	   cells	  were	   fixed	  with	  methanol,	   and	   stained	   for	   10	  minutes	  with	  Giemsa	  (Sigma).	   Slides	   were	   then	   examined	   by	   microscopy	   (immersion	   objective,	   630X	  magnification)	   and	   the	   reticulocytes	   were	   counted	   (a	   reticulocyte	   was	   defined	   as	   an	  enucleated	  cell	  with	  at	  least	  3	  spots	  of	  cresyl	  blue	  RNA	  was	  defined	  as	  a	  reticulocyte).	  
Hemoglobin	  (Hb)	  stages	  were	  defined	  using	  the	  Kleihauer	  method	  (Kleihauer	  and	  Betke,	  1960),	   based	   on	   elution	   and	   specific	  Hb	   staining.	   Briefly,	   a	   thin	   smear	  was	  made	   and	  fixed	  10	  minutes	  with	  80%	  ethanol.	  After	  drying,	  the	  slide	  was	  incubated	  5	  minutes	  with	  elution	  buffer	  pre-­‐warmed	  at	  37°C.	  The	  next	  steps	  were	  a	  primary	  staining	  of	  3	  minutes	  with	  Mayer’s	   hemalyum	   and	   after	  washing	   a	   2nd	   staining	  with	   0.1%	   eosin.	   The	   slides	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were	  then	  examined	  by	  microscopy	  and	  cells	  enumerated:	  the	  cells	  containing	  HbF	  were	  red	  stained	  while	  those	  containing	  HbA	  were	  not	  stained	  (“ghost	  cells”)	  enumerated.	  
The	   Hb	   concentration	   of	   Hb	   per	   cell	   was	   measured	   using	   the	   hemocue	   method.	   The	  mean	  corpuscular	  Hb	  (MCH)	  was	  calculated	  by	  dividing	  the	  measured	  Hb	  concentration	  measured	  by	  the	  number	  of	  enucleated	  cells.	  
	  
Plasmodium	  invasion	  assays	  
-­‐ P.	   falciparum:	   A	   vial	   of	   the	   laboratory	   strain	   3D7	   (cryobank,	   ITM	  Antwerp)	   was	   thawed	   as	   per	   the	   well-­‐established	   protocol	   (Blomqvist,	   2008).	   The	  parasites	  were	  maintained	   in	   culture	  with	   RPMI	  medium	   (Lonza)	   supplemented	  with	  Hepes	   (25	   mM,	   Lonza),	   L-­‐glutamine	   (1	   mM),	   gentamycin	   40	   μg/mL,	   Sigma),	   glucose	  (2%,	  Sigma),	  NaOH	  (1M),	  hypoxanthine	  (5O	  mg/mL,	  Sigma),	  and	  10%	  heat	   inactivated	  human	  serum	   in	  a	  37°C	   incubator	  with	  a	  gas	  mixture	  composed	  of	  90%	  N2,	  5%02,	  5%	  CO2.	  Mature	  forms	  of	  P.	  falciparum	  (schizonts)	  were	  concentrated	  on	  a	  percoll	  gradient	  (4mL	  90%	  percoll,	  2	  mL	  70%	  percoll,	  2	  mL	  40%	  percoll).	  After	  centrifugation,	  the	  layer	  between	  the	  70%	  and	  40%	  percoll,	  was	  transferred	  in	  a	  new	  tube	  and	  washed	  twice.	  A	  thin	   smear	   was	   done	   to	   check	   the	   efficiency	   of	   the	   concentration	   and	   when	   the	  population	  of	  parasitized	  RBCs	  (pRBCs)	  was	  over	  90%,	  cells	  were	  mixed	  with	  the	  target	  cells	  in	  a	  96	  wells	  plate	  and	  the	  initial	  parasitemia	  adjusted	  to	  0.5-­‐1%	  (final	  volume	  100	  μL,	  hematocrit	  2-­‐5%).	  The	  plate	  was	  placed	  in	  a	  37°C	  incubator	  with	  90%	  N2,	  5%	  02,	  5%	  
CHAPTER	  II:	  Hb	  influence	  and	  HSC	  sources	   	   	  
	  	  	  	  	  	  	  	  	  	  	  	  
78	  
CO2.	   	  The	  parasitemia	  was	  checked	  daily	  on	  a	  microscopy	  slide	  made	  using	  cytospin	  (3	  minutes	  at	  700	  rpm)	  and	  giemsa	  staining.	  
-­‐	  P.	  vivax	  isolates	  and	  invasion	  assays	  (supplementary	  data	  4):	  Cryopreserved	  P.	  
vivax	   isolates	   (Rossan,	   1985)	   from	   patient	   were	   provided	   by	   the	   Shoklo	   malaria	  research	   unit	   (SMRU,	   Mae	   Sot,	   Thailand).	   The	   samples	   were	   thawed	   with	   a	   NaCl	  solutions	  and	  cultivated	  for	  30	  hours	  with	  McCoy’s	  medium	  (Gibco)	  supplemented	  with	  glucose	  (2%)	  and	  20%	  human	  serum	  heat	  inactivated.	  Mature	  forms	  were	  concentrated	  on	  a	  45%	  percoll	  after	  a	  5	  minutes	   treatment	  with	  0.05%	  trypsin.	  After	  15	  minutes	  of	  centrifugation	  at	  1600g,	   cells	  above	   the	  45%	  percoll	  were	  collected	  and	  washed	   twice	  before	   checking	   the	   quality	   of	   the	   concentration.	   If	   more	   than	   90	   %	   of	   the	   cells	  contained	   parasites,	   they	   were	   mixed	   with	   our	   target	   cells	   (containing	   the	   same	  percentage	  of	  reticulocyte	  for	  all)	  in	  a	  96	  wells	  plate	  and	  adjusted	  the	  initial	  parasitemia	  on	  a	  1:6	  ratio	  (final	  volume	  100	  μL,	  hematocrit	  2-­‐5%).	  Cells	  were	  checked	  at	  24	  hours	  post-­‐invasion	  by	  cytospin	  slide	  and	  giemsa	  staining.	  
Data	  analyses:	  	  
Data	  were	  entered	  and	  cleaned	  in	  Excel	  (version?);	  data	  analyzed	  was	  performed	  with	  STATA12.	  Reticulocytes	  were	  counted	  after	  14	  days	  of	  differentiation	  and	  the	  mean	  ±SD	  calculated	   for	   each	   source	   of	   HSPC.	   The	   Kruskall-­‐wallis	   test	   was	   used	   to	   test	   for	  significant	   differences	   between	   the	   three	   population	   means.	   Parasite	   densities	   were	  counted	   for	  500	   cells	   and	   the	  number	  of	   infected	   cells	  divided	  by	   the	   total	  number	  of	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cells	   to	   obtain	   of	   percentage	   of	   infection.	   The	   mean	   and	   standard	   deviation	   were	  calculated	  for	  HSPC	  expansion	  rates.	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   samples	   were	   collected	   from	   the	   cord	   blood	   bank	   at	   the	  Gasthuisberg	  hospital,	  Leuven,	  Belgium:	  ethical	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  number	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Figure	  legends:	  
Table	  1:	  Comparison	  of	   the	  differentiation	  output	   for	   the	  different	  hematopoietic	   stem	  progenitor	   cells	   (HSPC)	   sources	   (6	   independent	   experiments	   for	   each	   HSPC	   source).	  Results	   show	   the	   median	   value	   and	   interquartile	   range	   (IQR)	   of	   the	   proportion	   of	  reticulocytes	   observed	   at	   the	   peak	   of	   enucleation	   after	   14	   days	   of	   culture.	   The	  hemoglobin	   stage	   was	   checked	   by	   Kleihauer	   method	   and	   the	   concentration	   of	  hemoglobin	  per	  cells	  was	  measured	  by	  the	  Hemocue	  method.	  	  
	  
Table	  2:	  	  Comparison	  of	  the	  cell	  expansion	  rate	  at	  different	  time	  points	  for	  the	  different	  hematopoietic	  stem	  progenitor	  cells	   (HSPC)	  sources.	  The	  number	  of	  cells	  was	  counted	  after	  5	  days	  of	  expansion	  and	  divided	  by	  the	  initial	  number	  of	  plated	  MACS/CD34+	  cells	  to	  assess	  expansion	  rate.	  After	  7	  days	  of	  HSPC	  differentiation,	   the	  number	  of	  cells	  was	  counted	  and	   compared	   to	   the	   cells	   that	  were	  not	   expanded	   in	   step	  1.	  The	  enucleation	  rate	  was	  also	  calculated	  by	  divided	  the	  number	  of	  reticulocytes	  obtained	  after	  14	  days	  of	  differentiation	   for	   cells	   that	   underwent	   the	   expansion	   step	   and	   cells	   that	   were	  differentiated	  without	  prior	  expansion.	  The	  average	  of	  3	  independent	  experiments	  and	  the	  standard	  deviation	  were	  calculated	  and	  reported	  in	  this	  table.	  
	  
Figure	  1:	  FACS	  analyses	  of	  the	  CD34+	  cells	  from	  UCB,	  PBMNC	  and	  BM,	  after	  isolation	  and	  following	  5	  days	  of	  expansion.	  The	  Q2	  gate	  represents	  the	  population	  double	  positive	  for	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CD34	   and	   CD45.	  We	   observed	   an	   increase	   CD34+APC/CD45+PE	   frequency	   in	   all	   three	  cases.	  
	  
Figure	  2:	   Proportion	  of	   the	  different	   stages	  of	  P.	   falciparum	   in	   culture	  on	   a	  daily	  base.	  The	   proportion	   of	   rings	   (blue),	   trophozoites	   (red),	   schizonts	   (green)	   and	   gametocytes	  (purple)	  was	   counted	   and	   adjusted	   to	   100	   parasites	   to	   obtain	   the	   proportion	   of	   each	  stage.	  The	  average	  of	  3	  independent	  experiments	  has	  been	  calculated	  for	  each	  day	  of	  the	  culture.	   The	   P.	   falciparum	   culture	   become	   asynchronous	   after	   5	   days	   in	   presence	   of	  adult	   peripheral	   blood,	   after7	   days	   in	   presence	   of	   beta	   thalassemia	   blood,	  while	  with	  cord	  blood	  it	  remained	  synchronous	  up	  to	  day	  7.	  	  
	  
Figure	  3:	  Cytospin	  of	  the	  HSPC-­‐derived	  reticulocytes	  with	  by	  P.	  vivax	  24h	  post	  invasion.	  Cells	   were	   stained	   with	   Giemsa.	   a)	   UCB/HSPC-­‐derived	   reticulocytes	   b)	   BM/HSPC-­‐derived	  reticulocytes;	  c)	  PBMC/HSPC-­‐derived	  reticulocytes.	  
	  
Figure	   4:	   Parasite	   densities	   24	   hours	   post-­‐invasion	   with	   P.	   vivax.	   a)	   comparison	   of	  parasites	  density	  of	  P.	  vivax	  24	  hours	  post-­‐invasion	  for	  the	  different	  HSPC	  sources	  and	  reticulocytes	  concentrated	  from	  blood	  for	  a	  same	  parasite	  isolate.	  b)	  parasite	  densities	  for	   4	   different	  P.	  vivax	   isolates	  with	   different	   reticulocyte	   sources.	   PV1	   and	  PV2	  were	  tested	  with	  the	  same	  HSPC-­‐derived	  reticulocyte.	  The	  parasite	  density	  was	  counted	  for	  at	  least	  500	  cells,	  dividing	  the	  number	  of	  infected	  cells	  by	  the	  total	  number	  of	  cells.	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Table	  1:	  Reticulocyte	  differentiation	  in	  3	  different	  sources	  of	  HSPC	  
HSPC	  source	   Mean	  reticulocyte	  proportion	  at	  D14°	   Hb	  stage	   Hb	  concentration	  (pg/cell)°*	  
UCB	   18.3%	  [17-­‐19]	   Fetal	   60[50-­‐70]	  
BM	   20.5%	  [20-­‐21]	   Adult	   60.5	  [60-­‐61]	  
PBMC	   32%	  [29-­‐32]	   Adult	   44.5	  [39-­‐50]	  °	  Proportion	  of	  reticulocytes	  (%)	  with	  interquartile	  range	  [IQR]	  *Range	  Hb	  concentration	  in	  vivo:	  (29.5-­‐33.5	  pg/cell)	  	  
Table	   2:	   	   Cell	   expansion	   rate	   at	   different	   time	   points	   for	   the	   three	   sources	   of	   HSPC.	  Results	  are	  expressed	  in	  mean±	  SD	  fold	  increase	  
	   Following	  5	  days	  of	  expansion	   Following	  7	  days	  of	  differentiation	  
UCB	   11.5±	  2.3	   33.5	  +	  2.4	  
BM	   3.1	  ±	  0.3	   8.6	  ±	  0.5	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Figure	   1:	   FACS	   analyses	   of	   the	   CD34+	   cells	   from	  UCB,	   PBMNC	   and	  BM,	   after	   isolation	  (day	  0)	  and	  after	  5	  days	  of	  expansion.	  
D0	  of	  expansion	   	   	   	   	   D5	  of	  expansion	  
UCB:	  
	  	   	   	   	  BM	  
	  	   	   	   	  PBMC	  
49,5% 
3,9% 0,4% 
46,3% 70,9% 29,1% 
0% 0% 
43,9% 55,5% 
0,4% 0,2% 0% 0% 
39,7% 60,3% 
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Figure	  2:	   Percentage	  of	   each	  P.	  falciparum	   stage	  at	  different	   time	  points	  of	   the	   in	  vitro	  culture.	  	  
	  





















CHAPTER	  II:	  Hb	  influence	  and	  HSC	  sources	   	   	  





Figure	  3:	  Cytospin	  of	  the	  HSPC-­‐derived	  reticulocytes	  24h	  after	  invasion	  with	  P.	  vivax.	  P.	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a	  	   	  	  	  	  	  	  	  	  	  	  	  	  b	  	  	   	  	  	  	  	  	  	  	  	  	  	  c	   	  
	  
Figure	  4:	  Parasite	  densities	  24	  hours	  post-­‐invasion	  with	  P.	  vivax.	  
a)	  Parasite	  density	  for	  different	  source	  of	  reticulocyte	  with	  1	  P.	  vivax	   isolate.	  The	  mean	  and	   SD	   of	   2	   different	   batches	   of	   differentiated	   reticulocytes	   was	   calculated	   for	   each	  source	  of	  HSPC	  and	  tested	  for	  invasion	  with	  the	  same	  P.	  vivax	  isolate.	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the	  total	  number	  of	  cells.	  Different	  reticulocytes	  sources	  were	  tested;	  blue:	  UCB/HSPC-­‐derived	  reticulocytes,	  red:	  BM/HSPC-­‐derived	  reticulocytes,	  yellow:	  PBMC/HSPC-­‐derived	  reticulocytes,	   violet:	   reticulocyte	   concentrated	   from	   UCB,	   black:	   reticulocytes	  concentrated	  from	  adult	  peripheral	  blood.	  
PV1	  and	  PV2	  were	  tested	  with	  the	  same	  batches	  of	  HSPC-­‐derived	  reticulocytes	  for	  the	  3	  different	  sources	  (UCB,	  BM	  and	  PBMC).	  For	  PV4,	  the	  proportion	  of	  reticulocyte	  was	  20%	  for	   HSCP-­‐derived	   reticulocytes	   and	   respectively	   70%	   and	   60%	   for	   reticulocytes	  concentrated	  from	  UCB	  adult	  peripheral	  blood	  



















P.	  vivax	  isolates	  
CHAPTER	  II:	  Hb	  influence	  and	  HSC	  sources	   	   	  









Hematopoietic	  stem	  cell 
Proerythroblast 
Basophilic	  erythroblast Polychromatophilic	  erythroblast Orthochromic	  erythroblast 
	  
	   Reticulocyte 









1	  day 	   
Colony	  factor	  unit-­‐erythroid 7	  days 	   	   	   















CHAPTER	  II:	  Hb	  influence	  and	  HSC	  sources	   	   	  




Supplementary	  data	  2:	  Parasite	  densities	  24	  hours	  post	  invasion	  for	  different	  sources	  of	  reticulocytes	  and	  different	  P.	  vivax	  isolates.	  Invasion	  tests	  were	  done	  with	  HSPC-­‐derived	  reticulocytes	  from	  umbilical	  cord	  blood	  (UCB),	  bone	  marrow	  (BM)	  and	  adult	  peripheral	  blood	   mononuclear	   cells	   (PBMC)	   as	   well	   as	   reticulocyte-­‐concentrated	   blood	   from	  umbilical	   cord	   blood	   (UCB	   cc)	   and	   adult	   peripheral	   blood	   (Ad	   cc).	   The	   number	   of	  parasitized	  cells	  was	  divided	  by	  the	  number	  total	  of	  cells	  and	  multiplied	  by	  100	  obtain	  a	  percentage	  of	  infected	  cells.	  
	   UCB	   BM	   PBMC	   UCB	  cc	   Ad	  cc	  
PV1	   3.9%	   3.8%	   4.2%	   1.4%	   0.2%	  
PV2	   1.8%	   2.3%	   2.1%	   0.2%	   0.1%	  
PV3	   2.2%	   2.2%	   1.6%	   NA	   0.2%	  
PV4	   5%	   4.9%	   4.6%	   4.6%	   3.5%	  
NA:	  Not	  applicable,	  no	  UCB	  cc	  was	  tested	  for	  this	  sample	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Supplementary	  data	  3:	  Timeline	  of	  the	  expansion/differentiation	  protocol	  of	  HSPC	  into	  reticulocytes.	  Timeline	  showing	  the	  different	  growth	  factors	  used	  during	  the	  expansion	  and	   differentiation	   protocols.	   The	   days	   of	   cryopreservation	   of	   the	   cells	   were	   also	  indicated.	  
	  	  
	  
Supplementary	   data	   4:	   Pictures	   of	   the	   invasion	   assay	   protocol	   for	   UCB/HSPC	   source.	  Cytopsin	   slides	   stained	   with	   Giemsa	   a)	   After	   P.	   vivax	   thawing;	   b)	   after	   40	   hours	   of	  culture;	  c)	  after	  percoll	  concentration;	  d)	  starting	  parasitemia	  during	  invasion	  test	  with	  HSPC-­‐derived	  reticulocytes	  e)	  24	  hours	  post-­‐invasion;	   f)	  48	  hours	  post-­‐invasion;	  g)	  72	  hours	  post-­‐invasion.	  P.	  vivax	  parasites	  are	  shown	  under	  arrow	  
5	  days 7	  days 	   	  
Expansion step Differentiation step 
reticulocytes HSPC HSPC 
D0 D7 D14 D8 D11 
cryopreservation cryopreservation 
SCF,	  HDS,	   IL-­‐3,	  EPO EPO SCF,TPO, IL-­‐6,	  FLT3 
Medium/10%	  DMSO/40%	  FCS Medium/10%	  DMSO/40%	  FCS 
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  Production	  of	  embryonic	  stem	  cell-­‐derived	  reticulocytes	  for	  the	  in	  vitro	  culture	  of	  P.	  
vivax	  	  	  
Summary:	  A	  continuous	  in	  vitro	  culture	  of	  Plasmodium	  vivax	  (P.	  vivax)	  parasite	  is	  an	  essential	  tool	  to	   understand	   the	   biology	   of	   this	   parasite.	   The	   preference	   of	   P.	   vivax	   to	   invade	  immature	   erythrocytes	   (reticulocytes)	   has	   been	   regarded	   as	   the	  main	  bottleneck	   for	  the	  establishment	  of	   an	   in	  vitro	   culture	   system.	  To	  date,	   several	  protocols	  have	  been	  developed	  to	  obtain	  large	  amounts	  of	  reticulocytes	  to	  feed	  P.	  vivax	  parasites	  in	  culture;	  including	  reticulocyte	  enrichment	  from	  different	  sources	  of	  blood	  [1],	  and	  reticulocyte	  production	  from	  hematopoietic	  stem/	  progenitor	  cells	  (HSPC)[2].	  	  	  Here	  we	  investigated	  the	  use	  embryonic	  stem	  cells	  (ESC)	  as	  an	  inexhaustible	  source	  of	  cells	  to	  generate	  reticulocytes.	  Using	  standard	  published	  protocols	  we	  here	  fated	  ESC	  to	  hematopoietic	  progenitor	  cells	  and	  then	  reticulocytes.	  Although	  some	  reticulocytes	  could	   be	   generated	   the	   efficiency	   of	   the	   culture	   at	   generating	   reticulocytes	  was	   low,	  and	  insufficient	  to	  serve	  as	  a	  source	  of	  reticulocytes	  for	  P.	  vivax	  infection.	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Introduction:	  	  
Plasmodium	  vivax	   (P.	  vivax)	   is	   now	  considering	   as	   a	  major	  health	  problem	  due	   to	   its	  morbidity	  [3]	  and	  emergence	  of	  drug	  resistance	  [4].	  The	  biology	  of	  the	  parasite	  is	  still	  poorly	  understood	  as	  proven	  by	  the	  recent	  observation	  of	  P.	  vivax	  infections	  in	  Duffy-­‐negative	  populations	  [5]	  whereas	  for	  a	  long	  period,	  Duffy	  receptor	  has	  been	  point	  out	  to	  be	  essential	  for	  P.	  vivax	  entry	  into	  erythrocyte	  [6].	  	  To	  better	  understand	   its	  biology	  and	   the	  molecular	  mechanisms	   involved	   in	  parasite	  invasion	   process,	   the	   development	   of	   a	   continuous	   in	   vitro	   culture	   is	   essential.	  However	  a	  major	  problem	  to	  achieve	   this	  goal	   is	   the	  preference	  of	  P.	  vivax	  for	  young	  erythrocytes	   (reticulocyte)	   [7].	   Reticulocytes	   represent	   a	   small	   subpopulation	   of	  erythrocytes	   (0.5-­‐1%	   of	   RBC	   population	   in	   adult	   peripheral	   blood)	   with	   a	   short	  lifespan	  (2	  days).	  If	  enough	  reticulocyte	  cells	  have	  to	  be	  regularly	  added	  in	  culture	  to	  maintain	  the	  growth	  and	  multiplication	  of	  the	  P.	  vivax	  parasite,	  a	  continuous	  source	  of	  reticulocytes	  is	  necessary.	  Several	  strategies	  including	  reticulocyte	  concentration	  from	  whole	   blood	   [8,	   9]	   and	   reticulocyte	   differentiation	   from	   hematopoietic	  stem/progenitor	   cells	   (HSPC)	   of	   different	   sources	   have	   been	   used,	   which	   allow	  invasion	  of	   the	  parasite	  but	  not	   its	   long	   term	  maintenance	   in	  vitro	   [2,	  10].	  Moreover,	  even	   if	   reticulocytes	   can	   be	   generated	   from	   HSPC	   sources,	   HSPC	   do	   not	   long-­‐term	  expand,	   and	   hence,	   variability	   between	   donor	   sources	   may	   also	   interfere	   with	   the	  creation	  of	  a	  reliable	  P.	  vivax	  culture	  system.	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Embryonic	  stem	  cells	   (ESC)	  are	  pluripotent	  cells	   isolated	   from	  the	   inner	  cell	  mass	  of	  the	   blastocyst.	   Compared	   with	   adult	   stem	   cells,	   they	   can	   proliferate	   symmetrically	  without	   senescence.	   In	   addition,	   the	   can	   differentiate	   into	   cells	   of	   the	   three	   germ	  layers,	  including	  hematopoietic	  cells.	  Therefore	  they	  could	  provide	  a	  consistent	  source	  of	  stem	  cells	  for	  generating	  reticulocytes.	  Different	  protocols	  of	  erythrocyte	  production	  from	   human	   ESC	   have	   been	   recently	   described	   [11]	   opening	   new	   opportunities	   to	  produce	  reticulocytes	  suitable	  for	  P.	  vivax	  in	  vitro	  culture	  establishment.	  Here,	   we	   attempted	   to	   differentiate	   reticulocytes	   from	   ESC	   to	   test	   infection	   with	   P.	  
vivax	  using	  2	  protocols	  previously	  published:	  Lapillonne	  et	  al	  [12]	  who	  obtained	  a	  final	  amount	   of	   55	   to	   60%	   of	   enucleated	   erythroid	   cells	   and	   Niwa	   et	  al	   [13]	  who	   used	   a	  serum	  free	  medium	  with	  a	  different	  timeline	  of	  growth	  factor	  used	  but	  obtained	  a	  less	  important	  amount	  of	  enucleated	  cells	  (9%).	  	  	  
Material	  and	  methods:	  	   i) Inactivated	  mouse	  embryonic	  fibroblast	  (iMEF)	  coating	  iMEF	   were	   plated	   with	   a	   density	   of	   220	   000	   cells	   per	   well	   in	   a	   6	   wells	   plate	   and	  maintained	   in	   a	   iMEF	  medium	  with	  Dulbecco's	  modified	   eagle	  medium	  high	   glucose	  (DMEM	   HG,	   Invitrogen),	   fetal	   bovine	   serum	   (FBS,	   15%,	   HypoClone),	   penicillin/	  streptomycin	  (0.1X,	  Invitrogen),	  L-­‐glutamine	  (4mM,	  Gibco),	  non-­‐essential	  amino	  acids	  (NEAA,	  4	  mM,	  Invitrogen)	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ii) Maintenance	  of	  ESC	  (H9	  cell	  line)	  ESC	  (H9	  cell	  line)	  cells	  were	  maintained	  on	  iMEF	  in	  a	  6	  well	  plate.	  They	  were	  cultivated	  in	  2.5	  mL	  of	  ESC	  medium	  composed	  of	  Dulbecco's	  modified	  eagle	  medium	  (DMEM)	  +	  Hepes	  (Invitrogen)	  supplemented	  with	  knockout	  serum	  replacer	  (KOS,	  Invitrogen),	  L-­‐glutamine	   (2	   mM,	   Gibco),	   β-­‐mercapto-­‐ethanol	   (0.7X,	   Sigma),	   NEAA	   (1X,	   Invitrogen),	  penicillin-­‐streptomycin	  (O.1X,	  Invitrogen)	  and	  basic	  fibroblast	  growth	  factors	  (b-­‐FGF;	  4	  10-­‐3	   μg/mL,	  R&D	   system).	   Cells	  were	  placed	   in	   a	  5%	  CO2,	   37	   °C	   incubator	   and	   the	  medium	  was	  changed	  every	  day	  by	  removing	  supernatant	  and	  adding	  2.5	  mL	  of	  fresh	  medium.	  Cells	  were	  split	  every	  5-­‐7	  days	  depending	  on	  how	  fast	  colonies	  expanded.	  Cells	  were	  washed	   with	   PBS	   (Lonza),	   treated	   with	   1	   mL	   of	   pre-­‐warmed	   collagenase	   IV	   (0.1%,	  Sigma)	  and	  left	  5	  minutes	  at	  37°C.	  After	  5	  minutes,	  the	  supernatant	  was	  discarded	  and	  1	  mL/	  well	  of	  ESC	  medium	  was	  added.	  Using	  a	  cell	  scraper,	  cells	  were	  detached	  from	  the	   bottom	   of	   the	   well	   and	   transferred	   into	   a	   15	  mL	   falcon	   tube	   and	   centrifuged	   5	  minutes	   at	   0.2	   g.	   The	   supernatant	  was	   discarded	   and	   500	   μL	   of	   ESC	  medium	   added	  using	  a	  1000	  μL	  tip	  to	  get	  as	  little	  colonies	  as	  possible.	  ESC	  were	  then	  platted	  on	  a	  new	  iMEF	  layer	  previously	  washed	  with	  PBS	  and	  immerged	  in	  2	  mL	  of	  ESC	  medium.	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iii) Differentiation	  protocols	  	  
Lapillonne	  et	  al	  protocol:	  When	  ESC	  cultures	  reached	  confluence,	   they	  were	  detached	  using	   the	  method	  described	   for	  ESC	  passaging	   (see	   ii)..	  After	   the	   centrifugation	   step,	  cells	   were	   re-­‐suspended	   and	   plated	   in	   a	   low	   attachment	   6	   well	   plate	   with	   IMDM	  medium	   (Biochrom)	   supplemented	   with	   SCF	   (100	   ng/mL,	   Bioke),	   thrombopoietin	  (TPO,	  100	  ng/mL,	  R&D	  system),	  FLT-­‐3	  ligand	  (100	  ng/mL,	  R&D	  system),	  recombinant	  human	  bone	  morphogenetic	  protein	  4	  (BMP-­‐4,	  10	  ng/mL,	  R&D	  system),	  recombinant	  human	  vascular	  endothelial	  growth	  factor	  (VEGF;	  5	  ng/mL,	  R&D	  system),	  interleukin-­‐6	  (IL-­‐6,	  5	  ng/mL,	  R&D	  system),	  IL-­‐3	  (5	  ng/mL,	  R&D	  system),	  EPO	  (3	  U/mL,	  R&D	  system)	  and	  5	  %	  human	  plasma.	   The	   cells	  were	   cultivated	   at	   5%	  CO2	   in	   a	   37°C	   incubator	   as	  clumps	  to	  form	  embryoid	  bodies	  (EBs,	  figure	  1)	  and	  the	  medium	  was	  changed	  every	  2	  days	   by	   centrifuging	   EBs	   5	   minutes	   at	   0.2g.	   After	   20	   days	   of	   culture,	   cells	   were	  dissociated	   by	   incubation	   30	  minutes	   at	   37°C	   with	   collagenase	   B	   (0.4	   U/mL,	   Roche	  applied	  science)	  and	  10	  minutes	  with	  dissociation	  buffer	  (invitrogen).	  Dissociated	  cells	  were	  then	  platted	  in	  a	  6	  wells	  plate	  	  and	  the	  hematopoietic	  stem	  cells	  (HSC)	  	  protocol	  previously	   described	   applied	   [14].	   The	   cells	   were	   dispended	   with	   4	   mL	   of	   Iscove's	  Modified	  Dulbecco's	  Medium	  (IMDM)+	  10%	  human	  plasma	  supplemented	  with	  Stem	  Cell	  Factor	  (SCF,	  100	  ng/ml,	  Bioke),	  IL-­‐3	  (5	  ng/ml,	  R&D	  System),	  Hydrocortisone	  (HDS,	  10-­‐6	  M,	  Sigma),	  and	  Erythropoietin	  (EPO,	  3	  IU/ml,	  R&D	  System).	  After	  8	  days,	  the	  cells	  were	   centrifuged	  5	  minutes	   at	   0.2	   g	   and	   resupended	   in	   a	   25	   cm2	   flask	  with	  5	  mL	  of	  IMDM	   medium	   supplemented	   with	   EPO	   (5	   IU/mL).	   After	   3	   days,	   the	   medium	   was	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changed	   with	   an	   IMDM	   medium	   without	   supplementation.	   The	   medium	   was	   then	  changed	  every	  3	  days.	  	  
Niwa	  et	  al	  protocol:	  5-­‐6	  colonies	  of	  ESC	  were	  plated	  in	  a	  new	  6	  wells	  plate	  previously	  coated	   with	   1	   mL	   of	   matrigel	   (BD	   biosciences)	   with	   mTeSR1	   medium	   (Stemcell	  technologies)	  and	  left	  in	  a	  5%	  CO2,	  37	  °C	  incubator.	  When	  the	  colonies	  reached	  nearly	  500	   μm	   of	   diameter,	   the	   medium	   was	   removed	   and	   changed	   with	   Stemline	   II	  hematopoietic	   stem	   cell	   expansion	   medium	   (Sigma)	   supplemented	   with	   insulin-­‐transferrin-­‐selenium-­‐X	   supplement	   (ITS,	   Invitrogen),	   corresponding	   to	   the	   day	   0	   of	  differentiation.	  For	  the	  first	  4	  days,	  BMP	  4	  (20	  ng/mL)	  was	  added	  and	  for	  the	  following	  2	  days,	  new	  medium	  without	  BMP4	  but	  with	  VEGF	  (50	  ng/mL)	  and	  SCF	  (10	  ng/mL).	  On	  day	  6	  of	  differentiation,	  medium	  was	  changed	  to	  medium	  supplemented	  with	  BMP	  4	  (20	  ng/mL),	  VEGF	  (50	  ng/mL),	  TPO	  (10	  ng/mL),	   IL	  3	  (50	  ng/mL),	   IL-­‐6	  (50	  ng/mL,	  R&D	   system),	   FLT-­‐3	   ligand	   (50	   ng/mL)	   and	   EPO	   (5	   IU/mL).	   The	  medium	  was	   then	  changed	  every	  5	  days.	  	   iv) FACS	  and	  FACS	  sorting	  analyses	  
Briefly,	  200	  000	  cells	  were	  centrifuged	  for	  5	  min	  at	  650	  g.	  The	  pellet	  was	  re-­‐suspended	  in	   100µL	   of	   PBS	   buffer.	   5	   µl	   of	   CD45-­‐PE	   (BD	   bioscience),	   10	   µL	   of	   CD71-­‐APC	   (BD	  bioscience),	   5	   µL	   of	   CD36-­‐FITC	   (BD	   bioscience),	   and	   5	   µL	   of	   CD235-­‐PerCP	   (BD	  bioscience),	  were	  added	  to	   the	  cells	  and	   incubated	   for	  15	  min	  at	  room	  temperature	   in	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the	   dark.	   One	   tube	   containing	   only	   antibody	   isotypes	   coupled	   to	   fluorochromes	   was	  used	   as	   a	   negative	   control:	   10	   µL	   of	   IgG1γ-­‐PE	   (BD	   bioscience),	   5	   µL	   of	   IgM-­‐FITC	   (BD	  bioscience),	  5	  µL	  of	   IgG1	  K	   isotype-­‐PerCP	  (BD	  bioscience),	  and	  5	  µL	  of	   IgG1	  K	   isotype-­‐APC	   (BD	   bioscience).	   	   After	   incubation	   cells	   were	  washed	  with	   FACS	   buffer	   (Miltenyi	  Biotech)	   and	   re-­‐suspended	   in	   500	   µL	   of	   buffer	   before	   analysis.	   FACS	   analyses	   were	  carried	  out	  on	  a	  FACScalibur	  4	  color	  cytometer	  (BD	  bioscience).	  	  
Different	  antibodies	  were	  used	  to	  characterize	  the	  different	  stages	  of	  the	  cells:	  CD34-­‐APC	   (ebioscience),	   CD45-­‐PE	   (ebioscience)	   and	   CD43-­‐FITC	   (ebioscience)	   for	  hematopoiesis.	  For	  erythropoiesis,	  CD235a-­‐APC	  (ebioscience),	  DARC-­‐FITC	  (BDscience)	  and	   CD71-­‐PE	   (ebioscience)	   were	   used.	   The	   following	   isotype	   controls	   were	   used:	  	  mouse	  IgM-­‐FITC,	  mouse	  IgG1	  K-­‐FITC,	  mouse	  IgG1	  K-­‐APC,	  mouse	  IgG2a-­‐PE	  and	  IgG1γ-­‐PE	  (all	  from	  ebioscience).	  Cells	  were	   centrifuged	  5	  minutes	   at	  0.2g	  and	   resuspended	   in	  100	  µL	  of	  PBS.	   For	   the	  controls,	  5	  µL	  of	  each	   isotype	  control	  were	  added	  to	  the	  cells,	  5	  µL	   	  of	  each	  antibody	  was	   added	   for	   the	   sample	   tube	   and	   no	   antibody	   for	   the	   bare	   cell	   tube.	   Cells	   were	  incubated	  15	  minutes	  in	  the	  dark	  before	  been	  washed	  twice	  with	  PBS.	  The	  pellet	  	  was	  resuspended	  in	  200	  µL	  of	  PBS	  before	  the	  processing	  of	  the	  tube	  on	  a	  FACS	  DIVA.	  	  The	  CD34+	  cells,	  after	  the	  1st	  step	  of	  differentiation,	  were	  purified	  using	  a	  FACS	  ARIA	  III	  sorter.	  based	  on	  the	  expression	  of	  CD34+.	  	  	  
CHAPTER	  III:	  ESC	  source	  	   	   	  
	  	  	  	  	  	  	  	  	  	  	  	  
103	  
v) Magnetic	  assorted	  cell	  sorting	  (MACS)	  The	  CD34+	  population	  was	  purified	  by	  MACS,	  cells	  were	  washed	  with	  PBS	  and,	  after	  a	  centrifugation	  of	  5	  minutes	  at	  0.2	  g,	  resuspended	  in	  500	  µL	  of	  PBS/0.5%	  FBS.	  100	  µL	  of	  blocking	  solution	  and	  100	  µL	  of	  CD34	  magnetics	  beads	  (Myltenyl	  biotech)	  were	  added	  and	  the	  tube	  left	  30	  minutes	  at	  4°C.	  After	  30	  minutes,	  the	  cells	  were	  washed	  with	  the	  PBS/0.5%	  FBS	  solution	  and	  passed	  through	  a	  magnet	   that	  will	  retain	  the	  cells	  CD34+	  bind	   to	   the	   beads.	  When	   all	   the	   cells	  were	   passed,	   the	   column	  was	  washed	   3	   times	  before	  to	  be	  flushed	  to	  recuperate	  the	  CD34+	  cells.	  	   vi) Ethic	  statement:	  The	   use	   of	   H9	   cell	   line	   was	   approved	   by	   the	   ethical	   commission	   of	   the	   Katholieke	  Universiteit	  Leuven.	  	  
Results:	  	   i) Production	  of	  reticulocytes	  with	  the	  Lapillonne	  protocol	  	  On	  day	  20,	  we	  obtained	  3.5	  %	  of	  CD34	  cells	  and	  after	  43	  days,	  up	  to	  22%	  of	  CD235a+	  cells.	  However,	  very	  few	  erythroid	  cells	  were	  enucleated	  (<	  0.01%)	  (figure	  2).	  A	  MACS	  or	  FACS	  sorter	  selection	  of	   the	  CD34+	  cells	  at	   the	  end	  of	   the	  1st	  step	  (day	  20)	  did	  not	  lead	   improved	   enucleation	   when	   enriched	   cells	   were	   allowed	   to	   differentiate	   to	  erythroid	  cells,	  using	  the	  methods	  we	  have	  used	  for	  adult	  HSPC	  differentiation.	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   ii) Production	  of	  reticulocyte	  with	  the	  Niwa	  protocol	  	  After	   15	   days,,	   corresponding	   to	   the	   peak	   of	   CD34+	   cells	   expression	   in	   the	   work	   of	  Niwa	  et	  al,	  we	  could	  observe	  10%	  CD34+	  cells	  and	  after	  43	  days,	  7%	  of	  the	  cells	  were	  CD235a+(erythroid	  cells),	  with	  very	  few	  enucleated	  cells	  (<	  0.01%).	  Selection	  of	  cells	  at	  day	  15	  based	  on	  their	  CD34+	  expression	  using	  FACS	  sorter	  or	  MACS	  did	  not	   improve	  erythroid	   commitment	   or	   enucleation.	   The	   CD34+	   differentiation	   protocol	   was	   also	  tested	  on	  the	  CD34+	  cells	  after	  15	  days	  but	  we	  could	  not	  obtain	  more	  significant	  results	  in	  term	  of	  erythroid	  differentiation.	  	  	  	  
Discussion:	  
	  Production	   of	   erythrocytes	   from	   ESC	   using	   several	   different	   protocols	   has	   been	  described,	   including	   co-­‐culture	  with	   a	   human	   fetal	   liver	   cell	   line	   [15],	   co-­‐culture	   on	  murine	  stromal	  cells	  (OP9,	  MS5)	  [16,	  17],	  erythroid	  bodies	  [18],	  and	  this	  for	  a	  number	  of	   ESC	   lines	   [19].,	   Erythrocytes	   obtained	   were	   reported	   to	   resemble	   erythrocytes	  found	   cord	  blood,	  with	  presence	  of	   fetal	   hemoglobin	   (HbF).	   In	  most	   of	   these	   studies	  the	   ratio	   of	   enucleation	   was	   low.	   Thus,	   the	   enucleation	   process	   in	   vitro	   is	   very	  challenging	  [20]	  an	  will	  require	  optimization	  to	  allow	  the	  production	  of	  erythrocytes.	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An	  additional	  difficulty	  to	  create	  reticulocytes	  for	  P.	  vivax	  studies	  is	  that	  differentiation	  should	  be	  synchronized	  to	  obtain	  a	  homogeneous	  population	  of	  erythroblasts	  that	  then	  enucleate	  simultaneously	  to	  become	  reticulocytes.	  Further	   studies	  will	   be	   needed	   to	   develop	   a	   consistent	   and	   synchronized	   erythroid-­‐directed	  differentiation.	   Finally,	   the	   relative	  high	   cost	  of	   the	   large	  number	  of	   growth	  factors	  needed	  in	  important	  quantities,	  will	  likely	  impede	  the	  use	  of	  such	  protocols	  for	  
P.	  vivax	  research.	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Fig	  1:	  Embryoid	  bodies	  after	  5	  days	  of	  Lapillonne’s	  differentiation	  protocol	  	  
	  	  	  	  Fig	  2:	  Assemblage	  of	  cytospin	  slides	  of	  cells	  after	  43	  days	  in	  culture.	  Enucleated	  cells	  are	  shown	  under	  arrows.	   	  
	  	  	  	  	  	  
DISCUSSION	  
	  	  	  	  	  	  	  	  	  	  	  	  
109	  
DISCUSSION	  	  	  The	  establishment	  of	  a	  reliable	  and	  continuous	  in	  vitro	  P.	  vivax	  culture	  is	  needed	  to	  better	  understand	  its	  biology	  and	  the	  molecular	  mechanisms	  involved	  in	  the	  process	  of	  reticulocyte	  invasion	  [91].	  The	  recent	  reports	  of	  P.	  vivax	  infections	  in	  Duffy	   negative-­‐individuals	   [92]	   demonstrate	   that	   the	  mechanisms	   of	   invading	  reticulocytes	   and	   other	   aspects	   of	   the	   biology	   of	   the	   parasite	   are	   largely	  unknown.	  Despite	   the	   several	   attempts	   over	   the	   last	   100	   years,	   a	   satisfactory	  and	   reproducible	   model	   supporting	   the	   whole	   blood	   cycle	   of	   P.	   vivax	   is	   not	  currently	   available	   [40,	   42,	   93].	   A	   critical	   factor	   for	   achieving	   a	   successful	   in	  
vitro	  P.	  vivax	  culture	  is	  the	  access	  to	  a	  continuous	  source	  of	  reticulocytes.	  During	  my	  PhD	  thesis,	  we	  assessed	  the	  suitability	  of	  different	  sources	  of	  stem	  cells	   to	  obtain	  reticulocytes	  that	  can	  be	  infected	  with	  P.	  vivax,	  and	  wished	  to	  develop	  a	  model	   that	   would	   allow	   P.	   vivax	   to	   multiply	   and	  mature	   to	   every	   schizogony	  stage.	  	  	  
Use	  of	  HSPC	  as	  source	  of	  reticulocytes	  
	  
	   -­‐	  HSPC	  isolated	  from	  umbilical	  cord	  blood	  	  Reticulocytes	  derived	  from	  CD34+	  cells	  isolated	  from	  umbilical	  cord	  blood	  could	  provide	  a	  good	  source	  of	  reticulocyte	  for	  P.	  vivax	  as	  UCB	  is	  considered	  medical	  waste	   and	   is	   easy	   to	   obtain.	   	   Although	   UCB	   derived	   CD34+	   cells	   had	   already	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been	  used	   for	   culturing	  P.	  vivax	   [54],	   the	  percentage	  of	   reticulocytes	   obtained	  was	  very	   low	  (0.5%	  after	  14	  days	  of	  culture	  compared	   to	  0.5-­‐1%	  in	  vivo)	  and	  did	   not	   represent	   a	   significant	   advantage	   compared	   to	   peripheral	   blood.	  Conversely,	  we	  were	  able	   to	   increase	   the	  percentage	  of	   reticulocytes	  obtained	  after	   14	   days	   of	   culture	   from	   HSPC-­‐UCB	   source	   to	   20%	   and	   these	   could	   be	  successfully	   used	   to	   culture	  P.	   falciparum	   	   (for	   at	   least	   15	  days)	   and	   could	   be	  invaded	   by	   P.	   vivax	   (up	   to	   2.5	   %	   of	   parasitemia)	   though	   no	   parasite	  multiplication	   could	   be	   observed.	   The	   invasion	   rate	   was	   dependent	   of	   the	   P.	  
vivax	   isolate,	  but	  not	  on	  the	  UCB/HSPC	  derived	  reticulocyte	  batches,	  indicating	  that	   the	   latter	   could	   be	   used	   for	   the	   culture.	   	   In	   addition,	   invasion	   was	   not	  affected	   by	   cryopreservation	   so	   that	   it	   would	   be	   possible	   to	   start	   a	   P.	   vivax	  culture	  by	  using	  cryopreserved	  cells,	  both	  parasite	   isolates	  and	  CD34+-­‐derived	  reticulocytes,	  opening	   the	  possibility	  of	  carrying	  out	  ex	  vivo	   invasion	  assays	   in	  laboratories	  localized	  in	  non-­‐endemic	  countries.	  	  	  
	   -­‐	  HSPC	  isolated	  from	  different	  sources	  	  To	  identify	  the	  best	  source	  of	  CD34+	  cells	  to	  obtain	  reticulocytes	  suitable	  for	  P.	  
vivax	   invasion,	   we	   tested	   CD34+	   enriched	   cell	   populations	   from	   un-­‐mobilized	  peripheral	   blood	   (PB),	   bone	   marrow	   (BM)	   and	   umbilical	   cord	   blood	   (UCB).	  Reticulocytes	  produced	  from	  CD34+	  cells	  isolated	  from	  UCB	  [53]	  BM	  and	  PB	  [94]	  were	   shown	   to	   be	   permissive	   to	  P.	  vivax	   though	   it	   is	   unknown	   if	   there	   is	   any	  difference	  in	  suitability	  as	  a	  direct	  comparison	  between	  sources	  has	  never	  been	  done.	  We	   could	   differentiate	   CD34+	   enriched	   fractions	   from	   different	   sources	   and	  characterize	   the	   reticulocytes	   obtained.	   The	   reticulocyte	   production	   after	   14	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days	  from	  UCB-­‐CD34+	  enriched	  cells	  reached	  18	  %.	  The	  reticulocytes	  contained	  HbF	   and	   the	   Hb	   concentration	   was	   higher	   than	   the	   in	   vivo	   range	   while	  reticulocytes	   from	   CD34+	   enriched	   BM	   and	   PB	   contained	   HbA,	   with	  concentrations	   higher	   than	   the	   normal	   range,	   but	   the	   percentage	   of	  reticulocytes	   obtained	   after	   14	   days	   was	   significantly	   higher	   than	   for	  UCB/CD34+	  cells.	  	  We	  also	  added	  an	  expansion	  step	  prior	  to	  differentiating	  of	  the	  CD34+	  enriched	  UCB,	  BM	  and	  PB,	  with	  the	  hypothesis	  that	   if	  more	  CD34+	  cells	  were	  present	  at	  the	   beginning	   of	   reticulocyte	   production,	   a	   significantly	   larger	   numbers	   of	  reticulocytes	   could	   be	   generated	   from	   a	   single	   sample.	   CD34+	   enriched	   cells	  isolated	   from	   UCB	   expanded	   significantly	   more	   than	   those	   from	   BM	   or	   PB,	  consistent	  with	   published	   studies	   and	  with	   the	   concept	   that	  UCB/CD34+	   have	  greater	   proliferative	   potential	   [95].	   Combining	   the	   expansion	   as	   well	   as	   the	  enucleation	  capacity,	  UCB/CD34+	  cells	  appear	  to	  be	  the	  most	  appropriate	  source	  to	  generate	  reticulocytes	  in	  suitable	  quantities	  to	  provide	  target	  cells	  to	  P.	  vivax	  
in	  vitro.	  	  The	  reticulocytes	  produced	  from	  the	  3	  different	  HSPC	  sources	  (with	  or	  without	  expansion	   step)	   could	   be	   invaded	   and	   allowed	   the	   intra-­‐erythrocyte	  development	   of	   P.	   falciparum	   for	   at	   least	   1	   week.	   No	   differences	   were	   seen	  between	  the	  cell	  sources	  in	  terms	  of	  permissiveness	  and	  parasite	  growth.	  These	  reticulocytes	   could	   also	   be	   invaded	   by	   P.	   vivax	   with	   the	   same	   efficiency;	  however	   few	   new	   ring	   forms	   could	   be	   observed	   after	   3	   days	   of	   culture,	  regardless	  of	  the	  HSC	  sources,	  and	  the	  parasites	  could	  not	  develop	  further.	  Interestingly,	  while	  comparing	  the	  P.	  vivax	   invasion	  rate	  of	  differences	  sources	  of	  reticulocytes	  (CD34+-­‐derived	  or	  blood-­‐concentrated)	  by	  P.	  vivax,	  we	  observed	  that	  permissiveness	  of	  the	  CD34+-­‐derived	  reticulocytes	  was	  higher	  than	  that	  of	  reticulocyte-­‐concentrated	  UCB	  or	  from	  adult	  peripheral	  blood.	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These	  results	  appear	  consistent	  with	  the	  studies	  by	  Paterakis	  et	  al	  in	  1993	  [96]	  	  in	   which	   the	   reticulocyte	   populations	   in	   UCB	   and	   PB	   were	   compared.	   They	  classified	  reticulocytes	   in	  3	  groups	  based	  on	  RNA	  content:	  young,	  average	  and	  old.	  They	  found	  13%	  of	  young	  reticulocyte	  in	  UCB	  while	  only	  1%	  could	  be	  found	  in	   PB.	   This	   may	   explain	   the	   differences	   of	   invasion	   observed	   in	   the	   CD34+-­‐derived	  reticulocytes,	  which	  are	  harvested	  at	  the	  peak	  of	  enucleation,	  and	  hence	  likely	   to	   contain	   a	   larger	   fraction	   of	   “young”	   reticulocytes	   compared	   with	  reticulocytes	  concentrated	  from	  UCB	  and	  PB.	  These	  observations	  are	  also	  in	  line	  with	  the	  study	  of	  Martin-­‐Jaular	  et	  al	  [97]who	  demonstrated	  a	  preference	  of	  Plasmodium	  yoelii	  (a	  mouse-­‐infecting	  plasmodium	  that	  has	  also	  a	  preference	  for	  reticulocyte	  as	  target)	  for	  CD71high	  expression	  cells	  (immature	  reticulocytes).	  If	   these	   results	   are	   confirmed,	   this	   might	   provide	   a	   good	  model	   to	   study	   the	  mechanisms	  underlying	  P.	  vivax	  invasion.	  	  
Influence	  of	  hemoglobin	  on	  Plasmodium	  development	  
	  It	   has	  previously	  been	  hypothesized	   that	  using	  UCB/CD34+	   cells	   as	   source	   for	  reticulocytes,	   which	   contain	   HbF,	   would	   be	   less	   suitable	   for	   the	   intra-­‐erythrocyte	  development	  of	  P.	  vivax.	  Pasvol	  et	  al	  [68]	  described	  a	  slowdown	  of	  the	   intra-­‐erythrocyte	   development	   of	   P.	   falciparum	   but	   for	   P.	   vivax	   no	   data	  exists.	  In	  order	  to	  revise	  and	  test	  this	  hypothesis,	  we	  investigated	  the	  influence	  of	  HbA	  and	  HbF	  on	  the	  intra-­‐erythrocyte	  development	  of	  both	  P.	  falciparum	  and	  
P.	  vivax.	  We	  also	   investigated	  the	   importance	  of	   the	  hemoglobin	  concentration	  on	   the	  parasite	  culture	  by	   testing	  minor	  β	   thalassemia	  blood	  whose	  RBC	  have	  less	  hemoglobin	  than	  normal.	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None	  of	  the	  conditions	  tested,	  i.e.	  HbF	  and	  minor	  β	  thalassemia,	  was	  associated	  with	   a	   significant	   delay	   in	   the	   in	   vitro	   maturation	   of	   P.	   falciparum	   whose	  development	   remained	   synchronous	   for	   at	   least	   7	   days.	   These	   results	   are	  opposite	   to	   those	   published	   by	   Pasvol	   et	   al	   and	   could	   be	   explained	   by	   the	  difference	   of	   gas	   mixture	   used	   to	   cultivate	   P.	   falciparum	   under	   hypoxia	  conditions	   (5%	   O2).	   Therefore,	   the	   greater	   affinity	   of	   HbF	   for	   O2	   [98]	   may	  compensate	  for	  the	  hypoxic	  condition	  and	  thus	  decrease	  the	  influence	  of	  HbF	  on	  the	  parasite	  development.	  HbF	  did	  not	  influence	  the	  invasion	  rate	  of	  CD34+-­‐derived	  reticulocytes	  from	  UCB	  (HbF)	  vs	  BM	  and	  PB	  (HbA)	  by	  P.	  vivax	  either.	  However,	   irrespective	  of	  the	  cell	  source,	   parasites	   could	   not	   complete	   a	   first	   schizogony	   cycle	   in	   vitro,	   and	  we	  could	  only	  detect	  rare	  parasites	  having	  survived	  for	  3	  days.	  Though	  from	  these	  results	  it	   is	  not	  possible	  to	  identify	  the	  important	  factors	  influencing	  the	  intra-­‐reticulocyte	  development	  (or	  the	  lack	  of	   it)	  of	  P.	  vivax	  in	  vitro,	  probably	  HbF	  is	  not	  one	  of	  them.	  	  	  
ESC-­‐	  derived	  reticulocytes	  
	  Whereas	  CD34+	  cells	  are	  a	  good	  source	  of	  cells	   to	  generate	  reticulocytes	   for	  P.	  
vivax	   culture,	   the	  number	  of	   cells	   that	   can	  be	  produced	   remains	   limited,	   even	  when	   performing	   CD34+	   cell	   expansion.	   Although	   we	   did	   not	   see	   significant	  differences	  between	  different	  UCB	  donors	  as	  it	  relates	  to	  P.	  vivax	  invasion,	  inter-­‐individual	  variations	  might	  still	  pose	  a	  problem	  for	  the	  reticulocyte	  generation.	  Therefore,	   the	   use	   of	   human	   embryonic	   stem	   cells	   that	   have	   theoretically	  limitless	  expansion	  potential	  could	  be	  an	  alternative	  source	  of	  cells	  to	  generate	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reticulocytes.	   ESCs	   are	   amenable	   to	   genome	   editing	   that	   would	   result	   in	   a	  modification	  of	  cell	  surface	  receptors	  or	  intracellular	  proteins,	  possibly	  opening	  the	  opportunity	   for	  not	  only	   identifying	  the	  receptors	   involved	   in	   the	   invasion	  but	  also	  for	  recognizing	  essential	  factors	  needed	  for	  the	  development	  of	  P.	  vivax	  development	   in	  vitro.	   To	  date,	   several	   protocols	   exist	   to	  produce	   erythrocytes	  from	   embryonic	   stem	   cells	   (ESC)	   [99-­‐101]	   or	   induced	   pluripotent	   stem	   cells	  (iPSC)	  [102-­‐104].	  	  	  One	   of	   the	   main	   difficulties	   met	   for	   the	   use	   of	   ESC	   in	   the	   production	   of	  reticulocytes/	  erythrocytes	  is	  the	  enucleation	  step	  that	  is	  difficult	  to	  reproduce	  efficiently	  in	  vitro	  [105].	  Concerning	   the	   generation	   of	   reticulocytes,	   the	   differentiation	   should	   be	  stopped	   in	   the	   extremely	   narrow	   time	   window	   of	   48	   hours,	   between	   the	  orthonormoblast	   stage	   and	   erythrocyte	   stage.	   To	   date,	   most	   of	   the	   ESC	  differentiation	   protocols	   aim	   to	   generate	   erythrocytes	   and	   thus	   are	   not	  concerned	  by	  this	  time	  window	  problem.	  Nevertheless,	  different	  ESC	  differentiation	  protocols	  are	  available	  with	  different	  approaches	  [103]	  allowing	  to	  choose	  the	  more	  suitable	  one.	  	  The	  now	  well-­‐established	  differentiation	  of	  CD34+	  into	  reticulocytes	  can	  also	  be	  a	   great	   asset	   as	   we	   could	   generate	   CD34+	   cells	   from	   ESC	   and	   then	   apply	   the	  CD34+	  differentiation	  protocol.	  As	  the	  CD34+-­‐derived	  reticulocytes	  have	  shown	  their	  permissiveness	   to	  P.	  vivax	   and	   seemed	   to	  be	   the	  most	   suitable	   source	  of	  reticulocyte	   for	   the	   parasite,	   research	   on	   ESC-­‐derived	   reticulocytes	   should	   be	  consider	   a	   priority	   for	   the	   generation	   of	   reticulocytes	   for	   a	   P.	   vivax	   in	   vitro	  culture.	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Future	  perspectives	  
	  During	  my	  thesis,	  we	  focused	  on	  the	  reticulocyte	  production	  in	  order	  to	  provide	  cell	  targets	  to	  sustain	  P.	  vivax	  development	  in	  vitro.	  Although	  we	  made	  progress	  in	   finding	   cell	   populations	   that	   can	   produce	   a	   large	   numbers	   of	   reticulocytes	  that	  can	  also	  be	  cryopreserved	  and	  later	  invaded	  by	  P.	  vivax,	  the	  parasite	  could	  not	   be	   maintained	   in	   culture	   for	   more	   than	   one	   schizogony	   cycle.	   We	   also	  demonstrated	   that	  HbF	  did	   not	   influence	   the	   development	   of	  P.	   falciparum	   or	  the	  invasion	  of	  P.	  vivax.	  The	  1st	  schizogony	  of	  P.	  vivax	  was	  also	  possible	  for	  rare	  parasites	  and	  we	  could	  hypothesis	  that	  HbF	  would	  not	  have	  such	  an	  important	  influence	  on	  the	  intra-­‐reticulocyte	  development	  of	  P.	  vivax.	  Future	  studies	  should	  focus	  on	  differences	  between	  infection	  occurring	  in	  vivo	  vs.	  
in	   vitro	   to	   identify	   the	   essential	   proteins	   or	   pathways	   that	   may	   explain	   the	  inability	   of	  P.	   vivax	   to	   develop	   further	   in	   vitro.	   Metabolomics	   studies	   could	   be	  used	  to	  identify	  those	  factors	  as	  previously	  shown	  for	  P.	  falciparum	  [106].	  If	  such	  differences	   could	   be	   identified,	   they	   could	   be	   tested	   to	   improve	   the	   in	   vitro	  conditions	  of	  the	  P.	  vivax	  culture.	  	  	  	  The	  preliminary	  observations	  on	  the	  preference	  of	  P.	  vivax	  to	  invade	  immature	  reticulocytes	   also	   need	   to	   be	   confirmed.	   For	   this,	   a	   comparison	   of	   P.	   vivax	  invasion	   rates	   between	   reticulocytes	   harvested	   after	   14,	   15	   and	   16	   days	   of	  differentiation	  would	  be	  useful.	  The	  level	  expression	  of	  CD71	  will	  be	  monitored	  by	   FACS	   to	   discriminate	   the	   immature	   from	   the	   old	   reticulocytes.	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  Vitae	  	  




2010-­‐Now:	  Institute	  of	  Tropical	  Medicine,	  Antwerp	  (Belgium)	  	  
Topic:	  Culture	  of	  Plasmodium	  Vivax	  
	  →	  Production	  of	  reticulocytes	  from	  Hematopoietic	  Stem	  Cells,	  P.	  vivax	  invasion	  tests	  
	  
2009:	  6	  month	  as	  Visiting	  Scientist	  at	  the	  New	  York	  Blood	  Center	  (Lindsay	  F	  Kimball	  Research	  Institute)	  in	  collaboration	  with	  the	  Evandro	  Chagas	  Institute	  in	  Belem	  (Brazil)	  	  
Topic:	  Invasion	  Profile	  of	  Plasmodium	  falciparum	  field	  Isolates	  in	  Red	  Blood	  
Cells.	  	  →	  Project	  management,	  coordination	  between	  several	  teams,	  training	  of	  a	  master	  student	  and	  local	  team	  to	  biological	  techniques,	  Pf	  culture,	  invasion	  tests,	  RBC	  enzyme	  treatments	  	  	  	  
2006-­‐2008:	  Research	  assistant	  (international	  volunteer	  for	  French	  cooperation)	  at	  the	  “Centre	  International	  de	  Recherches	  Médicales	  de	  Franceville	  (CIRMF)”	  Gabon	  (Central	  Africa).	   	  	  	  Topic:	  Analysis	  of	  immune	  response	  against	  putatives	  apoptogenic	  recombinant	  
antigens	  of	  P.	  Falciparum	   	  →	  Project	  management,	  Student	  training,	  stock	  management,	  biological	  technical	  advises	  to	  center	  researcher	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2005:	  6	  month	  (master	  thesis)	  at	  the	  	  	  «	  Commissariat	  à	  l’Energie	  Atomique	  (CEA)/	  Inserm	  U566	  »	  Fontenay	  aux	  Roses	  	  	  	  
Topic:	  Oocyte	  maturation	  in	  vitro	  and	  apoptotic	  modelling.	  
	  →	  Work	  on	  mice	  oocytes,	  Oocyte	  maturation	  from	  Mouse	  ovarian	  follicles,	  confocal	  and	  electronic	  microscopy	  	  
	  
2004:	  2	  month	  (1st	  year	  master)	  at	  the	  “Centre	  de	  Biophysique	  Moléculaire”	  (CNRS,	  Orléans)	  	   	  Topic:	  Directed	  mutagenesis	  of	  Human	  Phosphatidylethanolamine	  Biding	  
Protein	  (PEBP).	  
EDUCATION	  	  








2003:	   Bachelor’s	  Degree	  of	  Cellular	  Biology	  and	  Physiology	  (Orléans	  University,	  France)	  	  
	  
SCIENTIFIC	  ACHIEVEMENTS	  	  
Peer-­‐reviewed	  journal	  publications:	  
	  
Florian	   Noulin,	   Javed	   Karim	   Manesia,	   Anna	   Rosanas-­‐Urgell,	   Annette	   Erhart,	  Céline	   Borlon,	   Jan	   Van	   Den	   Abbeele,	   Umberto	   d’Alessandro,	   Catherine	   M.	  Verfaillie.	   Influence	   of	   CD34+	   source	   and	   hemoglobin	   type	   for	   culturing	  
Plasmodium	  parasites.	  Under	  review	  	  
Noulin	   F,	  Borlon	  C,	  Van	  Den	  Abbeele	   J,	  D'Alessandro	  U,	  Erhart	  A.	  1912-­‐2012:	  A	  
century	  of	  research	  on	  Plasmodium	  Vivax	  in-­‐vitro	  culture.	  Trends	  Parasitol.	  2013	  Apr	  24.	  pii:	  S1471-­‐4922(13)00056-­‐1.	  doi:	  10.1016/j.pt.2013.03.012.	  
Year	  1:	  	  	   	  
Ø Molecular	  biology	  	  
Ø Genetic	  
Ø Neuroscience	  
Ø Animal	  physiology	  	  
Ø Physiopathology	  	  
Year	  2:	  
Ø Cell	  culture	  
Ø Immunology	  
Ø Instrumentation	  
Ø Bio	  imagery	  
Ø Gene	  therapy	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Noulin	   F,	   Borlon	   C,	   van	   den	   Eede	   P,	   Boel	   L,	   Verfaillie	   CM,	   et	   al.	   (2012)	  Cryopreserved	   Reticulocytes	   Derived	   from	   Hematopoietic	   Stem	   Cells	   Can	   Be	  Invaded	  by	  Cryopreserved	  Plasmodium	  vivax	  Isolates.	  PloS	  one	  7:	  e40798.	  	  Ulrick	   Bisvigou	   ESZ-­‐E,	   Florian	   Noulin,	   Rafika	   Zatra,	   Ludovic	   Mevono,	   Jean-­‐Bernard	  Lékana-­‐Douki,	  Dominique	  Mazier,	  Frédérick	  Gay	  and	  Fousseyni	  S.	  Touré	  Ndouo	   (2012)	   Antigenicity	   of	   Synthetic	   Peptides	   Derived	   from	   Plasmodium	  Apoptosis-­‐Linked	  Pathogenicity	  Factors.	  Journal	  of	  Life	  Sciences	  6:	  587-­‐594.	  	  Ouwe-­‐Missi-­‐Oukem-­‐Boyer	   O,	   Toure	   Ndouo	   FS,	   Ollomo	   B,	   Mezui-­‐Me-­‐Ndong	   J,	  
Noulin	  F,	  Lachard	  I,	  Ndong	  Atome	  G.R,	  Makuwa	  M,	  Roques	  P,	  Branger	  M,	  Preux	  PM,	  Mazier	  D,	  Bisser	  S.	  Hepatitis	  C	  Virus	  Infection	  May	  Lead	  to	  Slower	  Emergence	  
of	  P.	  falciparum	  in	  Blood.	  PLoS	  One.	  2011	  Jan	  10;6(1)	  	  	  
Conference	  presentations:	  	  Mai	  2013:	  Poster	  presentation	  at	  the	  vivax	  conference	  in	  Barcelona:	  “Influence	  of	  Hematopoietic	   stem	   cell	   (HSC)	   source	   to	   produce	   reticulocytes	   for	   the	   in	   vitro	  culture	  of	  Plasmodium	  vivax”	  	  August	   2012:	   Poster	   presentation	   at	   the	   12th	   ISEH	   meeting	   (Amsterdam):	  “Reticulocytes	   derived	   from	   hematopoietic	   stem	   cells	   can	   be	   successfully	  cryopreserved	  and	  later	  used	  for	  P.	  vivax	  invasion	  tests”	  	  December	  2011:	  Poster	  presentation	  at	  the	  60th	  ASTMH	  meeting	  (Philadelphia):	  “Reticulocytes	   derived	   from	   hematopoietic	   stem	   cells	   can	   be	   successfully	  cryopreserved	  and	  later	  used	  for	  P.	  vivax	  invasion	  tests”	  	  
